Professional Documents
Culture Documents
AEAAAA3
AEAAAA3
Biomedical
Engineering
Research and
Application
2013 Edition
ISBN: 978-1-490-10871-1
iii
Table of Contents
1 Biomedical Engineering . . . . . . . . . . . . . . . . . . 1
3 Biomedicine . . . . . . . . . . . . . . . . . . . . . . . . . . 895
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1120
iv
Introduction
v
Chapter 1
Biomedical Engineering
1
CHAPTER 1 BIOMEDICAL ENGINEERING
2
CHAPTER 1 BIOMEDICAL ENGINEERING
3
CHAPTER 1 BIOMEDICAL ENGINEERING
4
CHAPTER 1 BIOMEDICAL ENGINEERING
5
CHAPTER 1 BIOMEDICAL ENGINEERING
6
CHAPTER 1 BIOMEDICAL ENGINEERING
7
CHAPTER 1 BIOMEDICAL ENGINEERING
8
CHAPTER 1 BIOMEDICAL ENGINEERING
9
CHAPTER 1 BIOMEDICAL ENGINEERING
10
CHAPTER 1 BIOMEDICAL ENGINEERING
11
CHAPTER 1 BIOMEDICAL ENGINEERING
12
CHAPTER 1 BIOMEDICAL ENGINEERING
13
CHAPTER 1 BIOMEDICAL ENGINEERING
14
CHAPTER 1 BIOMEDICAL ENGINEERING
15
CHAPTER 1 BIOMEDICAL ENGINEERING
16
CHAPTER 1 BIOMEDICAL ENGINEERING
17
CHAPTER 1 BIOMEDICAL ENGINEERING
18
CHAPTER 1 BIOMEDICAL ENGINEERING
19
CHAPTER 1 BIOMEDICAL ENGINEERING
20
CHAPTER 1 BIOMEDICAL ENGINEERING
21
CHAPTER 1 BIOMEDICAL ENGINEERING
22
CHAPTER 1 BIOMEDICAL ENGINEERING
23
CHAPTER 1 BIOMEDICAL ENGINEERING
24
CHAPTER 1 BIOMEDICAL ENGINEERING
25
CHAPTER 1 BIOMEDICAL ENGINEERING
26
CHAPTER 1 BIOMEDICAL ENGINEERING
27
CHAPTER 1 BIOMEDICAL ENGINEERING
28
CHAPTER 1 BIOMEDICAL ENGINEERING
29
CHAPTER 1 BIOMEDICAL ENGINEERING
30
CHAPTER 1 BIOMEDICAL ENGINEERING
stated, “This study investigated the use of center of mass (COM) accel-
eration feedback for improving performance of a functional neuromus-
cular stimulation control system to restore standing function to a sub-
ject with complete, thoracic-level spinal cord injury. The approach for
linearly relating changes in muscle stimulation to changes in COM ac-
celeration was verified experimentally and subsequently produced data
to create an input-output map driven by sensor feedback.”
The news reporters obtained a quote from the research from Vet-
erans Affairs Medical Center, “The feedback gains were systematically
tuned to reduce upper extremity (UE) loads applied to an instrumented
support device while resisting external postural disturbances. Total
body COM acceleration was accurately estimated (>89% variance
explained) using 3-D outputs of two accelerometers mounted on the
pelvis and torso. Compared to constant muscle stimulation employed
clinically, feedback control of stimulation reduced UE loading by 33%.
COM acceleration feedback is advantageous in constructing a standing
neuroprosthesis since it provides the basis for a comprehensive control
synergy about a global, dynamic variable and requiresminimal instru-
mentation.”
According to the news reporters, the research concluded: “Future
work should include tuning and testing the feedback control system dur-
ing functional reaching activity that is more indicative of activities of
daily living.”
For more information on this research see: Center of Mass Accelera-
tion Feedback Control of Standing Balance by Functional Neuromuscu-
lar Stimulation Against External Postural Perturbations. IEEE Trans-
actions on Biomedical Engineering, 2013;60(1):10-19. IEEE Trans-
actions on Biomedical Engineering can be contacted at: Ieee-Inst
Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ
08855-4141, USA. (Institute of Electrical and Electronics Engineers
- http://www.ieee.org/; IEEE Transactions on Biomedical Engi-
neering - http://ieeexplore.ieee.org/xpl/RecentIssue.jsp?
punumber=10)
Our news correspondents report that additional information may
be obtained by contacting R. Nataraj, Cleveland Louis Stokes Vet Af-
fairs Med Center, Mot Study Lab, Cleveland, OH 44106, United States.
(2013 Feb 13)
31
CHAPTER 1 BIOMEDICAL ENGINEERING
32
CHAPTER 1 BIOMEDICAL ENGINEERING
33
CHAPTER 1 BIOMEDICAL ENGINEERING
34
CHAPTER 1 BIOMEDICAL ENGINEERING
35
CHAPTER 1 BIOMEDICAL ENGINEERING
36
CHAPTER 1 BIOMEDICAL ENGINEERING
has been introduced, and various studies using the U-ECG device are
in progress. Because it uses two electrodes-within a small torso sur-
face area, the design of the U-ECG must be suitable for detecting ECG
signals.”
Our news journalists obtained a quote from the research from Sam-
sung Electronics, “Using a 3-D model of cardiac electrophysiology, we
have developed a simulation method for identifying the optimal place-
ment of U-ECG electrodes on the torso surface. We simulated the heart-
torso model to obtain a body surface potential map and ECG waveforms,
which were compared with the empirical data. Using this model, we de-
termined the optimal placement of the two U-ECG electrodes, spaced 5
cm apart, for detecting the P, R, and T waves. The ECG data, obtained
using the optimal U-ECG placement for a specific wave, showed a clear
shape for the target wave, but equivocal shapes for the other waves.”
According to the news editors, the research concluded: “The present
study provides an efficient simulation method to identify the optimal at-
tachment position and direction of the U-ECG electrodes on the surface
of the torso.”
For more information on this research see: Patient-Specific Identi-
fication of Optimal Ubiquitous Electrocardiogram (U-ECG) Placement
Using a Three-Dimensional Model of Cardiac Electrophysiology. IEEE
Transactions on Biomedical Engineering, 2013;60(2):245-249. IEEE
Transactions on Biomedical Engineering can be contacted at: Ieee-Inst
Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ
08855-4141, USA. (Institute of Electrical and Electronics Engineers
- http://www.ieee.org/; IEEE Transactions on Biomedical Engi-
neering - http://ieeexplore.ieee.org/xpl/RecentIssue.jsp?
punumber=10)
Our news journalists report that additional information may be ob-
tained by contacting K.M. Lim, Samsung Elect, Yongin, Gyunggi Do,
South Korea. (2013 Feb 11)
37
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
State University of Campinas, “Here, we propose a stimulatory ap-
proach, namely rapidly switching multidirectional stimulation (RSMS),
in which stimuli are delivered in three directions within the electric re-
fractory period. In populations of randomly oriented isolated rat car-
diomyocytes, RSMS doubled the percentage of cells excited by near-
threshold E (P < 0.001), which was more than the increase in re-
cruitment in a single direction achieved by doubling E intensity. This
effect was similar for monophasic and biphasic pulses, but for the latter,
a given percent recruitment was obtained with 20-30% lower E inten-
sity (P < 0.01), so that RSMS with biphasic pulses allowed at least
60% reduction of E intensity for recruitment of >70% of the cells.”
According to the news editors, the research concluded: “RSMS can
be applied to improve stimulation efficiency in experiments with iso-
lated cardiac myocytes, and may be a promising alternative for decreas-
ing shock intensity requirements for cardioversion and defibrillation.”
For more information on this research see: Greater Cardiac Cell
Excitation Efficiency With Rapidly Switching Multidirectional Elec-
trical Stimulation. IEEE Transactions on Biomedical Engineering,
2013;60(1):28-34. IEEE Transactions on Biomedical Engineering can
be contacted at: Ieee-Inst Electrical Electronics Engineers Inc, 445
Hoes Lane, Piscataway, NJ 08855-4141, USA. (Institute of Electrical
and Electronics Engineers - http://www.ieee.org/; IEEE Transac-
tions on Biomedical Engineering - http://ieeexplore.ieee.org/
xpl/RecentIssue.jsp?punumber=10)
Our news journalists report that additional information may be ob-
tained by contacting A.V.S. Fonseca, Campinas State University, Dept.
of Biomed Engn, Sch Elect & Comp Engn, BR-13083881 Campinas, SP,
Brazil. (2013 Feb 11)
38
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research from the Uni-
versity of Leicester, “We report here a rapid, sensitive and specific hy-
drophilic interaction liquid chromatographytandem mass spectrome-
try method for the direct and simultaneous quantitation of ALA and
PBG in serum or plasma following simple protein precipitation with
acetonitrile and centrifugation prior to injection. ALA and PBG were
detected using selected reaction monitoring mode, following positive at-
mospheric pressure chemical ionization. Calibration was linear from
0.05 to 50?mu mol/L for ALA and PBG. For both analytes, impreci-
sion (relative standard deviation) was <13% and accuracy (percent-
age nominal concentrations) was between 92 and 107%.”
According to the news editors, the research concluded: “The method
was successfully applied to the measurement of ALA and PBG in serum
or plasma samples for the screening, biochemical diagnosis and treat-
ment monitoring of patients with acute hepatic porphyrias.”
For more information on this research see: Direct and simul-
taneous quantitation of 5-aminolaevulinic acid and porphobilino-
gen in human serum or plasma by hydrophilic interaction liq-
uid chromatography-atmospheric pressure chemical ionization/tandem
mass spectrometry. Biomedical Chromatography, 2013;27(2):267-
272. Biomedical Chromatography can be contacted at: Wiley-
Blackwell, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-
Blackwell - http://www.wiley.com/; Biomedical Chromatography
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-0801)
The news editors report that additional information may be obtained
by contacting C.M. Benton, University of Leicester, RKCSB, Leicester
LE2 7LX, Leics, United Kingdom. (2013 Feb 11)
39
CHAPTER 1 BIOMEDICAL ENGINEERING
40
CHAPTER 1 BIOMEDICAL ENGINEERING
polydimethyl siloxane (PDMS) having four inlets and one outlet with a
200 m wide, 250 m deep, and 100 mm long microchannel.”
The news reporters obtained a quote from the research from Kyung-
pook National University, “Ag(+) was used as a chemiluminogenic oxi-
dant in this CL reaction which oxidized luminol to produce strong CL
signal in the presence of AuNPs. Luminol reacted with AgNO(3) under
the catalysis of AuNPs to produce luminol radicals which reacted with
dissolved oxygen and emitted CL light. The proposed CL system was
applied to determine the amount of VB12 in VB12 tablets and multivi-
tamin. Under the optimum conditions, the CL intensity of the system
was increased with the concentration of VB12 in the range of 0.25-100
ng mL(-1) with the correlation coefficient of 0.9982. The limit of detec-
tion was found to be 0.04 ng mL(-1) with the relative standard deviation
of 1.56 % for five replicate determinations of 25 ng mL(-1) of VB12.”
According to the news reporters, the research concluded: “The CL
reaction mechanism was demonstrated by UV-visible spectra and CL
emission spectra.”
For more information on this research see: Chemiluminescence
microfluidic system of gold nanoparticles enhanced luminol-silver ni-
trate for the determination of vitamin B12. Biomedical Microde-
vices, 2013;15(1):195-202. Biomedical Microdevices can be con-
tacted at: Springer, 233 Spring Street, New York, NY 10013, USA.
(Springer - www.springer.com; Biomedical Microdevices - http://
www.springerlink.com/content/1387-2176/)
Our news correspondents report that additional information may be
obtained by contacting M. Kamruzzaman, Dept. of Chemistry, Kyung-
pook National University, Daegu, 702-701, South Korea.
The publisher of the journal Biomedical Microdevices can be con-
tacted at: Springer, 233 Spring Street, New York, NY 10013, USA.
(2013 Feb 08)
41
CHAPTER 1 BIOMEDICAL ENGINEERING
42
CHAPTER 1 BIOMEDICAL ENGINEERING
43
CHAPTER 1 BIOMEDICAL ENGINEERING
44
CHAPTER 1 BIOMEDICAL ENGINEERING
45
CHAPTER 1 BIOMEDICAL ENGINEERING
46
CHAPTER 1 BIOMEDICAL ENGINEERING
47
CHAPTER 1 BIOMEDICAL ENGINEERING
48
CHAPTER 1 BIOMEDICAL ENGINEERING
49
CHAPTER 1 BIOMEDICAL ENGINEERING
50
CHAPTER 1 BIOMEDICAL ENGINEERING
51
CHAPTER 1 BIOMEDICAL ENGINEERING
52
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from Rice
University, “This study explored the fabrication of trilayer hydrogel
quasilaminates. A novel sandwich method was devised to create quasil-
aminates with layers of varying stiffnesses. The trilayer structure was
comprised of two ‘stiff’ outer layers and one ‘soft’ inner layer. Tensile
testing of bilayer quasilaminates demonstrated that these scaffolds do
not fail at the interface. Flexural testing showed that the bending mod-
ulus of acellular quasilaminates fell between the bending moduli of the
‘stiff’ and ‘soft’ hydrogel layers. The bending modulus and swelling of
trilayer scaffolds with the same formulations were not significantly dif-
ferent than single layer gels of the same formulation. The encapsula-
tion of cells and the addition of phenol red within the hydrogel layers
decreased bending modulus of the trilayer scaffolds.”
According to the news editors, the research concluded: “The data
presented demonstrates that this fabrication method can make quasil-
aminates with robust interfaces, integrating layers of different mechan-
ical properties and biofunctionalization, and thus forming the founda-
tion for a multilaminate scaffold that more accurately represents native
tissue.”
For more information on this research see: Fabrication and me-
chanical evaluation of anatomically-inspired quasilaminate hydrogel
structures with layer-specific formulations. Annals of Biomedical En-
gineering, 2013;41(2):398-407. (Springer - www.springer.com; An-
nals of Biomedical Engineering - http://www.springerlink.com/
content/0090-6964/)
The news correspondents report that additional information may be
obtained from H. Tseng, Dept. of Bioengineering, Rice University, PO
Box 1892, MS 142, Houston, TX, 77251-1892, United States. (2013 Feb
06)
53
CHAPTER 1 BIOMEDICAL ENGINEERING
54
CHAPTER 1 BIOMEDICAL ENGINEERING
55
CHAPTER 1 BIOMEDICAL ENGINEERING
56
CHAPTER 1 BIOMEDICAL ENGINEERING
57
CHAPTER 1 BIOMEDICAL ENGINEERING
58
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from the Uni-
versity of California, “This approach retains all the advantages of bio-
logical scaffolds while developing a strong extracellular matrix back-
bone to withstand dynamic loading. This study aims to test the inflam-
matory response of hybrid tissue-engineered leaflets based on charac-
terizing the activation of macrophage cells cultured on the surfaces of
the tissue construct. The results indicate that integration of biological
layers around a metal mesh core-regardless of its type-may reduce the
evoked inflammatory responses by THP-1 monocyte-like cells.”
According to the news reporters, the research concluded: “This ob-
servation implies that masking a metal implant within a tissue con-
struct prior to implantation can hide it from the immune system and
may improve the implant’s biocompatibility.”
For more information on this research see: Inflammatory re-
sponse assessment of a hybrid tissue-engineered heart valve leaflet.
Annals of Biomedical Engineering, 2013;41(2):316-26. (Springer -
www.springer.com; Annals of Biomedical Engineering - http://www.
springerlink.com/content/0090-6964/)
Our news correspondents report that additional information may be
obtained by contacting S.H. Alavi, The Edwards Lifesciences Center for
Advanced Cardiovascular Technology, Dept. of Biomedical Engineer-
ing, University of California, Irvine, CA, 92697, United States. (2013
Feb 06)
59
CHAPTER 1 BIOMEDICAL ENGINEERING
microvessels within a Petri dish over a large volume without any me-
chanical scanning. This on-chip method uses partially coherent illumi-
nation and a CMOS sensor to record in-line holographic images of the
sample. For digital reconstruction of the measured holograms, we im-
plement a multiheight phase recovery method to obtain phase images of
capillary morphogenesis over a large FOV (24 mm2) with ? 1.5 m spatial
resolution. On average, measured capillary length in our method was
within approximately 2% of lengths measured using a 10 x microscope
objective.”
According to the news editors, the research concluded: “These re-
sults suggest lens-free on-chip imaging is a useful toolset for high-
throughput monitoring and quantitative analysis of microvascular 3-D
networks.”
For more information on this research see: Lens-free computa-
tional imaging of capillary morphogenesis within three-dimensional
substrates. Journal of Biomedical Optics, 2012;17(12):126018.
The news correspondents report that additional information may be
obtained from J. Weidling, University of California Irvine, Biomedical
Engineering Department, Irvine, California, United States. (2013 Feb
06)
60
CHAPTER 1 BIOMEDICAL ENGINEERING
61
CHAPTER 1 BIOMEDICAL ENGINEERING
Clarke’s error grid analysis on the as-obtained glycemic data has indi-
cated that all of the measured glucose readings fell in the desired Zones
A & B and none fell in the erroneous Zones C, D and E.”
According to the news editors, the research concluded: “Such repro-
ducible operation of the transcutaneous sensor system, together with
low power (140 W) consumption and capability for current-to-frequency
conversion renders this a versatile platform for continuous glucose mon-
itoring and other biomedical sensing devices.”
For more information on this research see: A miniaturized tran-
scutaneous system for continuous glucose monitoring. Biomedical Mi-
crodevices, 2013;15(1):151-60. Biomedical Microdevices can be con-
tacted at: Springer, 233 Spring Street, New York, NY 10013, USA.
(Springer - www.springer.com; Biomedical Microdevices - http://
www.springerlink.com/content/1387-2176/)
The news editors report that additional information may be obtained
by contacting R.A. Croce, Electrical & Computer Engineering, Univer-
sity of Connecticut, Storrs, CT, 06269, United States.
Publisher contact information for the journal Biomedical Microde-
vices is: Springer, 233 Spring Street, New York, NY 10013, USA. (2013
Feb 06)
62
CHAPTER 1 BIOMEDICAL ENGINEERING
63
CHAPTER 1 BIOMEDICAL ENGINEERING
64
CHAPTER 1 BIOMEDICAL ENGINEERING
65
CHAPTER 1 BIOMEDICAL ENGINEERING
66
CHAPTER 1 BIOMEDICAL ENGINEERING
67
CHAPTER 1 BIOMEDICAL ENGINEERING
68
CHAPTER 1 BIOMEDICAL ENGINEERING
69
CHAPTER 1 BIOMEDICAL ENGINEERING
70
CHAPTER 1 BIOMEDICAL ENGINEERING
71
CHAPTER 1 BIOMEDICAL ENGINEERING
72
CHAPTER 1 BIOMEDICAL ENGINEERING
73
CHAPTER 1 BIOMEDICAL ENGINEERING
74
CHAPTER 1 BIOMEDICAL ENGINEERING
75
CHAPTER 1 BIOMEDICAL ENGINEERING
76
CHAPTER 1 BIOMEDICAL ENGINEERING
77
CHAPTER 1 BIOMEDICAL ENGINEERING
(L=5 mm) than for a larger plaque (L=10 mm), and the maximum wall
shear stress is increased by 100%.”
According to the news editors, the research concluded: “Provided
that they are confirmed by experimental investigations, these results
may offer some new perspectives for understanding the vulnerability of
short plaques.”
For more information on this research see: A numerical parametric
study of the mechanical action of pulsatile blood flow onto axisymmetric
stenosed arteries. Medical Engineering & Physics, 2012;34(10):1483-
95. (Elsevier - www.elsevier.com; Medical Engineering & Physics -
http://www.elsevier.com/wps/product/cws_home/30456)
The news editors report that additional information may be obtained
by contacting T. Belzacq, Ecole Nationale Superieure des Mines, Centre
Ingenierie et Sante, CNRS UMR 5146, Saint-Etienne, France. (2013
Feb 01)
78
CHAPTER 1 BIOMEDICAL ENGINEERING
79
CHAPTER 1 BIOMEDICAL ENGINEERING
80
CHAPTER 1 BIOMEDICAL ENGINEERING
81
CHAPTER 1 BIOMEDICAL ENGINEERING
82
CHAPTER 1 BIOMEDICAL ENGINEERING
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-0801)
Our news journalists report that additional information may be ob-
tained by contacting P. Deshpande, Syngene International Limited Bio-
con Park, Jigani Link Road, Bangalore, 560099, India. (2013 Jan 30)
83
CHAPTER 1 BIOMEDICAL ENGINEERING
84
CHAPTER 1 BIOMEDICAL ENGINEERING
85
CHAPTER 1 BIOMEDICAL ENGINEERING
86
CHAPTER 1 BIOMEDICAL ENGINEERING
87
CHAPTER 1 BIOMEDICAL ENGINEERING
inner ear cannot be biopsied today without destroying hearing, and in-
tracochlear cells have not been imaged with resolution sufficient to es-
tablish diagnosis. Intracochlear imaging has been technologically chal-
lenging because of the cochlea’s small size and encasement in bone.”
Our news journalists obtained a quote from the research from the
School of Engineering, “We report, for the first time, imaging of the
mouse cochlea in situ without exogenous dyes, through a membranous
round window, using a near-infrared femtosecond laser as the excita-
tion and endogenous two-photon excitation fluorescence (TPEF) and
second harmonic generation as the contrast mechanisms. We find that
TPEF exhibits strong contrast allowing cellular, and even subcellular
resolution, and detection of specific, noise-induced pathologic changes.”
According to the news editors, the research concluded: “Our re-
sults demonstrate that the round window provides a useful access to
the cochlea through the middle ear, and they motivate future develop-
ment of a new and efficient diagnostic tool based on two-photon micro-
endoscopy.”
For more information on this research see: Two-photon microscopy
of the mouse cochlea in situ for cellular diagnosis. Journal of Biomedi-
cal Optics, 2013;18(3):31104.
Our news journalists report that additional information may be ob-
tained by contacting X. Yang, Ecole Polytechnique Federale de Lau-
sanne, School of Engineering, Optics Laboratory, BM 4107, Station 17,
CH-1015 Lausanne, Switzerland. (2013 Jan 30)
88
CHAPTER 1 BIOMEDICAL ENGINEERING
89
CHAPTER 1 BIOMEDICAL ENGINEERING
90
CHAPTER 1 BIOMEDICAL ENGINEERING
91
CHAPTER 1 BIOMEDICAL ENGINEERING
92
CHAPTER 1 BIOMEDICAL ENGINEERING
93
CHAPTER 1 BIOMEDICAL ENGINEERING
94
CHAPTER 1 BIOMEDICAL ENGINEERING
95
CHAPTER 1 BIOMEDICAL ENGINEERING
96
CHAPTER 1 BIOMEDICAL ENGINEERING
97
CHAPTER 1 BIOMEDICAL ENGINEERING
98
CHAPTER 1 BIOMEDICAL ENGINEERING
99
CHAPTER 1 BIOMEDICAL ENGINEERING
100
CHAPTER 1 BIOMEDICAL ENGINEERING
101
CHAPTER 1 BIOMEDICAL ENGINEERING
102
CHAPTER 1 BIOMEDICAL ENGINEERING
103
CHAPTER 1 BIOMEDICAL ENGINEERING
104
CHAPTER 1 BIOMEDICAL ENGINEERING
105
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from Na-
tional Central University, “During RSA calculation, the implants are
often reversely scanned and input in the form of meshes to estimate
the outline error between prosthetic projection and roentgen images.
However, the execution efficiency of the RSA iterative calculation may
limit its clinical practicability, and one reason for inefficiency may be
very large number of meshes in the model. This study uses two meth-
ods of mesh manipulation to improve the execution efficiency of RSA
calculation. The first is to simplify the model meshes and the other is
to segment and delete the meshes of insignificant regions. An index
(i.e. critical percentage) of an optimal element number is defined as
the trade-off between execution efficiency and result accuracy. The pre-
dicted results are numerically validated by total knee prosthetic system.
The outcome shows that the optimal strategy of the mesh manipulation
is simplification and followed by segmentation. On average, the ele-
ment number can even be reduced to 1% of the original models. After
the mesh manipulation, the execution efficiency can be increased about
75% without compromising the accuracy of the predicted RSA results
(the increment of rotation and translation error: 0.06° and 0.02
mm).”
According to the news editors, the research concluded: “Prosthetic
models should be manipulated by simplification and segmentation
methods prior to the RSA calculation to increase the execution efficiency
and then to improve clinical applicability of the RSA method.”
For more information on this research see: Improved execution effi-
ciency of model-based roentgen stereophotogrammetric analysis: sim-
plification and segmentation of model meshes. Computer Methods In
Biomechanics and Biomedical Engineering, 2012;15(12):1347-57.
The news correspondents report that additional information may be
obtained from C.B. Syu, Dept. of Mechanical Engineering, National
Central University, Taoyuan, Taiwan. (2013 Jan 23)
106
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from Na-
tional University, “Also the strain and the density field are obtained
inside each element, at Gauss points or at the nodes of the mesh. A
square plate with 1.00 m of side subjected to non-uniform pressure is
simulated with two meshes of quadrilateral element with size [Formula:
see text] and [Formula: see text] m. Two increments time size: [For-
mula: see text] and [Formula: see text] days are used. The results show
that Euler, Heun and Runge-Kutta’s methods correctly approached the
problem of bone remodelling and that there were no appreciable dif-
ferences in the patterns obtained by the mesh and time step used. In
contrast, using an element-based approach and node-based approach,
substantial differences were produced in bone remodelling density pat-
tern. ‘Chess board’ type discontinuities were found in the element ap-
proach near the applied pressure area, as were well-defined columns
away from this. The node-based approach showed continuity in density
distribution. These patterns were well represented by the methods for
resolving the density equation.”
According to the news reporters, the research concluded: “This study
concluded that any method of time integration could be used for these
meshes and time steps size.”
For more information on this research see: Comparative analysis of
numerical integration schemes of density equation for a computational
model of bone remodelling. Computer Methods In Biomechanics and
Biomedical Engineering, 2012;15(11):1189-96.
Our news correspondents report that additional information may be
obtained by contacting D.A. Garzon-Alvarado, Group of Mathematical
Modeling and Numerical Methods GNUM-UN, National University of
Colombia, Bogota, Colombia. (2013 Jan 23)
107
CHAPTER 1 BIOMEDICAL ENGINEERING
108
CHAPTER 1 BIOMEDICAL ENGINEERING
109
CHAPTER 1 BIOMEDICAL ENGINEERING
110
CHAPTER 1 BIOMEDICAL ENGINEERING
111
CHAPTER 1 BIOMEDICAL ENGINEERING
112
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research from the Uni-
versity of Warsaw, “At present, there is no experimental data for these
elastic constants C (ijkl) for comparison. Besides the elastic constants,
we also present the calculated macroscopic mechanical parameters,
namely the bulk modulus (K), the shear modulus (G) and Young’s mod-
ulus (E). The values of these moduli are found to be in good agreement
with available experimental data. Our results imply that the mechani-
cal stability of struvite is limited by the shear modulus, G.”
According to the news editors, the research concluded: “The study
also explores the energy-band structure to understand the obtained val-
ues of the elastic constants.”
For more information on this research see: Ab initio predictions of
structural and elastic properties of struvite: contribution to urinary
stone research. Computer Methods In Biomechanics and Biomedical
Engineering, 2012;15(12):1329-36.
The news editors report that additional information may be obtained
by contacting J. Piechota, Interdisciplinary Centre for Materials Mod-
elling, University of Warsaw, ul Pawinskiego 5a, 02-106 Warszawa,
Poland. (2013 Jan 23)
113
CHAPTER 1 BIOMEDICAL ENGINEERING
114
CHAPTER 1 BIOMEDICAL ENGINEERING
highest in the pons, consistent with the known biochemistry of these re-
gions.”
According to the news reporters, the research concluded: “These
findings demonstrate that single-voxel (1)H MRS at ultra-high field
can reliably detect region-specific neurochemical patterns in the human
brain, and has the potential to objectively detect alterations in neuro-
chemical profiles associated with neurological diseases.”
For more information on this research see: Regional neurochem-
ical profiles in the human brain measured by ?H MRS at 7 T us-
ing local B1 shimming. Nmr In Biomedicine, 2012;25(1):152-60.
(Wiley-Blackwell - http://www.wiley.com/; Nmr In Biomedicine
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-1492)
Our news correspondents report that additional information may be
obtained by contacting U.E. Emir, Center for Magnetic Resonance Re-
search, Dept. of Radiology, School of Medicine, University of Minnesota,
Minneapolis, MN 55455, United States. (2013 Jan 22)
115
CHAPTER 1 BIOMEDICAL ENGINEERING
116
CHAPTER 1 BIOMEDICAL ENGINEERING
117
CHAPTER 1 BIOMEDICAL ENGINEERING
118
CHAPTER 1 BIOMEDICAL ENGINEERING
119
CHAPTER 1 BIOMEDICAL ENGINEERING
120
CHAPTER 1 BIOMEDICAL ENGINEERING
121
CHAPTER 1 BIOMEDICAL ENGINEERING
122
CHAPTER 1 BIOMEDICAL ENGINEERING
123
CHAPTER 1 BIOMEDICAL ENGINEERING
124
CHAPTER 1 BIOMEDICAL ENGINEERING
125
CHAPTER 1 BIOMEDICAL ENGINEERING
126
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from the
University of California, “However, estimation of blood related absorp-
tion in skin can be confounded by the strong absorption of melanin in
the epidermis and epidermal thickness and pigmentation varies with
anatomic location, race, gender, and degree of disease progression.
Therefore, a method is desired that decouples the effect of melanin ab-
sorption in the epidermis from blood absorption in the dermis for a large
range of skin types and thicknesses. A previously developed inverse
method based on a neural network forward model was applied to sim-
ulated spatial frequency domain reflectance of skin for multiple wave-
lengths in the near infrared. It is demonstrated that the optical thick-
ness of the epidermis and absorption and reduced scattering coefficients
of the dermis can be determined independently and with minimal cou-
pling. Then, the same inverse method was applied to reflectance mea-
surements from a tissue simulating phantom and in vivo human skin.”
According to the news reporters, the research concluded: “Oxygen
saturation and total hemoglobin concentrations were estimated from
the volar forearms of weakly and strongly pigmented subjects using a
standard homogeneous model and the present two layer model.”
For more information on this research see: In vivo spatial frequency
domain spectroscopy of two layer media. Journal of Biomedical Optics,
2012;17(10):107006.
Our news correspondents report that additional information may be
obtained by contacting D. Yudovsky, Laser Microbeam and Medical Pro-
gram, Beckman Laser Institute, University of California, Irvine, 1002
Health Sciences Road, Irvine, California 92612, United States. (2013
Jan 16)
127
CHAPTER 1 BIOMEDICAL ENGINEERING
available data, while also capturing dominant dynamics and trends ob-
served in ARDS patients. In this study, an existing static recruitment
model is enhanced by considering alveolar distension and implemented
in a novel time-continuous dynamic respiratory mechanics model. The
model was tested for structural identifiability and a hierarchical gra-
dient descent approach was used to fit the model to low-flow test re-
sponses of 12 ARDS patients. Finally, a comprehensive practical iden-
tifiability analysis was performed to evaluate the impact of data qual-
ity on the model parameters. Identified parameter values were physio-
logically plausible and very accurately reproduced the measured pres-
sure responses. Structural identifiability of the model was proven, but
practical identifiability analysis of the results showed a lack of con-
vexity on the error surface indicating that successful parameter iden-
tification is currently not assured in all test sets. Overall, the model
presented is physiologically and clinically relevant, captures ARDS dy-
namics, and uses clinically descriptive parameters. The patient-specific
models show the ability to capture pulmonary dynamics directly rele-
vant to patient condition and clinical guidance.”
According to the news editors, the research concluded: “These char-
acteristics currently cannot be directly measured or established without
such a validated model.”
For more information on this research see: Structural Identifia-
bility and Practical Applicability of an Alveolar Recruitment Model
for ARDS Patients. IEEE Transactions on Biomedical Engineering,
2012;59(12):3396-3404. IEEE Transactions on Biomedical Engineering
can be contacted at: Ieee-Inst Electrical Electronics Engineers Inc, 445
Hoes Lane, Piscataway, NJ 08855-4141, USA. (Institute of Electrical
and Electronics Engineers - http://www.ieee.org/; IEEE Transac-
tions on Biomedical Engineering - http://ieeexplore.ieee.org/
xpl/RecentIssue.jsp?punumber=10)
The news correspondents report that additional information may be
obtained from C. Schranz, University of Canterbury, Dept. of Mech
Engn, Christchurch 8140, New Zealand. (2013 Jan 16)
128
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research from Veterans
General Hospital, “In traditional clinical practice, gaze stabilization ex-
ercise is commonly used to rehabilitate patients. In this study, we es-
tablished a computer-aided vestibular rehabilitation system by coupling
infrared LEDs to an infrared receiver.”
According to the news editors, the research concluded: “This sys-
tem enabled the subjects’ head-turning actions to be quantified, and
the training was performed using vestibular exercise combined with
computer games and interactive video games that simulate daily life
activities.”
For more information on this research see: Interactive wiimote gaze
stabilization exercise training system for patients with vestibular hypo-
function. Journal of Neuroengineering and Rehabilitation, 2012;9():77.
(BioMed Central - http://www.biomedcentral.com/; Journal of
Neuroengineering and Rehabilitation - www.jneuroengrehab.com)
The news editors report that additional information may be obtained
by contacting P.Y. Chen, Dept. of Physical Medicine & Rehabilitation,
Taipei Veterans General Hospital, Taipei, Taiwan. (2013 Jan 16)
129
CHAPTER 1 BIOMEDICAL ENGINEERING
130
CHAPTER 1 BIOMEDICAL ENGINEERING
131
CHAPTER 1 BIOMEDICAL ENGINEERING
Engineering - http://ieeexplore.ieee.org/xpl/RecentIssue.
jsp?punumber=10)
Our news correspondents report that additional information may be
obtained by contacting A. Gopinath, Univ Texas Austin, Dept. of Elect
& Comp Engn, Austin, TX 78712, United States. (2013 Jan 15)
132
CHAPTER 1 BIOMEDICAL ENGINEERING
133
CHAPTER 1 BIOMEDICAL ENGINEERING
134
CHAPTER 1 BIOMEDICAL ENGINEERING
135
CHAPTER 1 BIOMEDICAL ENGINEERING
136
CHAPTER 1 BIOMEDICAL ENGINEERING
137
CHAPTER 1 BIOMEDICAL ENGINEERING
138
CHAPTER 1 BIOMEDICAL ENGINEERING
139
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research from the De-
partment of Vascular Surgery, “In this work, a validation of the numer-
ical model developed in Demanget et al. (J. Mech. Behav. Biomed.
Mater. 5:272-282, 2012) is presented. Two commercially available SGs
were subjected to severe bending tests and their 3D geometries in un-
deformed and bent configurations were imaged from X-ray microtomog-
raphy. Dedicated image processing subroutines were used in order to
extract the stent centerlines from the 3D images. These skeletons in
the undeformed configurations were used to set up SG numerical mod-
els that are subjected to the boundary conditions measured experimen-
tally. Skeletons of imaged and deformed stents were then quantita-
tively compared to the numerical simulations. A good agreement is
found between experiments and simulations.”
According to the news editors, the research concluded: “This val-
idation offers promising perspectives to implementing the numerical
models in a computer-aided tool and simulating the endovascular treat-
ments.”
For more information on this research see: Severe Bending of Two
Aortic Stent-Grafts: An Experimental and Numerical Mechanical Anal-
ysis. Annals of Biomedical Engineering, 2012;40(12):2674-2686. An-
nals of Biomedical Engineering can be contacted at: Springer, 233
Spring St, New York, NY 10013, USA. (Springer - www.springer.com;
Annals of Biomedical Engineering - http://www.springerlink.
com/content/0090-6964/)
The news editors report that additional information may be obtained
by contacting N. Demanget, CHU Hopital Nord, Dept. of Vasc Surg, F-
42055 St Etienne, France. (2013 Jan 09)
140
CHAPTER 1 BIOMEDICAL ENGINEERING
141
CHAPTER 1 BIOMEDICAL ENGINEERING
142
CHAPTER 1 BIOMEDICAL ENGINEERING
polyps by comparing the predicted with the true polyp locations at OC.
The method can accurately predict polyp locations at OC to within +/-
0.5 colonoscope mark (5 cm) for more than 58% of polyps and to within
+/-1 colonoscope mark (10 cm) for more than 96% of polyps, significantly
improving upon previously published methods.”
According to the news editors, the research concluded: “This method
can be easily incorporated into routine OC practice and allow the colono-
scopist to begin the examination by targeting locations of potential
polyps found at CTC.”
For more information on this research see: Predicting Polyp Lo-
cation on Optical Colonoscopy From CT Colonography by Minimal-
Energy Curve Modeling of the Colonoscope Path. IEEE Transactions on
Biomedical Engineering, 2012;59(12):3531-3540. IEEE Transactions
on Biomedical Engineering can be contacted at: Ieee-Inst Electrical
Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ 08855-4141,
USA. (Institute of Electrical and Electronics Engineers - http://www.
ieee.org/; IEEE Transactions on Biomedical Engineering - http:
//ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=10)
The news editors report that additional information may be obtained
by contacting J.M. Liu, National Institutes of Health, Dept. of Radiol
& Imaging Sci, Bethesda, MD 20892, United States. (2013 Jan 09)
143
CHAPTER 1 BIOMEDICAL ENGINEERING
the walking speed and decreasing incorrect footsteps. In the second ex-
periment, we evaluated the Breathwalk-aware system to find a better
feedback mechanism for learning the techniques of Breathwalk while
walking meditation.”
According to the news reporters, the research concluded: “The ex-
perimental results show that the visual-auditory mechanism is a better
multimedia-assisted mechanism while walking meditation than visual
mechanism and auditory mechanism.”
For more information on this research see: Multimedia-Assisted
Breathwalk-Aware System. IEEE Transactions on Biomedical En-
gineering, 2012;59(12):3276-3282. IEEE Transactions on Biomedi-
cal Engineering can be contacted at: Ieee-Inst Electrical Electron-
ics Engineers Inc, 445 Hoes Lane, Piscataway, NJ 08855-4141, USA.
(Institute of Electrical and Electronics Engineers - http://www.
ieee.org/; IEEE Transactions on Biomedical Engineering - http:
//ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=10)
Our news journalists report that additional information may be ob-
tained by contacting M.C. Yu, National Taiwan University, Dept. of
Comp Sci & Informat Engn, Taipei 10617, Taiwan. (2013 Jan 09)
144
CHAPTER 1 BIOMEDICAL ENGINEERING
145
CHAPTER 1 BIOMEDICAL ENGINEERING
146
CHAPTER 1 BIOMEDICAL ENGINEERING
147
CHAPTER 1 BIOMEDICAL ENGINEERING
148
CHAPTER 1 BIOMEDICAL ENGINEERING
149
CHAPTER 1 BIOMEDICAL ENGINEERING
150
CHAPTER 1 BIOMEDICAL ENGINEERING
151
CHAPTER 1 BIOMEDICAL ENGINEERING
compute the model parameters. Toward this end, the rat tail tendon
fascicles are assumed to be incompressible and undergo an isochoric
axisymmetric deformation. A comparison with the experimental data
proves that, unlike the quasi-linear viscoelastic model (Fung, Biome-
chanics: Mechanics of Living Tissues.”
According to the news reporters, the research concluded: “Springer,
New York, 1993) the constitutive law can capture the observed nonlin-
earities in the stress relaxation response of rat tail tendon fascicles.”
For more information on this research see: A Nonlinear Consti-
tutive Model for Stress Relaxation in Ligaments and Tendons. An-
nals of Biomedical Engineering, 2012;40(12):2541-2550. Annals of
Biomedical Engineering can be contacted at: Springer, 233 Spring
St, New York, NY 10013, USA. (Springer - www.springer.com; An-
nals of Biomedical Engineering - http://www.springerlink.com/
content/0090-6964/)
Our news correspondents report that additional information may be
obtained by contacting F.M. Davis, Virginia Technical, Dept. of Engn
Sci & Mech, Mech Soft Biol Syst Lab, Blacksburg, VA 24061, United
States. (2013 Jan 09)
152
CHAPTER 1 BIOMEDICAL ENGINEERING
153
CHAPTER 1 BIOMEDICAL ENGINEERING
154
CHAPTER 1 BIOMEDICAL ENGINEERING
155
CHAPTER 1 BIOMEDICAL ENGINEERING
156
CHAPTER 1 BIOMEDICAL ENGINEERING
157
CHAPTER 1 BIOMEDICAL ENGINEERING
158
CHAPTER 1 BIOMEDICAL ENGINEERING
159
CHAPTER 1 BIOMEDICAL ENGINEERING
160
CHAPTER 1 BIOMEDICAL ENGINEERING
161
CHAPTER 1 BIOMEDICAL ENGINEERING
162
CHAPTER 1 BIOMEDICAL ENGINEERING
163
CHAPTER 1 BIOMEDICAL ENGINEERING
164
CHAPTER 1 BIOMEDICAL ENGINEERING
165
CHAPTER 1 BIOMEDICAL ENGINEERING
166
CHAPTER 1 BIOMEDICAL ENGINEERING
167
CHAPTER 1 BIOMEDICAL ENGINEERING
168
CHAPTER 1 BIOMEDICAL ENGINEERING
169
CHAPTER 1 BIOMEDICAL ENGINEERING
(600 mg/kg i.p.). The antinociceptive effect of EPI was reversed by pre-
treatment with naloxone and glibenclamide, ketanserin, yoimbine, at-
ropine and pindolol, which demonstrates the involvement of opioid re-
ceptors and potassium channels sensitive to ATP, the serotoninergic (re-
ceptor 5HT(1A) and 5HT(2A)), adrenergic (receptor alpha 2) and cholin-
ergic (muscarinic receptor) systems in the activities that were observed.
The effects of EPI, however, were not reversed by pretreatment with
caffeine, L-arginine or ondansetron, which shows that there is no in-
volvement of 5HT(3) receptors or the purinergic and nitrergic systems
in the antinociceptive effect of EPI. In the Open Field and Rotarod test,
EPI had no significant effect, which shows that there was no central
nervous system depressant or muscle relaxant effect on the results.”
According to the news editors, the research concluded: “This study
demonstrates that the antinociceptive activity of EPI in the glutamate
model involves the participation of the opioid system, serotonin, adren-
ergic and cholinergic.”
For more information on this research see: Mechanisms of the
antinociceptive action of (-) Epicatechin obtained from the hydroal-
coholic fraction of Combretum leprosum Mart & Eic in rodents.
Journal of Biomedical Science, 2012;19():1-6. Journal of Biomed-
ical Science can be contacted at: Biomed Central Ltd, 236 Grays
Inn Rd, Floor 6, London WC1X 8HL, England. (BioMed Central -
http://www.biomedcentral.com/; Journal of Biomedical Science -
www.jbiomedsci.com)
Our news journalists report that additional information may be ob-
tained by contacting L.D. Lopes, Nat Sci Center UFPI, Dept. of Chem,
Teresina, PI, Brazil. (2013 Jan 01)
170
CHAPTER 1 BIOMEDICAL ENGINEERING
control and LPS-injected wild type and Hfe KO mice were used. More-
over, human hepatoma cells (HuH7) were used to study the effect of IL-6
and TNF-alpha on HJV mRNA expression. Here we show that LPS re-
pressed hepatic Hjv and BMPs, while it induced hepcidin 1 expression
in wild-type and Hfe KO mice with no effect on hepatic pSMAD 1, 5, 8
protein levels. In addition, exogenous TNF-alpha (20 ng/mL) decreased
HJV mRNA and protein expression to 40% of control with no effect on
hepcidin mRNA expression in 24 hours. On the other hand, IL-6 in-
duced hepcidin mRNA and protein expression with no effect on HJV
mRNA expression levels. Moreover, using the HJV promoter-luciferase
reporter fusion construct (HJVP1.2-luc), we showed that the basal lu-
ciferase activity of HJVP1.2-luc was inhibited by 33% following TNF-
alpha treatment of HuH7 transfected cells suggesting that the TNF-
alpha down-regulation is exerted at the transcriptional level. Addition-
ally, mutation of a canonical TNF-alpha responsive element (TNFRE)
within HJVP1.2-luc abolished TNF-alpha response suggesting that this
TNFRE is functional. From these results, we conclude that TNF-alpha
suppresses HJV transcription possibly via a novel TNFRE within the
HJV promoter.”
According to the news reporters, the research concluded: “In addi-
tion, the results suggest that the proposed link between inflammation
and BMP-SMAD signalling is independent of HJV and BMP ligands.”
For more information on this research see: Tumour necrosis fac-
tor alpha downregulates human hemojuvelin expression via a novel re-
sponse element within its promoter. Journal of Biomedical Science,
2012;19():1-12. Journal of Biomedical Science can be contacted at:
Biomed Central Ltd, 236 Grays Inn Rd, Floor 6, London WC1X 8HL,
England. (BioMed Central - http://www.biomedcentral.com/;
Journal of Biomedical Science - www.jbiomedsci.com)
Our news correspondents report that additional information may
be obtained by contacting M.F. Salama, Mansoura University, Fac Vet
Med, Dept. of Biochem, Mansoura, Egypt. (2012 Dec 31)
171
CHAPTER 1 BIOMEDICAL ENGINEERING
172
CHAPTER 1 BIOMEDICAL ENGINEERING
single nodal plane was recorded as 108 s, 17 s, and 115 s for polystyrene
particles of 2 m diameter, bio-functionalized magnetic beads, and live
cells, respectively.”
According to the news editors, the research concluded: “These suc-
cessful alignments of the bio-functionalized magnetic beads along the
desired part of the channel can enhance the performance of a sensor
which is applicable for the bio-hybrid system and the alignment of live
cells without any damage can be used for sample pre-treatment for the
application of lab-on-a-chip type bioassays.”
For more information on this research see: Ultrasonic alignment of
bio-functionalized magnetic beads and live cells in PDMS micro-fluidic
channel. Biomedical Microdevices, 2012;14(6):1077-84. Biomedical Mi-
crodevices can be contacted at: Springer, 233 Spring Street, New York,
NY 10013, USA. (Springer - www.springer.com; Biomedical Microde-
vices - http://www.springerlink.com/content/1387-2176/)
Our news journalists report that additional information may be ob-
tained by contacting A.T. Islam, Dept. of Materials Science & Engi-
neering, Chungnam National University, Gungdong, Daejeon, 305-764,
South Korea.
Publisher contact information for the journal Biomedical Microde-
vices is: Springer, 233 Spring Street, New York, NY 10013, USA. (2012
Dec 26)
173
CHAPTER 1 BIOMEDICAL ENGINEERING
174
CHAPTER 1 BIOMEDICAL ENGINEERING
175
CHAPTER 1 BIOMEDICAL ENGINEERING
176
CHAPTER 1 BIOMEDICAL ENGINEERING
177
CHAPTER 1 BIOMEDICAL ENGINEERING
178
CHAPTER 1 BIOMEDICAL ENGINEERING
179
CHAPTER 1 BIOMEDICAL ENGINEERING
180
CHAPTER 1 BIOMEDICAL ENGINEERING
181
CHAPTER 1 BIOMEDICAL ENGINEERING
182
CHAPTER 1 BIOMEDICAL ENGINEERING
183
CHAPTER 1 BIOMEDICAL ENGINEERING
184
CHAPTER 1 BIOMEDICAL ENGINEERING
185
CHAPTER 1 BIOMEDICAL ENGINEERING
stress on implants and bone has been associated with the use of angled
abutments.”
Our news journalists obtained a quote from the research from Fu-
jian Medical University, “However, comparisons of clinical success rates
of implants restored with angled and straight abutments indicate no
significant differences. The aim of the present study was to deter-
mine whether angled abutments could result in decreased stress on
surrounding bone of single-unit dental implants. By means of finite
element analysis (FEA), four simplified models were designed to sim-
ulate clinical scenarios in which that implants were placed in an ideal
axial position or at an angled position. Each implant was paired with
a straight or angled abutment. A simulated occlusal load of 100N was
applied along the vertical axis of the jawbone. The von Mises stress and
strain were recorded for each model. The numerical results showed that
angled abutments resulted in decreased stresses when implants were
not placed in ideal axial position.”
According to the news editors, the research concluded: “The present
study identified by means of FEA that angled abutments could result
in decreased stress on the supporting bone of implant system and may
provide some clues to resolve the debate regarding the influence of an-
gled abutments.”
For more information on this research see: Angled abutments re-
sult in increased or decreased stress on surrounding bone of single-
unit dental implants: A finite element analysis. Medical Engineer-
ing & Physics, 2012;34(10):1526-31. (Elsevier - www.elsevier.com;
Medical Engineering & Physics - http://www.elsevier.com/wps/
product/cws_home/30456)
Our news journalists report that additional information may be ob-
tained by contacting K. Tian, School of Stomatology, Fujian Medical
University, Fuzhou, Fujian 350000, People’s Taiwan. (2012 Dec 21)
186
CHAPTER 1 BIOMEDICAL ENGINEERING
187
CHAPTER 1 BIOMEDICAL ENGINEERING
188
CHAPTER 1 BIOMEDICAL ENGINEERING
189
CHAPTER 1 BIOMEDICAL ENGINEERING
190
CHAPTER 1 BIOMEDICAL ENGINEERING
191
CHAPTER 1 BIOMEDICAL ENGINEERING
192
CHAPTER 1 BIOMEDICAL ENGINEERING
193
CHAPTER 1 BIOMEDICAL ENGINEERING
194
CHAPTER 1 BIOMEDICAL ENGINEERING
195
CHAPTER 1 BIOMEDICAL ENGINEERING
the hole. When Regisil Rigid was used, the peak frequency also showed
a linear relationship with the depth (R-2 = 0.555) and diameter (R-2 =
0.350) of the hole. The peak frequency also increased as the hardness of
the impression material increased. Differentiability of the system was
evaluated by an ANOVA test. A statistically significant difference (p
< 0.01) was found between all implantation conditions, except in one
case using the Regisil Rigid material. In contrast, the ISQ value did not
consistently differentiate under several implantation conditions.”
According to the news editors, the research concluded: “The devel-
oped method could differentiate the stability changes in simulated im-
plantation conditions with a wider dynamic range and with higher res-
olution than the ISQ value.”
For more information on this research see: A new method for the
evaluation of dental implant stability using an inductive sensor. Med-
ical Engineering & Physics, 2012;34(9):1247-1252. Medical Engineer-
ing & Physics can be contacted at: Elsevier Sci Ltd, The Boulevard,
Langford Lane, Kidlington, Oxford OX5 1GB, Oxon, England. (El-
sevier - www.elsevier.com; Medical Engineering & Physics - http:
//www.elsevier.com/wps/product/cws_home/30456)
Our news journalists report that additional information may be ob-
tained by contacting D.S. Kim, Hanyang University, Coll Engn, Dept.
of Biomed Engn, Seoul, South Korea. (2012 Dec 12)
196
CHAPTER 1 BIOMEDICAL ENGINEERING
197
CHAPTER 1 BIOMEDICAL ENGINEERING
198
CHAPTER 1 BIOMEDICAL ENGINEERING
199
CHAPTER 1 BIOMEDICAL ENGINEERING
200
CHAPTER 1 BIOMEDICAL ENGINEERING
201
CHAPTER 1 BIOMEDICAL ENGINEERING
202
CHAPTER 1 BIOMEDICAL ENGINEERING
203
CHAPTER 1 BIOMEDICAL ENGINEERING
204
CHAPTER 1 BIOMEDICAL ENGINEERING
205
CHAPTER 1 BIOMEDICAL ENGINEERING
206
CHAPTER 1 BIOMEDICAL ENGINEERING
207
CHAPTER 1 BIOMEDICAL ENGINEERING
208
CHAPTER 1 BIOMEDICAL ENGINEERING
209
CHAPTER 1 BIOMEDICAL ENGINEERING
210
CHAPTER 1 BIOMEDICAL ENGINEERING
211
CHAPTER 1 BIOMEDICAL ENGINEERING
212
CHAPTER 1 BIOMEDICAL ENGINEERING
213
CHAPTER 1 BIOMEDICAL ENGINEERING
214
CHAPTER 1 BIOMEDICAL ENGINEERING
215
CHAPTER 1 BIOMEDICAL ENGINEERING
216
CHAPTER 1 BIOMEDICAL ENGINEERING
217
CHAPTER 1 BIOMEDICAL ENGINEERING
218
CHAPTER 1 BIOMEDICAL ENGINEERING
219
CHAPTER 1 BIOMEDICAL ENGINEERING
220
CHAPTER 1 BIOMEDICAL ENGINEERING
221
CHAPTER 1 BIOMEDICAL ENGINEERING
222
CHAPTER 1 BIOMEDICAL ENGINEERING
223
CHAPTER 1 BIOMEDICAL ENGINEERING
224
CHAPTER 1 BIOMEDICAL ENGINEERING
and nonacid nature, while the commercial pH sensor missed events that
had similar, repeated pH values, and failed to detect pH values higher
than 10.”
According to the news editors, the research concluded: “Our battery-
less transponder does not require a battery thus allowing longer diagno-
sis and prognosis periods to monitor drug efficacy, as well as providing
accurate assessment of GERD symptoms.”
For more information on this research see: An Implantable, Battery-
less, and Wireless Capsule With Integrated Impedance and pH Sen-
sors for Gastroesophageal Reflux Monitoring. IEEE Transactions on
Biomedical Engineering, 2012;59(11):3131-3139. IEEE Transactions
on Biomedical Engineering can be contacted at: Ieee-Inst Electrical
Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ 08855-4141,
USA. (Institute of Electrical and Electronics Engineers - http://www.
ieee.org/; IEEE Transactions on Biomedical Engineering - http:
//ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=10)
The news correspondents report that additional information may be
obtained from H. Cao, Univ Texas SW Med Center Dallas, Dept. of
Internal Med, Dallas, TX 75390, United States. (2012 Dec 12)
225
CHAPTER 1 BIOMEDICAL ENGINEERING
226
CHAPTER 1 BIOMEDICAL ENGINEERING
227
CHAPTER 1 BIOMEDICAL ENGINEERING
For more information on this research see: Virtual Groups for Pa-
tient WBAN Monitoring in Medical Environments. IEEE Transac-
tions on Biomedical Engineering, 2012;59(11):3238-3246. IEEE Trans-
actions on Biomedical Engineering can be contacted at: Ieee-Inst
Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ
08855-4141, USA. (Institute of Electrical and Electronics Engineers
- http://www.ieee.org/; IEEE Transactions on Biomedical Engi-
neering - http://ieeexplore.ieee.org/xpl/RecentIssue.jsp?
punumber=10)
Our news journalists report that additional information may be ob-
tained by contacting S. Ivanov, Waterford Inst Technol, Telecommun
Software & Syst Grp TSSG, Waterford, Ireland. (2012 Dec 12)
228
CHAPTER 1 BIOMEDICAL ENGINEERING
Elect Engn, Key Lab Intelligent Percept & Image Understanding, Xian
710071, People’s Republic of China. (2012 Dec 12)
229
CHAPTER 1 BIOMEDICAL ENGINEERING
230
CHAPTER 1 BIOMEDICAL ENGINEERING
231
CHAPTER 1 BIOMEDICAL ENGINEERING
232
CHAPTER 1 BIOMEDICAL ENGINEERING
233
CHAPTER 1 BIOMEDICAL ENGINEERING
234
CHAPTER 1 BIOMEDICAL ENGINEERING
235
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from Hong
Kong Polytechnic University, “Vascular endothelium forming the mi-
crovessel wall and the glycocalyx layer at its surface are the principal
barriers to, and regulators of the material exchange between circulat-
ing blood and body tissues. The cleft between adjacent ECs (interen-
dothelial cleft) is the principal pathway for water and solutes transport
through the microvessel wall in health. It is also suggested to be the
pathway for high molecular weight plasma proteins, leukocytes and tu-
mor cells across microvessel walls in disease. Thus the first part of the
review introduced the mathematical models for water and solutes trans-
port through the interendothelial cleft. These models, combined with
the experimental results from in vivo animal studies and electron mi-
croscopic observations, are used to evaluate the role of the endothelial
surface glycocalyx, the junction strand geometry in the interendothelial
cleft, and the surrounding extracellular matrix and tissue cells, as the
determinants of microvascular transport.”
According to the news editors, the research concluded: “The sec-
ond part of the review demonstrated how the microvascular permeabil-
ity, hydrodynamic factors, microvascular geometry and cell adhesion
molecules affect tumor cell adhesion in the microcirculation.”
For more information on this research see: Microvascular Transport
and Tumor Cell Adhesion in the Microcirculation. Annals of Biomedical
Engineering, 2012;40(11):2442-2455. Annals of Biomedical Engineer-
ing can be contacted at: Springer, 233 Spring St, New York, NY 10013,
USA. (Springer - www.springer.com; Annals of Biomedical Engineering
- http://www.springerlink.com/content/0090-6964/)
Our news journalists report that additional information may be ob-
tained by contacting B.M.M. Fu, Hong Kong Polytechnic University,
Dept. of Mech Engn, Kowloon, Hong Kong, People’s Republic of China.
(2012 Dec 10)
236
CHAPTER 1 BIOMEDICAL ENGINEERING
237
CHAPTER 1 BIOMEDICAL ENGINEERING
238
CHAPTER 1 BIOMEDICAL ENGINEERING
239
CHAPTER 1 BIOMEDICAL ENGINEERING
240
CHAPTER 1 BIOMEDICAL ENGINEERING
241
CHAPTER 1 BIOMEDICAL ENGINEERING
242
CHAPTER 1 BIOMEDICAL ENGINEERING
243
CHAPTER 1 BIOMEDICAL ENGINEERING
(SO) and computed muscle control (CMC). SO and CMC make simpli-
fying assumptions to limit the computational time. Both methods min-
imise an instantaneous performance criterion. Furthermore, SO does
not impose muscle physiology. All methods are applied to a gait cycle
of six control subjects. The relative root mean square error averaged
over all subjects, e(RMS), between the joint torques simulated from the
optimised activations and the joint torques obtained from the inverse
dynamic analysis was about twice as large for SO (e(RMS)=86) as com-
pared with CMC (e(RMS)=39) and PIA-SCP (e(RMS)=50). e(RMS) was
at least twice as large for PIA-QP (e(RMS)=197) than for all other meth-
ods. As compared with CMC, muscle activation patterns predicted by
PIA-SCP better agree with experimental electromyography (EMG).”
According to the news editors, the research concluded: “This study
shows that imposing muscle physiology as well as globally optimising
performance is important to accurately calculate MT forces underlying
gait.”
For more information on this research see: A physiology-based in-
verse dynamic analysis of human gait using sequential convex program-
ming: a comparative study. Computer Methods In Biomechanics and
Biomedical Engineering, 2012;15(10):1093-102.
The news editors report that additional information may be ob-
tained by contacting F. De Groote, Dept. of Mechanical Engineering,
Katholieke Universiteit Leuven, Leuven, Belgium. (2012 Dec 05)
244
CHAPTER 1 BIOMEDICAL ENGINEERING
245
CHAPTER 1 BIOMEDICAL ENGINEERING
246
CHAPTER 1 BIOMEDICAL ENGINEERING
247
CHAPTER 1 BIOMEDICAL ENGINEERING
248
CHAPTER 1 BIOMEDICAL ENGINEERING
249
CHAPTER 1 BIOMEDICAL ENGINEERING
250
CHAPTER 1 BIOMEDICAL ENGINEERING
251
CHAPTER 1 BIOMEDICAL ENGINEERING
252
CHAPTER 1 BIOMEDICAL ENGINEERING
between 100 and 1000 MHz, where distinct spectral features are ob-
served that are related to the droplet composition. The measured pho-
toacoustic spectrum from NP-loaded perfluorocarbon droplets was com-
pared to a theoretical model that assumes a homogenous liquid. Good
agreement in the location of the spectral features was observed, which
suggests the NPs act primarily as optical absorbers to induce thermal
expansion of the droplet as a single homogenous object. The NP size
and composition do not affect the photoacoustic spectrum; therefore,
the photoacoustic signal can be maximized by optimizing the NP op-
tical absorbing properties. To confirm the theoretical parameters in
the model, photoacoustic, ultrasonic, and optical methods were used to
estimate the droplet diameter. Photoacoustic and ultrasonic methods
agreed to within 1.4%, while the optical measurement was 8.5% higher;
this difference decreased with increasing droplet size.”
According to the news editors, the research concluded: “The small
discrepancy may be attributed to the difficulty in observing the small
droplets through the partially translucent phantom.”
For more information on this research see: Acoustic and photoacous-
tic characterization of micron-sized perfluorocarbon emulsions. Jour-
nal of Biomedical Optics, 2012;17(9):179-187. Journal of Biomedical
Optics can be contacted at: Spie-Soc Photo-Optical Instrumentation En-
gineers, 1000 20TH St, PO Box 10, Bellingham, WA 98225, USA.
The news editors report that additional information may be obtained
by contacting E.M. Strohm, Sunnybrook Hlth Sci Center, Imaging Res
Department, Toronto, ON M4N 3M5, Canada. (2012 Dec 05)
253
CHAPTER 1 BIOMEDICAL ENGINEERING
different body rotational speeds, delayed onset of body rotation and dif-
ferent body mass distributions, as swing amplitudes were brought up
towards 90°. One technique was found to be extremely sensitive
to the timing of body actions, limiting swing amplitudes to 50°
and 8° when body action was delayed by 0.03 and 0.3 s, respec-
tively. Two other more robust techniques reached 90° even with
the largest of these delays, although more time (and endurance) was
needed.”
According to the news reporters, the research concluded: “However,
these two methods also differed with respect to maximum torque and
endurance, and none was preferable in both these aspects, being depen-
dent on the swinger goals and abilities.”
For more information on this research see: An assessment of
swinger techniques for the playground swing oscillatory motion.
Computer Methods In Biomechanics and Biomedical Engineering,
2012;15(10):1103-9.
Our news correspondents report that additional information may
be obtained by contacting S.O. Linge, Telemark University College, PO
Box 203, N-3901 Porsgrunn, Norway. (2012 Dec 05)
254
CHAPTER 1 BIOMEDICAL ENGINEERING
255
CHAPTER 1 BIOMEDICAL ENGINEERING
256
CHAPTER 1 BIOMEDICAL ENGINEERING
257
CHAPTER 1 BIOMEDICAL ENGINEERING
258
CHAPTER 1 BIOMEDICAL ENGINEERING
259
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
University of Central Oklahoma, “The DOF of a microscopic system
was theoretically analyzed and experimentally validated using stan-
dard resolution targets under 60x dry and 100x oil objective lenses, re-
spectively. Then cytogenetic samples were imaged at in-focused and
off-focused states to analyze the impact of DOF on the acquired image
qualities. For the investigated system equipped with the 60x dry and
100x oil objective lenses, the theoretical estimation of the DOF are 0.855
mu m and 0.703 mu m, and the measured DOF are 3.0 mu m and 1.8 mu
m, respectively. The observation reveals that the chromosomal bands
of metaphase cells are distinguishable when images are acquired up to
approximately 1.5 mu m or 1 mu m out of focus using the 60x dry and
100x oil objective lenses, respectively.”
According to the news editors, the research concluded: “The results
of this investigation provide important designing trade-off parameters
to optimize the digital microscopic image scanning systems in the fu-
ture.”
For more information on this research see: Impact of the optical
depth of field on cytogenetic image quality. Journal of Biomedical Op-
tics, 2012;17(9):189-195. Journal of Biomedical Optics can be contacted
at: Spie-Soc Photo-Optical Instrumentation Engineers, 1000 20TH St,
PO Box 10, Bellingham, WA 98225, USA.
The news correspondents report that additional information may be
obtained from Y.C. Qiu, Univ Cent Oklahoma, Dept. of Engn & Phys,
Edmond, OK 73034, United States. (2012 Dec 05)
260
CHAPTER 1 BIOMEDICAL ENGINEERING
261
CHAPTER 1 BIOMEDICAL ENGINEERING
262
CHAPTER 1 BIOMEDICAL ENGINEERING
263
CHAPTER 1 BIOMEDICAL ENGINEERING
264
CHAPTER 1 BIOMEDICAL ENGINEERING
265
CHAPTER 1 BIOMEDICAL ENGINEERING
266
CHAPTER 1 BIOMEDICAL ENGINEERING
267
CHAPTER 1 BIOMEDICAL ENGINEERING
268
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from Wash-
ington University, “Focused broadband ultrasound detection provides
a 44-mu m lateral resolution and a 28-mu m axial resolution based on
the envelope (a 15-mu m axial resolution based on the raw RF signal).
Due to the efficient bright-field light delivery, the system can image
as deep as 4.8 mm in vivo using low excitation pulse energy (28 mu
J per pulse, 0.35 mJ/cm(2) on the skin surface). The photoacoustic
probe is mounted on a fast-scanning voice-coil scanner to acquire 40
two-dimensional (2-D) B-scan images per second over a 9-mm range.
High-resolution anatomical imaging is demonstrated in the mouse ear
and brain.”
According to the news editors, the research concluded: “Via
fast dual-wavelength switching, oxygen dynamics of mouse cardio-
vasculature is imaged in realtime as well.”
For more information on this research see: Video-rate functional
photoacoustic microscopy at depths. Journal of Biomedical Optics,
2012;17(10):256-260. Journal of Biomedical Optics can be contacted
at: Spie-Soc Photo-Optical Instrumentation Engineers, 1000 20TH St,
PO Box 10, Bellingham, WA 98225, USA.
Our news journalists report that additional information may be
obtained by contacting L.D. Wang, Washington University, Dept. of
Biomed Engn, Opt Imaging Lab, St Louis, MO 63130, United States.
(2012 Dec 05)
269
CHAPTER 1 BIOMEDICAL ENGINEERING
270
CHAPTER 1 BIOMEDICAL ENGINEERING
271
CHAPTER 1 BIOMEDICAL ENGINEERING
272
CHAPTER 1 BIOMEDICAL ENGINEERING
273
CHAPTER 1 BIOMEDICAL ENGINEERING
274
CHAPTER 1 BIOMEDICAL ENGINEERING
275
CHAPTER 1 BIOMEDICAL ENGINEERING
276
CHAPTER 1 BIOMEDICAL ENGINEERING
277
CHAPTER 1 BIOMEDICAL ENGINEERING
278
CHAPTER 1 BIOMEDICAL ENGINEERING
279
CHAPTER 1 BIOMEDICAL ENGINEERING
280
CHAPTER 1 BIOMEDICAL ENGINEERING
281
CHAPTER 1 BIOMEDICAL ENGINEERING
282
CHAPTER 1 BIOMEDICAL ENGINEERING
283
CHAPTER 1 BIOMEDICAL ENGINEERING
284
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
Harvard University School of Medicine, “In this work, we investigated
wavelength tuning as a mechanism to achieve this aimed control over
injury depth by using the strong variation of water absorption close to
1900 nm. We developed a numerical model simulating in steps the pho-
ton propagation in the tissue, the diffusion of the absorbed heat, and the
resulting tissue damage. The model was compared with experimental
results on porcine esophageal specimens ex vivo and showed good agree-
ment. Combined with power tuning, the wavelength agility in the range
of 1860 to 1895 nm extends the injury range compared to a fixed wave-
length source beyond 1 mm, while at the same time improving control
over shallow depths and avoiding vaporization at the tissue surface.”
According to the news editors, the research concluded: “The combi-
nation of two or three discrete wavelengths combined at variable ratios
provides similar control, and may provide an improved strategy for the
treatment of endothelial lesions.”
For more information on this research see: Injury depth control from
combined wavelength and power tuning in scanned beam laser thermal
therapy. Journal of Biomedical Optics, 2011;16(11):118001.
The news correspondents report that additional information may be
obtained from M. Villiger, Harvard Medical School and Massachusetts
General Hospital, Wellman Center for Photomedicine, Boston, Mas-
sachusetts 02114, United States. (2012 Nov 28)
285
CHAPTER 1 BIOMEDICAL ENGINEERING
286
CHAPTER 1 BIOMEDICAL ENGINEERING
287
CHAPTER 1 BIOMEDICAL ENGINEERING
288
CHAPTER 1 BIOMEDICAL ENGINEERING
289
CHAPTER 1 BIOMEDICAL ENGINEERING
290
CHAPTER 1 BIOMEDICAL ENGINEERING
291
CHAPTER 1 BIOMEDICAL ENGINEERING
292
CHAPTER 1 BIOMEDICAL ENGINEERING
293
CHAPTER 1 BIOMEDICAL ENGINEERING
294
CHAPTER 1 BIOMEDICAL ENGINEERING
295
CHAPTER 1 BIOMEDICAL ENGINEERING
296
CHAPTER 1 BIOMEDICAL ENGINEERING
297
CHAPTER 1 BIOMEDICAL ENGINEERING
298
CHAPTER 1 BIOMEDICAL ENGINEERING
299
CHAPTER 1 BIOMEDICAL ENGINEERING
300
CHAPTER 1 BIOMEDICAL ENGINEERING
301
CHAPTER 1 BIOMEDICAL ENGINEERING
302
CHAPTER 1 BIOMEDICAL ENGINEERING
303
CHAPTER 1 BIOMEDICAL ENGINEERING
304
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from Tel Aviv
University, “For the nonocclusion case we found that the low-frequency
component of the DLS signal significantly correlates with the biologi-
cal age while the high-frequency component of the DLS signal resem-
bles the arterial pulse-wave and does correlate with age. However,
the most prominent correlation between the DLS characteristics and
age was noted with the stasis stage measurements. We propose that
the observed age-related phenomena are caused by alterations in local
blood viscosity and interactions of the endothelial cells with erythro-
cytes. Further, a new noninvasive index based on the age-related opti-
cal characteristics was introduced.”
According to the news reporters, the research concluded: “This non-
invasive index may be used as a research and diagnostic tool to examine
the endothelial and thrombolytic properties of the vascular system.”
For more information on this research see: New noninvasive index
for evaluation of the vascular age of healthy and sick people. Journal
of Biomedical Optics, 2012;17(8):338-344. Journal of Biomedical Op-
tics can be contacted at: Spie-Soc Photo-Optical Instrumentation Engi-
neers, 1000 20TH St, PO Box 10, Bellingham, WA 98225, USA.
Our news correspondents report that additional information may be
obtained by contacting I. Fine, Tel Aviv University, Sackler Sch Med,
IL-69978 Tel Aviv, Israel. (2012 Nov 27)
305
CHAPTER 1 BIOMEDICAL ENGINEERING
306
CHAPTER 1 BIOMEDICAL ENGINEERING
the extent and severity of the brain hemorrhage. The paper also dis-
cusses ideas to obtain the location and the severity of a localized injury.
Two-dimensional and three-dimensional simulations are performed as
a proof of concept for the numerical formulation being feasible for the
above mentioned detection/quantification.”
According to the news editors, the research concluded: “The results
demonstrate that this numerical NIRS formulation can be used as a
noninvasive technique for both qualitative and quantitative evaluation
of cerebral hemodynamics.”
For more information on this research see: A near-infrared spec-
troscopy computational model for cerebral hemodynamics. Interna-
tional Journal for Numerical Methods In Biomedical Engineering,
2012;28(11):1093-106. (Wiley-Blackwell - http://www.wiley.com/;
International Journal for Numerical Methods In Biomedical Engi-
neering - http://onlinelibrary.wiley.com/journal/10.1002/
(ISSN)2040-7947)
Our news journalists report that additional information may be ob-
tained by contacting R. Kannan, CFD Research Corporation 215 Wynn
Drive, Huntsville, AL, 35805, United States. (2012 Nov 26)
307
CHAPTER 1 BIOMEDICAL ENGINEERING
308
CHAPTER 1 BIOMEDICAL ENGINEERING
errors for both methods fell within the range specified in the Associa-
tion for the Advancement of Medical Instrumentation standards. The
BZ of an edema patient was about 5 times higher than normal. For pa-
tients with peripheral arterial occlusive disease (PAOD), the PF could
not be determined, and the tp was about twice the normal value.”
According to the news reporters, the research concluded: “The accu-
racy of blood pressure measurements using the laser Doppler flowme-
ter was comparable to that of the commonly used oscillometric sphyg-
momanometer, and the physiological circulation functional parameters
were useful in identifying signs of edema and PAOD.”
For more information on this research see: Application of the laser
Doppler flowmeter for measurement of blood pressure and functional
parameters of microcirculation. Bio-medical Materials and Engineer-
ing, 2012;22(6):351-9.
Our news correspondents report that additional information may be
obtained by contacting C.L. Hu, Dept. of Electrical Engineering, Na-
tional Tsing Hua University, Hsinchu, Taiwan Industrial Technology
Research Institute, Hsinchu, Taiwan. (2012 Nov 26)
309
CHAPTER 1 BIOMEDICAL ENGINEERING
310
CHAPTER 1 BIOMEDICAL ENGINEERING
311
CHAPTER 1 BIOMEDICAL ENGINEERING
312
CHAPTER 1 BIOMEDICAL ENGINEERING
313
CHAPTER 1 BIOMEDICAL ENGINEERING
314
CHAPTER 1 BIOMEDICAL ENGINEERING
315
CHAPTER 1 BIOMEDICAL ENGINEERING
316
CHAPTER 1 BIOMEDICAL ENGINEERING
317
CHAPTER 1 BIOMEDICAL ENGINEERING
articular surface are defined in the epiphysis. Each VOI is further sub-
divided into a medial and a lateral part. In each VOI, BMD is deter-
mined. In addition, a texture analysis is performed on a high-resolution
computed tomography (CT) reconstruction of the same CT scan in order
to quantify subchondral bone structure. Local and global homogeneity,
as well as local and global anisotropy were measured in all VOIs. Over-
all short-term precision of the technique was evaluated using double
measurements of 20 osteoarthritic cadaveric human knees. Precision
errors for volume were about 2-3% in the femur and 3-5% in the tibia.
Precision errors for BMD were about 1-2% lower.”
According to the news reporters, the research concluded: “Ho-
mogeneity parameters showed precision errors up to about 2% and
anisotropy parameters up to about 4%.”
For more information on this research see: An integrated segmen-
tation and analysis approach for QCT of the knee to determine sub-
chondral bone mineral density and texture. Ieee Transactions On Bio-
medical Engineering, 2012;59(9):2449-58.
Our news correspondents report that additional information may be
obtained by contacting P. Zerfass, Institute of Medical Physics, Univer-
sity of Erlangen-Nuernberg, 91052 Erlangen, Germany. (2012 Nov 09)
318
CHAPTER 1 BIOMEDICAL ENGINEERING
319
CHAPTER 1 BIOMEDICAL ENGINEERING
320
CHAPTER 1 BIOMEDICAL ENGINEERING
321
CHAPTER 1 BIOMEDICAL ENGINEERING
322
CHAPTER 1 BIOMEDICAL ENGINEERING
323
CHAPTER 1 BIOMEDICAL ENGINEERING
324
CHAPTER 1 BIOMEDICAL ENGINEERING
325
CHAPTER 1 BIOMEDICAL ENGINEERING
326
CHAPTER 1 BIOMEDICAL ENGINEERING
327
CHAPTER 1 BIOMEDICAL ENGINEERING
of the crown. The FE model estimated that the volume of the new im-
plant could be reduced by 17.9% of the traditional one and the biome-
chanical performances were similar, such as the stress of the implant,
stress of the implant-bone complex, lower displacement, and greater
stiffness than the traditional implant. The advantages of the new im-
plant increased the space to allow more new bone ingrowth or assist in
fusing more bone graft into the bone sustaining the implant stability
and saved material.”
According to the news editors, the research concluded: “Its disad-
vantage was higher stress level compared with that of the traditional
implant.”
For more information on this research see: Finite element analy-
sis of the dental implant using a topology optimization method. Med-
ical Engineering & Physics, 2012;34(7):999-1008. Medical Engineer-
ing & Physics can be contacted at: Elsevier Sci Ltd, The Boulevard,
Langford Lane, Kidlington, Oxford OX5 1GB, Oxon, England. (El-
sevier - www.elsevier.com; Medical Engineering & Physics - http:
//www.elsevier.com/wps/product/cws_home/30456)
The news editors report that additional information may be obtained
by contacting C.L. Chang, Mackay Memorial Hospital, Dept. of Biomed
Res, Tamsui, Taipei County, Taiwan. (2012 Nov 07)
328
CHAPTER 1 BIOMEDICAL ENGINEERING
329
CHAPTER 1 BIOMEDICAL ENGINEERING
330
CHAPTER 1 BIOMEDICAL ENGINEERING
331
CHAPTER 1 BIOMEDICAL ENGINEERING
332
CHAPTER 1 BIOMEDICAL ENGINEERING
333
CHAPTER 1 BIOMEDICAL ENGINEERING
334
CHAPTER 1 BIOMEDICAL ENGINEERING
335
CHAPTER 1 BIOMEDICAL ENGINEERING
336
CHAPTER 1 BIOMEDICAL ENGINEERING
337
CHAPTER 1 BIOMEDICAL ENGINEERING
338
CHAPTER 1 BIOMEDICAL ENGINEERING
339
CHAPTER 1 BIOMEDICAL ENGINEERING
340
CHAPTER 1 BIOMEDICAL ENGINEERING
341
CHAPTER 1 BIOMEDICAL ENGINEERING
342
CHAPTER 1 BIOMEDICAL ENGINEERING
343
CHAPTER 1 BIOMEDICAL ENGINEERING
344
CHAPTER 1 BIOMEDICAL ENGINEERING
& Elect Engn, Colchester CO4 3SQ, Essex, United Kingdom. (2012 Nov
07)
345
CHAPTER 1 BIOMEDICAL ENGINEERING
346
CHAPTER 1 BIOMEDICAL ENGINEERING
347
CHAPTER 1 BIOMEDICAL ENGINEERING
348
CHAPTER 1 BIOMEDICAL ENGINEERING
349
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research from the Uni-
versity of Rhode Island, “Nine transfemoral amputees who wore a pas-
sive hydraulic knee or powered prosthetic knee participated in this
study. Information about the walking terrain was simulated and mod-
eled as prior probability based on the principle of maximum entropy
and integrated into the discriminant functions of the classifier. When
the correct prior knowledge of walking terrain was simulated, the clas-
sification accuracy for each locomotion mode significantly increased and
no task transitions were missed. In addition, simulated incorrect prior
knowledge did not significantly reduce system performance, indicating
that our design is robust against noisy and imperfect prior information.
Furthermore, these observations were independent of the type of pros-
thesis applied.”
According to the news editors, the research concluded: “The promis-
ing results in this study may assist the further development of an
environment-aware adaptive system for locomotion-mode recognition
for powered lower limb prostheses or orthoses.”
For more information on this research see: Toward Design of an
Environment-Aware Adaptive Locomotion-Mode-Recognition System.
IEEE Transactions on Biomedical Engineering, 2012;59(10):2716-2725.
IEEE Transactions on Biomedical Engineering can be contacted at:
Ieee-Inst Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscat-
away, NJ 08855-4141, USA. (Institute of Electrical and Electronics En-
gineers - http://www.ieee.org/; IEEE Transactions on Biomedical
Engineering - http://ieeexplore.ieee.org/xpl/RecentIssue.
jsp?punumber=10)
The news editors report that additional information may be obtained
by contacting L. Du, University of Rhode Island, Dept. of Elect Comp &
Biomed Engn, Kingston, RI 02881, United States. (2012 Nov 07)
350
CHAPTER 1 BIOMEDICAL ENGINEERING
AMR-ACB were 73.9 +/- 7.6 mHz and using manometry were 73.8 +/-
7.9 mHz during the baseline (r = 98, p< 0.05). The amplitude of con-
traction using AMR-ACB was 396 +/- 108 mu T.s and using manometry
were 540 +/- 198 mmHg.s during the baseline. The amplitudes of sig-
nals for AMR-ACB and manometric recordings were similarly increased
to 86.4% and 89.3% by neostigmine, and also decreased to 27.2% and
21.4% by hyoscine butylbromide in all animals, respectively.”
According to the news editors, the research concluded: “The AMR-
ACB array is nonexpensive, portable, and has high-spatiotemporal res-
olution to provide helpful information about gastrointestinal tract.”
For more information on this research see: Development of an AMR-
ACB Array for Gastrointestinal Motility Studies. IEEE Transactions on
Biomedical Engineering, 2012;59(10):2737-2743. IEEE Transactions
on Biomedical Engineering can be contacted at: Ieee-Inst Electrical
Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ 08855-4141,
USA. (Institute of Electrical and Electronics Engineers - http://www.
ieee.org/; IEEE Transactions on Biomedical Engineering - http:
//ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=10)
The news editors report that additional information may be ob-
tained by contacting F.C. Paixao, University of Sao Paulo, BR-14015000
Ribeirao Preto, SP, Brazil. (2012 Nov 07)
351
CHAPTER 1 BIOMEDICAL ENGINEERING
352
CHAPTER 1 BIOMEDICAL ENGINEERING
353
CHAPTER 1 BIOMEDICAL ENGINEERING
354
CHAPTER 1 BIOMEDICAL ENGINEERING
355
CHAPTER 1 BIOMEDICAL ENGINEERING
356
CHAPTER 1 BIOMEDICAL ENGINEERING
357
CHAPTER 1 BIOMEDICAL ENGINEERING
358
CHAPTER 1 BIOMEDICAL ENGINEERING
359
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
New Jersey Institute of Technology, “As the absorption of major chro-
mophores in the skin is wavelength dependent, multispectral imaging
can provide the needed information to separate out relative amounts of
each chromophore. However, a critical challenge to this strategy is re-
lating the pixel intensities observed in a given image to the wavelength-
dependent total absorption existing at each spatial location. Conse-
quently, in this paper, we develop an extension to Beer’s law, estimated
through a novel voxel-based, parallel processing Monte Carlo simula-
tion of light propagation in skin which takes into account the specific
geometry of our transillumination imaging apparatus. We then use this
relation in a linear mixing model, solved using a multispectral image
set, for chromophore separation and oxygen saturation estimation of an
absorbing object located at a given depth within the medium. Valida-
tion is performed through the Monte Carlo simulation, as well as by
imaging on a skin phantom.”
According to the news editors, the research concluded: “Results
show that subsurface oxygen saturation can be reasonably estimated
with good implications for the reconstruction of 3-D skin lesion volumes
using transillumination toward early detection of malignancy.”
For more information on this research see: Transillumination imag-
ing for blood oxygen saturation estimation of skin lesions. Ieee Trans-
actions On Bio-medical Engineering, 2012;59(9):2660-7.
The news correspondents report that additional information may be
obtained from B. D’Alessandro, Dept. of Electrical and Computer Engi-
neering, New Jersey Institute of Technology, Newark, NJ 07102, United
States. (2012 Nov 06)
360
CHAPTER 1 BIOMEDICAL ENGINEERING
correlation structure. Almost half of the time series are forecast bet-
ter by unconditional mean than by persistence. Two methods are em-
ployed for forecasting: exponential smoothing and Gaussian process re-
gression. Neither approach gives an improvement over a persistence
baseline. We conclude that the depression time series from patients
with bipolar disorder are very heterogeneous and that this constrains
the accuracy of automated mood forecasting across the set of patients.”
According to the news editors, the research concluded: “However,
the dataset is a valuable resource and work remains to be done that
might result in clinically useful information and tools.”
For more information on this research see: Forecasting Depression
in Bipolar Disorder. IEEE Transactions on Biomedical Engineering,
2012;59(10):2801-2807. IEEE Transactions on Biomedical Engineering
can be contacted at: Ieee-Inst Electrical Electronics Engineers Inc, 445
Hoes Lane, Piscataway, NJ 08855-4141, USA. (Institute of Electrical
and Electronics Engineers - http://www.ieee.org/; IEEE Transac-
tions on Biomedical Engineering - http://ieeexplore.ieee.org/
xpl/RecentIssue.jsp?punumber=10)
The news correspondents report that additional information may be
obtained from P.J. Moore, University of Oxford, Dept. of Psychiat, Ox-
ford OX1 3LB, United Kingdom. (2012 Nov 06)
361
CHAPTER 1 BIOMEDICAL ENGINEERING
frequency are considerably more accurate for all f-wave amplitudes than
the AF estimates based on ABS.”
According to the news reporters, the research concluded: “The novel
method is particularly well suited for implementation in mobile health
systems where monitoring of AF during extended time periods is of in-
terest.”
For more information on this research see: An Echo State
Neural Network for QRST Cancellation During Atrial Fibrillation.
IEEE Transactions on Biomedical Engineering, 2012;59(10):2950-2957.
IEEE Transactions on Biomedical Engineering can be contacted at:
Ieee-Inst Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscat-
away, NJ 08855-4141, USA. (Institute of Electrical and Electronics En-
gineers - http://www.ieee.org/; IEEE Transactions on Biomedical
Engineering - http://ieeexplore.ieee.org/xpl/RecentIssue.
jsp?punumber=10)
Our news journalists report that additional information may be ob-
tained by contacting A. Petrenas, Lund University, Dept. of Elect &
Informat Technol, SE-22100 Lund, Sweden. (2012 Nov 05)
362
CHAPTER 1 BIOMEDICAL ENGINEERING
363
CHAPTER 1 BIOMEDICAL ENGINEERING
364
CHAPTER 1 BIOMEDICAL ENGINEERING
365
CHAPTER 1 BIOMEDICAL ENGINEERING
366
CHAPTER 1 BIOMEDICAL ENGINEERING
367
CHAPTER 1 BIOMEDICAL ENGINEERING
368
CHAPTER 1 BIOMEDICAL ENGINEERING
369
CHAPTER 1 BIOMEDICAL ENGINEERING
370
CHAPTER 1 BIOMEDICAL ENGINEERING
371
CHAPTER 1 BIOMEDICAL ENGINEERING
372
CHAPTER 1 BIOMEDICAL ENGINEERING
373
CHAPTER 1 BIOMEDICAL ENGINEERING
374
CHAPTER 1 BIOMEDICAL ENGINEERING
375
CHAPTER 1 BIOMEDICAL ENGINEERING
376
CHAPTER 1 BIOMEDICAL ENGINEERING
377
CHAPTER 1 BIOMEDICAL ENGINEERING
378
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
Medical College of Wisconsin, “The Virtual Physiological Rat (VPR)
Project, a National Institute of General Medical Sciences (NIGMS)
funded National Center of Systems Biology, is tasked with mechanis-
tically describing several complex diseases and is therefore identifying
methods to facilitate the process of model integration across physiolog-
ical scales. In addition, the VPR has a considerable experimental com-
ponent and the resultant data must be integrated into these composite
multiscale models and made available to the research community. A
perspective of the current state of the art in model integration and shar-
ing along with archiving of experimental data will be presented here in
the context of multiscale physiological models.”
According to the news editors, the research concluded: “It was found
that current ontological, model and data repository resources and inte-
grative software tools are sufficient to create composite models from
separate existing models and the example composite model developed
here exhibits emergent behavior not predicted by the separate models.”
For more information on this research see: Multiscale modeling
and data integration in the virtual physiological rat project. An-
nals of Biomedical Engineering, 2012;40(11):2365-78. (Springer -
www.springer.com; Annals of Biomedical Engineering - http://www.
springerlink.com/content/0090-6964/)
The news correspondents report that additional information may be
obtained from D.A. Beard, Biotechnology and Bioengineering Center
and Center for Computational Medicine, Medical College of Wisconsin,
Milwaukee, WI, United States. (2012 Oct 31)
379
CHAPTER 1 BIOMEDICAL ENGINEERING
380
CHAPTER 1 BIOMEDICAL ENGINEERING
motion, the decrease in SNR for the BCG signal was found to be cor-
related to the increase in rms power for the lower body EMG (r=0.89,
p<; 0.01). The EMG could, thus, be used to flag noise-corrupted seg-
ments of the BCG, increasing the measurement robustness.”
According to the news reporters, the research concluded: “This setup
could be used for monitoring the cardiovascular health of patients at
home.”
For more information on this research see: Noninvasive measure-
ment of physiological signals on a modified home bathroom scale. Ieee
Transactions On Bio-medical Engineering, 2012;59(8):2137-43.
Our news journalists report that additional information may be ob-
tained by contacting O.T. Inan, Dept. of Electrical Engineering, Stan-
ford University, Stanford, CA 94305, United States. (2012 Oct 31)
381
CHAPTER 1 BIOMEDICAL ENGINEERING
382
CHAPTER 1 BIOMEDICAL ENGINEERING
383
CHAPTER 1 BIOMEDICAL ENGINEERING
384
CHAPTER 1 BIOMEDICAL ENGINEERING
385
CHAPTER 1 BIOMEDICAL ENGINEERING
386
CHAPTER 1 BIOMEDICAL ENGINEERING
387
CHAPTER 1 BIOMEDICAL ENGINEERING
the change in oxygen levels since the brain functions require more glu-
cose and oxygen upon stimulus that implies a change in blood flow. In
the literature, different approaches to estimate and model the haemody-
namic response have been proposed. These approaches can be discrim-
inated in model structures that either provide a proper representation
of the obtained measurements but provide no or a limited amount of
physiological information, or provide physiological insight but lacks a
proper fit to the data. In this paper, a novel model structure is studied
for describing the haemodynamics in fMRI measurements: fractional
models.”
According to the news editors, the research concluded: “We show
that these models are flexible enough to describe the gathered data with
the additional merit of providing physiological information.”
For more information on this research see: Fractional-order time se-
ries models for extracting the haemodynamic response from functional
magnetic resonance imaging data. Ieee Transactions On Bio-medical
Engineering, 2012;59(8):2264-72.
The news correspondents report that additional information may be
obtained from K. Barbee, Dept. of Fundamental Electricity and Instru-
mentation, Vrije Universiteit Brussel, Brussels, Belgium. (2012 Oct 29)
388
CHAPTER 1 BIOMEDICAL ENGINEERING
389
CHAPTER 1 BIOMEDICAL ENGINEERING
390
CHAPTER 1 BIOMEDICAL ENGINEERING
391
CHAPTER 1 BIOMEDICAL ENGINEERING
392
CHAPTER 1 BIOMEDICAL ENGINEERING
393
CHAPTER 1 BIOMEDICAL ENGINEERING
394
CHAPTER 1 BIOMEDICAL ENGINEERING
395
CHAPTER 1 BIOMEDICAL ENGINEERING
396
CHAPTER 1 BIOMEDICAL ENGINEERING
397
CHAPTER 1 BIOMEDICAL ENGINEERING
398
CHAPTER 1 BIOMEDICAL ENGINEERING
399
CHAPTER 1 BIOMEDICAL ENGINEERING
400
CHAPTER 1 BIOMEDICAL ENGINEERING
401
CHAPTER 1 BIOMEDICAL ENGINEERING
402
CHAPTER 1 BIOMEDICAL ENGINEERING
403
CHAPTER 1 BIOMEDICAL ENGINEERING
separate insulating traps like PDMS and the bottom gold electrodes.
Further the improved uniformity of the electric field between the trap-
ping electrodes as observed from COVENTORWARE simulation signif-
icantly reduces the effect of cell position inside the microwell on the
electrical measurement unlike previous reports. This makes it possi-
ble to directly extract the equivalent cell parameters from the electrical
measurement without introducing any correction factor corresponding
to cell position. We have performed impedance spectroscopy with both
the microwell electrode structures with single HeLa cell at two differ-
ent positions of trapping. It has been observed that there is almost no
change in the extracted values of cell resistance and capacitance for dif-
ferent positions within parallel electrodes and there is only 0.7 % and
0.85 % change in cell resistance and capacitance for the two positions
within elliptical electrodes.”
According to the news editors, the researchers concluded: “Thus
these microwell electrode structures can be used as an improved and
a more convenient platform for single cell electrical characterization.”
For more information on this research see: Microtrap electrode de-
vices for single cell trapping and impedance measurement. Biomed-
ical Microdevices, 2012;14(5):955-64. Biomedical Microdevices can
be contacted at: Springer, 233 Spring Street, New York, NY 10013,
USA. (Springer - www.springer.com; Biomedical Microdevices - http:
//www.springerlink.com/content/1387-2176/)
The news editors report that additional information may be obtained
by contacting D. Mondal, School of Materials Science and Engineering,
Bengal Engineering and Science University Shibpur, Howrah, 711103,
India.
Publisher contact information for the journal Biomedical Microde-
vices is: Springer, 233 Spring Street, New York, NY 10013, USA. (2012
Oct 10)
404
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from Boston
University, “By taking advantage of the small dimensions and lami-
nar flow inherent in microfluidic systems, recent studies have created
in vitro models that reproduce many features of the in vivo vascular
microenvironment with fine spatial and temporal resolution. In this
review, we highlight the advantages of microfluidics in four areas: the
investigation of hemodynamics on a capillary length scale, the modu-
lation of fluid streams over vascular cells, angiogenesis induced by the
exposure of vascular cells to well-defined gradients in growth factors or
pressure, and the growth of microvascular networks in biomaterials.”
According to the news reporters, the researchers concluded: “Such
unique capabilities at the microscale are rapidly advancing the under-
standing of microcirculatory dynamics, shear responses, and angiogen-
esis in health and disease as well as the ability to create in vivo-like
blood vessels in vitro.”
For more information on this research see: Microfluidic models
of vascular functions. Annual Review of Biomedical Engineering,
2012;14():205-30.
Our news correspondents report that additional information may be
obtained by contacting K.H. Wong, Dept. of Biomedical Engineering,
Boston University, Boston, Massachusetts 02215, United States. (2012
Oct 10)
405
CHAPTER 1 BIOMEDICAL ENGINEERING
406
CHAPTER 1 BIOMEDICAL ENGINEERING
values of TEI. Six new subjects were enrolled to measure and predict
transthoracic impedance and hence to quantify IFV.”
According to the news reporters, the researchers concluded: “A sim-
ilar difference was also observed in the measured and predicted values
of TEI for the new subjects.”
For more information on this research see: Prediction of quantita-
tive intrathoracic fluid volume to diagnose pulmonary oedema using
LabVIEW. Computer Methods In Biomechanics and Biomedical Engi-
neering, 2012;15(8):859-64.
Our news correspondents report that additional information may be
obtained by contacting S. Urooj, Dept. of Electronics and Instrumen-
tation Engineering, Galgotias College of Engineering and Technology,
Greater Noida, 201306, India. (2012 Oct 10)
407
CHAPTER 1 BIOMEDICAL ENGINEERING
408
CHAPTER 1 BIOMEDICAL ENGINEERING
409
CHAPTER 1 BIOMEDICAL ENGINEERING
410
CHAPTER 1 BIOMEDICAL ENGINEERING
411
CHAPTER 1 BIOMEDICAL ENGINEERING
412
CHAPTER 1 BIOMEDICAL ENGINEERING
413
CHAPTER 1 BIOMEDICAL ENGINEERING
414
CHAPTER 1 BIOMEDICAL ENGINEERING
415
CHAPTER 1 BIOMEDICAL ENGINEERING
416
CHAPTER 1 BIOMEDICAL ENGINEERING
417
CHAPTER 1 BIOMEDICAL ENGINEERING
418
CHAPTER 1 BIOMEDICAL ENGINEERING
419
CHAPTER 1 BIOMEDICAL ENGINEERING
420
CHAPTER 1 BIOMEDICAL ENGINEERING
421
CHAPTER 1 BIOMEDICAL ENGINEERING
422
CHAPTER 1 BIOMEDICAL ENGINEERING
423
CHAPTER 1 BIOMEDICAL ENGINEERING
muscle oxygen consumption (ICC: 0.84; CV: 6.51%; SEM: 7.11%), time
to basal O(2)Hb (ICC: 0.63, CV: 20.04%, SEM 27.22%), time to max-
imal O(2)Hb (ICC: 0.71; CV: 15.61%; SEM: 19.27%), peak of O(2)Hb
(ICC: 0.63, CV: 6.68%, SEM 8.53%), time to maximal tHb (ICC: 0.73,
CV: 19,61%, SEM 24.56%) and area under the O(2)Hb and tHb curves
(ICC: 0.68, CV: 16.15%, SEM 22.93% and ICC: 0.62, CV: 18.59%, SEM
26.64%, respectively). Moreover, inter-observer reproducibility ranged
from excellent to perfect (ICC from 0.85 to 1.00) for every parameter.”
According to the news editors, the researchers concluded: “NIRS
parameters during reactive hyperemia are highly reproducible which
enables their repeated measurement to study microvascular function
in healthy subjects.”
For more information on this research see: Reproducibility of near-
infrared spectroscopy parameters measured during brachial artery oc-
clusion and reactive hyperemia in healthy men. Journal of Biomed-
ical Optics, 2012;17(7):492-496. Journal of Biomedical Optics can be
contacted at: Spie-Soc Photo-Optical Instrumentation Engineers, 1000
20TH St, PO Box 10, Bellingham, WA 98225, USA.
Our news journalists report that additional information may be ob-
tained by contacting S. Lacroix, CHU Dijon, Inserm CIC P 803, Dijon,
France. (2012 Oct 10)
424
CHAPTER 1 BIOMEDICAL ENGINEERING
425
CHAPTER 1 BIOMEDICAL ENGINEERING
72% and 91% for sound areas, 36% and 79% for lesions on the enamel,
and 82% and 69% for lesions in dentin were found.”
According to the news editors, the researchers concluded: “These
results suggest that NIR spectral imaging is a novel and promising
method for the detection, quantification, and mapping of dental caries.”
For more information on this research see: Histological valida-
tion of near-infrared reflectance multispectral imaging technique for
caries detection and quantification. Journal of Biomedical Optics,
2012;17(7):246-253. Journal of Biomedical Optics can be contacted at:
Spie-Soc Photo-Optical Instrumentation Engineers, 1000 20TH St, PO
Box 10, Bellingham, WA 98225, USA.
The news correspondents report that additional information may be
obtained from S. Salsone, University of Calabria, CNR, IPCF Unit Sup-
port Cosenza, LiCryL Lab, I-87036 Arcavacata Di Rende, Italy. (2012
Oct 10)
426
CHAPTER 1 BIOMEDICAL ENGINEERING
427
CHAPTER 1 BIOMEDICAL ENGINEERING
428
CHAPTER 1 BIOMEDICAL ENGINEERING
429
CHAPTER 1 BIOMEDICAL ENGINEERING
430
CHAPTER 1 BIOMEDICAL ENGINEERING
431
CHAPTER 1 BIOMEDICAL ENGINEERING
432
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from Wash-
ington University, “Interestingly, blood pulse wave-induced fluctua-
tions in blood flow speed were clearly observed in arteries and arteri-
oles, but not in veins or venules. Simultaneously recorded electrocar-
diograms served as references to measure the travel time of the pulse
wave between two cross sections of a chosen vessel and vessel segmen-
tation analysis enabled accurate quantification of the travel distance.
PWVs were quantified in ten vessel segments from two mice.”
According to the news reporters, the researchers concluded: “Sta-
tistical analysis shows a linear correlation between the PWV and the
vessel diameter which agrees with known physiology.”
For more information on this research see: Photoacoustic microscopy
of blood pulse wave. Journal of Biomedical Optics, 2012;17(7):12-14.
Journal of Biomedical Optics can be contacted at: Spie-Soc Photo-
Optical Instrumentation Engineers, 1000 20TH St, PO Box 10, Belling-
ham, WA 98225, USA.
Our news correspondents report that additional information may
be obtained by contacting C.H. Yeh, Washington University, Dept. of
Biomed Engn, Opt Imaging Lab, St Louis, MO 63130, United States.
(2012 Oct 10)
433
CHAPTER 1 BIOMEDICAL ENGINEERING
434
CHAPTER 1 BIOMEDICAL ENGINEERING
435
CHAPTER 1 BIOMEDICAL ENGINEERING
436
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from Ghent
University, “This introductory review provides a summary of the cur-
rent status of this emerging research field. In addition to the inactiva-
tion of bacteria on nonliving surfaces, this review also focuses on the
sterilization of living surfaces, such as animal and human tissues.”
According to the news editors, the researchers concluded: “Clearly,
nonthermal plasmas have undoubtedly great potential as a novel
method for low-temperature sterilization.”
For more information on this research see: Nonthermal plasma ster-
ilization of living and nonliving surfaces. Annual Review of Biomedical
Engineering, 2012;14():255-74.
The news correspondents report that additional information may be
obtained from N. De Geyter, Research Unit Plasma Technology, Dept.
of Applied Physics, Faculty of Engineering and Architecture, Ghent
University, 9000 Gent, Belgium. (2012 Oct 09)
437
CHAPTER 1 BIOMEDICAL ENGINEERING
438
CHAPTER 1 BIOMEDICAL ENGINEERING
439
CHAPTER 1 BIOMEDICAL ENGINEERING
440
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
University of Connecticut, “Parameters for each SHG image were calcu-
lated using the Fourier transform matrix and gray-level co-occurrence
matrix (GLCM). Cancer versus normal and cancer versus all other di-
agnoses showed the greatest separation using the parameters derived
from power in the highest-frequency region and GLCM energy. Mixed
effects models showed that these parameters were significantly differ-
ent between cancer and normal (P < 0.008). Images were classified
with a support vector machine, using 25% of the data for training and
75% for testing. Utilizing all images with signal greater than the noise
level, cancer versus not-cancer specimens were classified with 81.2%
sensitivity and 80.0% specificity, and cancer versus normal specimens
were classified with 77.8% sensitivity and 79.3% specificity. Utilizing
only images with greater than of 75% of the field of view containing
signal improved sensitivity and specificity for cancer versus normal to
81.5% and 81.1%.”
According to the news editors, the researchers concluded: “These
results suggest that using SHG to visualize collagen structure in ovaries
could help with early cancer detection.”
For more information on this research see: Analysis of second-
harmonic-generation microscopy in a mouse model of ovarian carci-
noma. Journal of Biomedical Optics, 2012;17(7):190-198. Journal
of Biomedical Optics can be contacted at: Spie-Soc Photo-Optical In-
strumentation Engineers, 1000 20TH St, PO Box 10, Bellingham, WA
98225, USA.
Our news journalists report that additional information may be ob-
tained by contacting J.M. Watson, University of Connecticut, Center
Hlth, Carole & Ray Neag Comprehens Canc Center, Div Gynecol On-
col, Farmington, CT 06030, United States. (2012 Oct 09)
441
CHAPTER 1 BIOMEDICAL ENGINEERING
which aims to develop robots that assist people with special needs
through social interactions. In this review, we discuss the past decade’s
work in SAR systems designed for autism therapy by analyzing robot
design decisions, human-robot interactions, and system evaluations.”
According to the news reporters, the researchers concluded: “We
conclude by discussing challenges and future trends for this young but
rapidly developing research area.”
For more information on this research see: Robots for use in autism
research. Annual Review of Biomedical Engineering, 2012;14():275-94.
Our news correspondents report that additional information may be
obtained by contacting B. Scassellati, Dept. of Computer Science, Yale
University, New Haven, Connecticut 06520, United States. (2012 Oct
09)
442
CHAPTER 1 BIOMEDICAL ENGINEERING
443
CHAPTER 1 BIOMEDICAL ENGINEERING
444
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from Aix-
Marseille University, “Among the 20 tested molecules, four exhibited
significant antiplasmodial activity on the W2 multi-resistant Plasmod-
ium falciparum strain (0.7 < IC50 < 1.7 mu M), in comparison
with two references drugs (chloroquine and doxycycline), and a low cy-
totoxicity. These beta-carbolines were also evaluated concerning their
in vitro antileshmanial activity on Leishmania donovani promastigotes,
permitting to identify an antileshmanial hit compound, displaying quite
promising activity (IC50 = 6.1 mu M) in comparison with amphotericin
B and pentamidine chosen as reference drugs.”
According to the news editors, the researchers concluded: “Fi-
nally, structure-activity relationships were discussed, pointing out that
molecules presenting a para-substituted phenyl moiety at position 1 of
the beta-carboline ring displayed the best biological profile.”
For more information on this research see: Preparation and antipro-
tozoal evaluation of promising beta-carboline alkaloids. Biomedicine
& Pharmacotherapy, 2012;66(5):339-347. Biomedicine & Pharma-
cotherapy can be contacted at: Elsevier France-Editions Scientifiques
Medicales Elsevier, 23 Rue Linois, 75724 Paris, France. (Elsevier -
www.elsevier.com; Biomedicine & Pharmacotherapy - http://www.
elsevier.com/wps/product/cws_home/505810)
The news correspondents report that additional information may be
obtained from A. Gellis, Aix Marseille Univ, UMR MD3, Fac Pharm,
F-13385 Marseille 05, France. (2012 Oct 03)
445
CHAPTER 1 BIOMEDICAL ENGINEERING
come from nerves or muscles that were originally meant to produce the
intended movement and that feedback is perceived as originating in the
missing limb without requiring burdensome levels of concentration.”
According to the news editors, the researchers concluded: “After
scrutinizing different electrode designs and their clinical implementa-
tion, we concluded that the epimysial and cuff electrodes are currently
promising candidates to achieving a long-term stable and natural con-
trol of robotic prosthetics, provided that communication from the elec-
trodes to the outside of the body is guaranteed.”
For more information on this research see: On the viability of im-
plantable electrodes for the natural control of artificial limbs: Review
and discussion. Biomedical Engineering Online, 2012;11():33. (BioMed
Central - http://www.biomedcentral.com/; Biomedical Engineer-
ing Online - www.biomedical-engineering-online.com)
The news editors report that additional information may be obtained
by contacting M. Ortiz-Catalan, Dept. of Signals and Systems, Biomed-
ical Engineering Division, Chalmers University of Technology, Gote-
borg, Sweden. (2012 Oct 03)
446
CHAPTER 1 BIOMEDICAL ENGINEERING
mimicked by plug flow conditions. Peak wall shear stress (WSS) val-
ues increased from 18.16 dynes/cm(2) at HH16 to 671.24 dynes/cm(2)
at HH30. Spatiotemporally averaged WSS values also showed a mono-
tonic increase from 3.03 dynes/cm(2) at HH16 to 136.50 dynes/cm(2) at
HH30. Simulated velocity streamlines in the early heart suggest a lack
of mixing, which differed from classical ink injections. Changes in local
flow patterns preceded and correlated with key morphogenetic events
such as OFT septation and valve formation.”
According to the news reporters, the researchers concluded: “This
novel method to quantify local dynamic hemodynamics parameters af-
fords insight into sculpting role of blood flow in the embryonic heart and
provides a quantitative baseline dataset for future research.”
For more information on this research see: Computational fluid
dynamics of developing avian outflow tract heart valves. An-
nals of Biomedical Engineering, 2012;40(10):2212-27. (Springer -
www.springer.com; Annals of Biomedical Engineering - http://www.
springerlink.com/content/0090-6964/)
Our news correspondents report that additional information may be
obtained by contacting K.N. Bharadwaj, Dept. of Biomedical Engineer-
ing, Cornell University, 304 Weill Hall, Ithaca, NY, 14853-7501, United
States. (2012 Oct 03)
447
CHAPTER 1 BIOMEDICAL ENGINEERING
preliminary results are promising considering that this is the first at-
tempt to describe the clinical state of low-responsive patients in such
a global and quantitative way. This new model could complement the
clinical scores based on objective measurements in order to increase di-
agnostic reliability.”
According to the news reporters, the researchers concluded: “Never-
theless, more patients are necessary to prove the conclusions of a sta-
tistical model with 12 variables.”
For more information on this research see: Quantification of
clinical scores through physiological recordings in low-responsive
patients: a feasibility study. Journal of Neuroengineering and
Rehabilitation, 2012;9():30. (BioMed Central - http://www.
biomedcentral.com/; Journal of Neuroengineering and Rehabilita-
tion - www.jneuroengrehab.com)
Our news correspondents report that additional information may be
obtained by contacting M. Wieser, Sensory-Motor Systems Lab, Insti-
tute of Robotics and Intelligent Systems, Dept. of Health Science and
Technologies, ETH Zurich, Tannenstrasse 1, Zurich, 8092, Switzerland.
(2012 Oct 03)
448
CHAPTER 1 BIOMEDICAL ENGINEERING
449
CHAPTER 1 BIOMEDICAL ENGINEERING
450
CHAPTER 1 BIOMEDICAL ENGINEERING
Mech & Aerosp Engn, Piscataway, NJ 08855, United States. (2012 Oct
03)
451
CHAPTER 1 BIOMEDICAL ENGINEERING
452
CHAPTER 1 BIOMEDICAL ENGINEERING
stem cells (ESCs), and induced pluripotent stem cells (iPSCs). Com-
parative studies indicate that each cell type has advantages and disad-
vantages, and while direct comparisons are difficult to make, published
data suggest some sources may be more promising for cartilage regen-
eration than others. In this review, we identify current approaches for
isolating and chondrogenically differentiating MSCs from bone marrow,
fat, synovium, muscle, and peripheral blood, as well as cells from extra-
embryonic tissues, ESCs, and iPSCs. Additionally, we assess chondro-
genic induction with growth factors, identifying standard cocktails used
for each stem cell type.”
According to the news reporters, the researchers concluded: “Cell-
only (pellet) and scaffold-based studies are also included, as is a discus-
sion of in vivo results.”
For more information on this research see: Isolation, character-
ization, and differentiation of stem cells for cartilage regeneration.
Annals of Biomedical Engineering, 2012;40(10):2079-97. (Springer -
www.springer.com; Annals of Biomedical Engineering - http://www.
springerlink.com/content/0090-6964/)
Our news correspondents report that additional information may be
obtained by contacting O.S. Beane, Center for Biomedical Engineering,
Brown University, Providence, RI, United States. (2012 Oct 02)
453
CHAPTER 1 BIOMEDICAL ENGINEERING
two cell lines, suggesting that both K562 and K562R cells possess acti-
vated and major components of the Shh signaling pathway. Silencing
of Gli-1 by interference RNA was accompanied by inhibition of Bcr-Abl
protein expression. Pharmacological suppression of Bcr-Abl expression
was restored by the Smo agonist purmorpharmine. Treatment of Shh
peptide in both K562 and K562R cells not only increased Shh and Gli-
1 expression, but also up-regulated Bcr-Abl expression. Resveratrol, a
known Bcr-Abl inhibitor, reduced Gli-1 activation and inhibited the vi-
ability of CML cells. Shh signaling may regulate Bcr-Abl expression in
human chronic myeloid leukemia cells.”
According to the news reporters, the researchers concluded: “Novel
compounds inhibiting both Shh signaling and Bcr-Abl expression, such
as resveratrol, may have potential to be effective agents against CML
independent of IM resistance.”
For more information on this research see: Sonic hedgehog signaling
regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Biomedicine & Pharmacotherapy, 2012;66(5):378-383. Biomedicine &
Pharmacotherapy can be contacted at: Elsevier France-Editions Scien-
tifiques Medicales Elsevier, 23 Rue Linois, 75724 Paris, France. (El-
sevier - www.elsevier.com; Biomedicine & Pharmacotherapy - http:
//www.elsevier.com/wps/product/cws_home/505810)
Our news journalists report that additional information may be ob-
tained by contacting H.F. Liao, Columbia University, Dept. of Radiat
Oncol, New York, NY, United States. (2012 Oct 02)
454
CHAPTER 1 BIOMEDICAL ENGINEERING
455
CHAPTER 1 BIOMEDICAL ENGINEERING
456
CHAPTER 1 BIOMEDICAL ENGINEERING
457
CHAPTER 1 BIOMEDICAL ENGINEERING
458
CHAPTER 1 BIOMEDICAL ENGINEERING
459
CHAPTER 1 BIOMEDICAL ENGINEERING
460
CHAPTER 1 BIOMEDICAL ENGINEERING
461
CHAPTER 1 BIOMEDICAL ENGINEERING
462
CHAPTER 1 BIOMEDICAL ENGINEERING
463
CHAPTER 1 BIOMEDICAL ENGINEERING
464
CHAPTER 1 BIOMEDICAL ENGINEERING
465
CHAPTER 1 BIOMEDICAL ENGINEERING
the energy index is not suitable for the screw groups with rather tiny
threads compared with the other specifications.”
According to the news editors, the researchers concluded: “The un-
derestimated displacement leads to erroneous results in the screw-
pullout simulation. Among three numerical indices the reaction-force
is the optimal index for the screw-pullout problem.”
For more information on this research see: Correlation of the
experimental and numerical results for the holding power of den-
tal, traumatic, and spinal screws. Medical Engineering & Physics,
2012;34(8):1123-31. (Elsevier - www.elsevier.com; Medical Engineering
& Physics - http://www.elsevier.com/wps/product/cws_home/
30456)
The news correspondents report that additional information may be
obtained from C.C. Lee, Dept. of Mechanical Engineering, National
Central University, Taoyuan, Taiwan. (2012 Sep 28)
466
CHAPTER 1 BIOMEDICAL ENGINEERING
467
CHAPTER 1 BIOMEDICAL ENGINEERING
of the biliary system. From the hydrodynamic point of view, the cystic
duct lumen seems to serve as a passive resistor that strives to provide
a constant amount of resistance to control the flow of bile out of the
gallbladder.”
According to the news editors, the researchers concluded: “This is
mainly achieved by the coupling of the secondary flow effects and bile
rheology to provide flow resistance.”
For more information on this research see: Computational analysis
of the flow of bile in human cystic duct. Medical Engineering & Physics,
2012;34(8):1177-83. (Elsevier - www.elsevier.com; Medical Engineering
& Physics - http://www.elsevier.com/wps/product/cws_home/
30456)
Our news journalists report that additional information may be ob-
tained by contacting M. Al-Atabi, School of Engineering, Taylor’s Uni-
versity, No 1 Jalan Taylor’s, 47500 Subang Jaya, Selangor, Malaysia.
(2012 Sep 28)
468
CHAPTER 1 BIOMEDICAL ENGINEERING
importance given to the quality of bone in the success of the joint re-
placement.”
According to the news reporters, the researchers concluded: “Bear-
ing in mind the conditions addressed, the results lead to conclude that
the stress shielding is not a key factor for the humeral component failure
of shoulder arthroplasties in a healthy situation though several issues,
including muscle function and bone quality, may heighten its effect.”
For more information on this research see: Bone remodelling anal-
ysis of the humerus after a shoulder arthroplasty. Medical Engi-
neering & Physics, 2012;34(8):1132-8. (Elsevier - www.elsevier.com;
Medical Engineering & Physics - http://www.elsevier.com/wps/
product/cws_home/30456)
Our news journalists report that additional information may be ob-
tained by contacting C. Quental, IDMEC, Instituto Superior Tecnico,
Technical University of Lisbon, Av Rovisco Pais, 1049-001 Lisbon, Por-
tugal. (2012 Sep 28)
469
CHAPTER 1 BIOMEDICAL ENGINEERING
470
CHAPTER 1 BIOMEDICAL ENGINEERING
471
CHAPTER 1 BIOMEDICAL ENGINEERING
472
CHAPTER 1 BIOMEDICAL ENGINEERING
473
CHAPTER 1 BIOMEDICAL ENGINEERING
474
CHAPTER 1 BIOMEDICAL ENGINEERING
475
CHAPTER 1 BIOMEDICAL ENGINEERING
476
CHAPTER 1 BIOMEDICAL ENGINEERING
477
CHAPTER 1 BIOMEDICAL ENGINEERING
478
CHAPTER 1 BIOMEDICAL ENGINEERING
479
CHAPTER 1 BIOMEDICAL ENGINEERING
480
CHAPTER 1 BIOMEDICAL ENGINEERING
481
CHAPTER 1 BIOMEDICAL ENGINEERING
482
CHAPTER 1 BIOMEDICAL ENGINEERING
483
CHAPTER 1 BIOMEDICAL ENGINEERING
484
CHAPTER 1 BIOMEDICAL ENGINEERING
485
CHAPTER 1 BIOMEDICAL ENGINEERING
486
CHAPTER 1 BIOMEDICAL ENGINEERING
487
CHAPTER 1 BIOMEDICAL ENGINEERING
488
CHAPTER 1 BIOMEDICAL ENGINEERING
489
CHAPTER 1 BIOMEDICAL ENGINEERING
490
CHAPTER 1 BIOMEDICAL ENGINEERING
491
CHAPTER 1 BIOMEDICAL ENGINEERING
492
CHAPTER 1 BIOMEDICAL ENGINEERING
Human metabolic work rate was derived in real time from breath-by-
breath measurements of oxygen uptake and carbon dioxide output. The
results show that the feedback method provides close to nominal per-
formance for square-wave and ramp reference tracking tasks and that
good disturbance rejection properties are obtained. A collateral find-
ing of this work is an estimate of 14.5% of the metabolic efficiency of
robotics-assisted treadmill exercise. The use of feedback control of hu-
man metabolic work rate provides a direct measure of exercise intensity
as perceived by the exercising human as it directly reflects the energy
requirements of the working muscles. This complements previous ap-
proaches to guiding robotics-assisted treadmill training based on me-
chanical work rate, heart rate or oxygen uptake. The new approach
based on metabolic work rate may have advantages in populations with
compromised and widely varying exercise responses.”
According to the news editors, the researchers concluded: “This pro-
vides a new approach for driving and controlling active patient partici-
pation during robotics-assisted treadmill exercise.”
For more information on this research see: Feedback control of hu-
man metabolic work rate during robotics-assisted treadmill exercise.
Biomedical Signal Processing and Control, 2012;7(5):537-541. Biomed-
ical Signal Processing and Control can be contacted at: Elsevier Sci Ltd,
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, Oxon,
England. (Elsevier - www.elsevier.com; Biomedical Signal Process-
ing and Control - http://www.elsevier.com/wps/product/cws_
home/706718)
The news correspondents report that additional information may be
obtained from K.J. Hunt, Bern Univ Appl Sci, Dept. of Mech Engn,
Inst Rehabil & Performance Technol, CH-3400 Burgdorf, Switzerland.
(2012 Sep 18)
493
CHAPTER 1 BIOMEDICAL ENGINEERING
494
CHAPTER 1 BIOMEDICAL ENGINEERING
patients, twenty patients accepted ENT surgery, of which ten have re-
ceived Atropine, while the others have not. The other ten patients who
have accepted abdominal surgery with an electric knife were compared
with the previously mentioned ten patients who did not receive an At-
ropine injection for ENT surgery. As a result, the FFT that is applied in
this study was replaced with the HHT for analysing the data in a par-
ticular frequency range of sympathetic and parasympathetic divisions,
because of the lesser response of the results that were analysed by FFT
for intubation.”
According to the news editors, the researchers concluded: “Also,
BFV is proven to be a useful indicator for assisting doctors to assess
the state of the patients instead of HRV during the operation in com-
parison with HRV under drugs (i.e., Atropine and Glycopyrrolate) and
diathermy effects (i.e., high frequency interference from electric knife).”
For more information on this research see: A comparison of pa-
tients’ heart rate variability and blood flow variability during surgery
based on the Hilbert-Huang Transform. Biomedical Signal Process-
ing and Control, 2012;7(5):465-473. Biomedical Signal Processing and
Control can be contacted at: Elsevier Sci Ltd, The Boulevard, Lang-
ford Lane, Kidlington, Oxford OX5 1GB, Oxon, England. (Elsevier -
www.elsevier.com; Biomedical Signal Processing and Control - http:
//www.elsevier.com/wps/product/cws_home/706718)
Our news journalists report that additional information may be ob-
tained by contacting S.Z. Fan, Natl Cent Univ, Center Dynam Biomark-
ers & Translat Med, Taipei, Taiwan. (2012 Sep 17)
495
CHAPTER 1 BIOMEDICAL ENGINEERING
496
CHAPTER 1 BIOMEDICAL ENGINEERING
497
CHAPTER 1 BIOMEDICAL ENGINEERING
498
CHAPTER 1 BIOMEDICAL ENGINEERING
499
CHAPTER 1 BIOMEDICAL ENGINEERING
second copy of the morphed model was further refined through mesh
mapping, in which surface nodes of the initial morphed model were se-
lected in patches and remapped onto the surfaces of the target model.
Computed tomography intensity-based material properties were as-
signed to each model. The source, target, morphed and mapped models
were analyzed under axial compression using linear static FE analysis,
and their strain distributions were evaluated. Morphing and mapping
techniques were effectively applied to generate good quality and geo-
metrically complex specimen-specific pelvic FE models.”
According to the news reporters, the researchers concluded: “Map-
ping significantly improved strain concurrence with the target pelvis
FE model.C.”
For more information on this research see: Evaluation of mesh
morphing and mapping techniques in patient specific modelling of
the human pelvis. International Journal for Numerical Methods
in Biomedical Engineering, 2012;28(8):904-913. International Jour-
nal for Numerical Methods in Biomedical Engineering can be con-
tacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774,
NJ, USA. (Wiley-Blackwell - http://www.wiley.com/; Interna-
tional Journal for Numerical Methods in Biomedical Engineering
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
2040-7947)
Our news journalists report that additional information may be ob-
tained by contacting Z. Salo, Sunnybrook Res Inst, Holland Musku-
loskeletal Res Program Toronto, Toronto, ON, Canada. (2012 Sep 12)
500
CHAPTER 1 BIOMEDICAL ENGINEERING
501
CHAPTER 1 BIOMEDICAL ENGINEERING
502
CHAPTER 1 BIOMEDICAL ENGINEERING
503
CHAPTER 1 BIOMEDICAL ENGINEERING
504
CHAPTER 1 BIOMEDICAL ENGINEERING
505
CHAPTER 1 BIOMEDICAL ENGINEERING
polarization imaging identified the location, size, and shape of the tu-
mor in all the cases investigated. Averaged fluorescence polarization
values of tumor were higher as compared to normal tissue. Statistical
analysis confirmed the significance of these differences. Fluorescence
confocal imaging enabled cellular-level resolution. Evaluation and sta-
tistical analysis of MB fluorescence polarization values registered from
single tumor and normal cells demonstrated higher fluorescence polar-
ization from cancer.”
According to the news reporters, the researchers concluded: “Wide-
field high-resolution fluorescence and fluorescence polarization imaging
shows promise for intraoperative delineation of breast cancers.”
For more information on this research see: Multimodal optical
imaging for detecting breast cancer. Journal of Biomedical Optics,
2012;17(6):066008.
Our news correspondents report that additional information may be
obtained by contacting R. Patel, University of Massachusetts Lowell,
Advanced Biophotonics Laboratory, 175 Cabot Street, Suite 110-111,
Lowell, Massachusetts 01854, United States. (2012 Sep 11)
506
CHAPTER 1 BIOMEDICAL ENGINEERING
507
CHAPTER 1 BIOMEDICAL ENGINEERING
508
CHAPTER 1 BIOMEDICAL ENGINEERING
509
CHAPTER 1 BIOMEDICAL ENGINEERING
510
CHAPTER 1 BIOMEDICAL ENGINEERING
511
CHAPTER 1 BIOMEDICAL ENGINEERING
512
CHAPTER 1 BIOMEDICAL ENGINEERING
513
CHAPTER 1 BIOMEDICAL ENGINEERING
retina was regarded as a Lambertian surface and was assigned its cor-
responding reflectance at each wavelength. The optical performance of
the eye model was evaluated in CodeV and ASAP and presented by the
modulation transfer functions at single and multiple wavelengths. The
chromatic optical powers obtained from this model resembled that of
the average physiological eyes. The scattering property was assessed
by means of glare veiling luminance and compared with the CIE gen-
eral disability glare equation. By replacing the transparent lens with a
cataractous lens, the disability glare curve of cataracts was generated
to compare with the normal disability glare curve.”
According to the news editors, the researchers concluded: “This
model has high potential for investigating visual performance in ordi-
nary lighting and display conditions and under the influence of glare
sources.”
For more information on this research see: Development of a human
eye model incorporated with intraocular scattering for visual perfor-
mance assessment. Journal of Biomedical Optics, 2012;17(7):075009.
Our news journalists report that additional information may be ob-
tained by contacting Y.C. Chen, National Central University, Institute
of Lighting and Display Science, Dept. of Optics and Photonics, Jhongli
320, Taiwan. (2012 Sep 05)
514
CHAPTER 1 BIOMEDICAL ENGINEERING
515
CHAPTER 1 BIOMEDICAL ENGINEERING
516
CHAPTER 1 BIOMEDICAL ENGINEERING
517
CHAPTER 1 BIOMEDICAL ENGINEERING
518
CHAPTER 1 BIOMEDICAL ENGINEERING
519
CHAPTER 1 BIOMEDICAL ENGINEERING
520
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from Thorax
Center, “By subdividing the digitized spectrum into a number of dis-
tinct narrower windows, each with a different center frequency, several
independent speckle patterns result. These can be averaged to yield a
lower-resolution image with strongly reduced speckle. The full resolu-
tion image remains available for human interpretation; the low resolu-
tion version can be used for parametric imaging or quantitative analy-
sis.”
According to the news reporters, the researchers concluded: “We
demonstrate this technique using intravascular optical frequency do-
main imaging data acquired in vivo.”
For more information on this research see: Frequency domain multi-
plexing for speckle reduction in optical coherence tomography. Journal
of Biomedical Optics, 2012;17(7):076018.
Our news correspondents report that additional information may
be obtained by contacting G. van Soest, Thorax Center, Erasmus MC,
Rotterdam, Netherlands. (2012 Sep 05)
521
CHAPTER 1 BIOMEDICAL ENGINEERING
522
CHAPTER 1 BIOMEDICAL ENGINEERING
523
CHAPTER 1 BIOMEDICAL ENGINEERING
524
CHAPTER 1 BIOMEDICAL ENGINEERING
525
CHAPTER 1 BIOMEDICAL ENGINEERING
526
CHAPTER 1 BIOMEDICAL ENGINEERING
527
CHAPTER 1 BIOMEDICAL ENGINEERING
528
CHAPTER 1 BIOMEDICAL ENGINEERING
529
CHAPTER 1 BIOMEDICAL ENGINEERING
530
CHAPTER 1 BIOMEDICAL ENGINEERING
531
CHAPTER 1 BIOMEDICAL ENGINEERING
532
CHAPTER 1 BIOMEDICAL ENGINEERING
533
CHAPTER 1 BIOMEDICAL ENGINEERING
534
CHAPTER 1 BIOMEDICAL ENGINEERING
535
CHAPTER 1 BIOMEDICAL ENGINEERING
536
CHAPTER 1 BIOMEDICAL ENGINEERING
537
CHAPTER 1 BIOMEDICAL ENGINEERING
538
CHAPTER 1 BIOMEDICAL ENGINEERING
539
CHAPTER 1 BIOMEDICAL ENGINEERING
540
CHAPTER 1 BIOMEDICAL ENGINEERING
541
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research from Tsinghua
University, “We have developed a novel system of full-field optical coher-
ence tomography (FF-OCT) for noninvasive 3D subcellular live imaging
of preimplantation mouse embryos with no need of dye labeling. 3D
digitized embryos can be obtained by image processing. Label-free 3D
live imaging is demonstrated for the mouse embryos at various typical
preimplantation stages with a spatial resolution of 0.7 [micro sign]m
and imaging rate of 24 fps. Factors that relate to early patterning and
polarity, such as pronuclei in zygote, shapes of zona pellucida, location
of second polar body, cleavage planes, and the blastocyst axis, can be
quantitatively measured. The angle between the two second cleavage
planes is accurately measured to be 87 deg.”
According to the news editors, the researchers concluded: “It is
shown that FF-OCT provides a potential breakthrough for early pat-
terning, polarity formation, and many other preimplantation-related
studies in mammalian developmental biology.”
For more information on this research see: Label-free subcellu-
lar 3D live imaging of preimplantation mouse embryos with full-
field optical coherence tomography. Journal of Biomedical Optics,
2012;17(7):070503.
The news editors report that additional information may be obtained
by contacting J.G. Zheng, Tsinghua University, Dept. of Physics and
State Key Lab of Low-Dimensional Quantum Physics, Beijing, People’s
Taiwan. (2012 Sep 04)
542
CHAPTER 1 BIOMEDICAL ENGINEERING
543
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from the
University of Cincinnati, “In the preliminary experiment, we have col-
lected several thousand cell images over a period of 72 h of infection
with a 2-h sampling frequency that covers various stages of infection
by Francisella tularenesis (Ft). Segmentation of macrophages in im-
ages was accomplished using a fully automatic, parallel region growing
technique. Over two thousand feature descriptors for the host cell were
calculated. Multidimensional scaling, followed by hierarchical cluster-
ing, was used to group the cells.”
According to the news reporters, the researchers concluded: “Pre-
liminary results show that the host-cell phenotype, as defined by the
set of measureable features, groups into different classes that can be
mapped to the stages of infection.”
For more information on this research see: Mapping Infected
Cell Phenotype. IEEE Transactions on Biomedical Engineering,
2012;59(8):2362-2371. IEEE Transactions on Biomedical Engineering
can be contacted at: Ieee-Inst Electrical Electronics Engineers Inc, 445
Hoes Lane, Piscataway, NJ 08855-4141, USA. (Institute of Electrical
and Electronics Engineers - http://www.ieee.org/; IEEE Transac-
tions on Biomedical Engineering - http://ieeexplore.ieee.org/
xpl/RecentIssue.jsp?punumber=10)
Our news correspondents report that additional information may be
obtained by contacting U. Adiga, University of Cincinnati, Center Drug
Discovery, Cincinnati, OH 45237, United States. (2012 Sep 04)
544
CHAPTER 1 BIOMEDICAL ENGINEERING
545
CHAPTER 1 BIOMEDICAL ENGINEERING
546
CHAPTER 1 BIOMEDICAL ENGINEERING
547
CHAPTER 1 BIOMEDICAL ENGINEERING
548
CHAPTER 1 BIOMEDICAL ENGINEERING
549
CHAPTER 1 BIOMEDICAL ENGINEERING
550
CHAPTER 1 BIOMEDICAL ENGINEERING
551
CHAPTER 1 BIOMEDICAL ENGINEERING
552
CHAPTER 1 BIOMEDICAL ENGINEERING
553
CHAPTER 1 BIOMEDICAL ENGINEERING
554
CHAPTER 1 BIOMEDICAL ENGINEERING
555
CHAPTER 1 BIOMEDICAL ENGINEERING
556
CHAPTER 1 BIOMEDICAL ENGINEERING
557
CHAPTER 1 BIOMEDICAL ENGINEERING
558
CHAPTER 1 BIOMEDICAL ENGINEERING
559
CHAPTER 1 BIOMEDICAL ENGINEERING
children for both the tibialis anterior and the gastrocnemius, and their
tibialis anterior activation profile was different.”
According to the news reporters, the researchers concluded: “This
study showed that in children aged from 7 to 10 years old neuromuscu-
lar responses were not mature enough to generate continuous postural
corrective torque in response to the perturbation.”
For more information on this research see: Postural control adjust-
ments during progressive inclination of the support surface in chil-
dren. Medical Engineering & Physics, 2012;34(7):1019-23. (Elsevier
- www.elsevier.com; Medical Engineering & Physics - http://www.
elsevier.com/wps/product/cws_home/30456)
Our news correspondents report that additional information may be
obtained by contacting M. Blanchet, Universite du Quebec a Montreal -
Kinanthropologie, Faculte des Sciences, 141 President-Kennedy, Mon-
treal, QC H2X 1Y4, Canada. (2012 Aug 31)
560
CHAPTER 1 BIOMEDICAL ENGINEERING
561
CHAPTER 1 BIOMEDICAL ENGINEERING
562
CHAPTER 1 BIOMEDICAL ENGINEERING
which are used in these models, have been obtained from two orthogo-
nal X-ray images: one from anteroposterior, AP, direction and the other
from a lateral, L, direction. The quality of the results of this model is
dependent on the accuracy of the input parameters. Measuring these
parameters is a time-consuming issue, and the accuracy of the results
is also low. To increase the quality of the measurement, the reference
points should be chosen from the edges of the biomedical system, and
it is important to find the edges without noise. To achieve this purpose,
Sobel edge detector, binary large object analysis, thresholding and in-
verting are applied as image processing steps. The results are compared
with manual measurement values which have been obtained earlier.
The results show that semi-automatic measurement of the parameters
is more accurate and faster than manual measurement.”
According to the news editors, the researchers concluded: “It shows
that the efficiency of the fixator method has been improved.”
For more information on this research see: A hybrid image process-
ing system for X-ray images of an external fixator. Computer Methods
In Biomechanics and Biomedical Engineering, 2012;15(7):753-9.
Our news journalists report that additional information may be ob-
tained by contacting A. Aydin, Electrical and Electronics Engineering,
Cukurova University, Adana, Turkey. (2012 Aug 29)
563
CHAPTER 1 BIOMEDICAL ENGINEERING
564
CHAPTER 1 BIOMEDICAL ENGINEERING
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-0801)
Our news journalists report that additional information may be ob-
tained by contacting Z. Deng, Institute of Materia Medica, Shandong
Academy of Medical Sciences, Jinan 250062, People’s Taiwan. (2012
Aug 29)
565
CHAPTER 1 BIOMEDICAL ENGINEERING
566
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from the Uni-
versity of Leicester, “Techniques reviewed include high-performance
liquid chromatography, ultra-high-performance liquid chromatogra-
phy, capillary electrophoresis, ion mobility spectrometry, mass spec-
trometry and tandem mass spectrometry.”
According to the news reporters, the researchers concluded: “The
emphasis was on the analysis of biological and clinical samples.”
For more information on this research see: Liquid chromatog-
raphy and mass spectrometry of haem biosynthetic intermedi-
ates: a review. Biomedical Chromatography, 2012;26(8):1009-
1023. Biomedical Chromatography can be contacted at: Wiley-
Blackwell, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-
Blackwell - http://www.wiley.com/; Biomedical Chromatography
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-0801)
Our news correspondents report that additional information may be
obtained by contacting C.M. Benton, University of Leicester, RKCSB,
Leicester LE2 7LX, Leics, United Kingdom. (2012 Aug 28)
567
CHAPTER 1 BIOMEDICAL ENGINEERING
568
CHAPTER 1 BIOMEDICAL ENGINEERING
569
CHAPTER 1 BIOMEDICAL ENGINEERING
570
CHAPTER 1 BIOMEDICAL ENGINEERING
571
CHAPTER 1 BIOMEDICAL ENGINEERING
572
CHAPTER 1 BIOMEDICAL ENGINEERING
573
CHAPTER 1 BIOMEDICAL ENGINEERING
574
CHAPTER 1 BIOMEDICAL ENGINEERING
(HPLC and LC-MS/MS) that have been reported for direct quantitation
of aspirin along with its metabolite(s).”
According to the news editors, the researchers concluded: “The re-
view also provides general information on sample collection, sample
processing, internal standard selection, conditions for chromatographic
separation, succinct validation data and applicable conclusions for re-
ported assays in a structured manner.”
For more information on this research see: Review of HPLC meth-
ods and HPLC methods with mass spectrometric detection for direct
determination of aspirin with its metabolite(s) in various biological
matrices. Biomedical Chromatography, 2012;26(8):906-41. (Wiley-
Blackwell - http://www.wiley.com/; Biomedical Chromatography
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-0801)
Our news journalists report that additional information may be ob-
tained by contacting R. Mullangi, Drug Metabolism and Pharmacoki-
netics, Jubilant Biosys Ltd, Industrial Suburb, Yeshwanthpur, Banga-
lore, 560 022, India. (2012 Aug 13)
575
CHAPTER 1 BIOMEDICAL ENGINEERING
576
CHAPTER 1 BIOMEDICAL ENGINEERING
577
CHAPTER 1 BIOMEDICAL ENGINEERING
578
CHAPTER 1 BIOMEDICAL ENGINEERING
579
CHAPTER 1 BIOMEDICAL ENGINEERING
580
CHAPTER 1 BIOMEDICAL ENGINEERING
581
CHAPTER 1 BIOMEDICAL ENGINEERING
582
CHAPTER 1 BIOMEDICAL ENGINEERING
583
CHAPTER 1 BIOMEDICAL ENGINEERING
584
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
University of Southampton, “The experimental system consists of a mi-
crofluidic chamber for arraying the particles in a manner suitable for
high throughput imaging using a simple fluorescent microscope, to-
gether with custom software for automated code readout and analysis
of assay response. The platform is demonstrated with a multiplexed
antibody assay targeting 3 different human inflammatory cytokines.”
According to the news editors, the researchers concluded: “The suit-
ability of the platform for other bio-analytical applications is discussed.”
For more information on this research see: Multiplexed suspen-
sion array platform for high-throughput protein assays. Biomedi-
cal Microdevices, 2012;14(4):651-657. Biomedical Microdevices can be
contacted at: Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht,
Netherlands. (Springer - www.springer.com; Biomedical Microdevices
- http://www.springerlink.com/content/1387-2176/)
The news correspondents report that additional information may be
obtained from S.W. Birtwell, University of Southampton, Sch Chem,
Southampton SO17 1BJ, Hants, United Kingdom. (2012 Aug 07)
585
CHAPTER 1 BIOMEDICAL ENGINEERING
586
CHAPTER 1 BIOMEDICAL ENGINEERING
587
CHAPTER 1 BIOMEDICAL ENGINEERING
588
CHAPTER 1 BIOMEDICAL ENGINEERING
589
CHAPTER 1 BIOMEDICAL ENGINEERING
590
CHAPTER 1 BIOMEDICAL ENGINEERING
591
CHAPTER 1 BIOMEDICAL ENGINEERING
592
CHAPTER 1 BIOMEDICAL ENGINEERING
593
CHAPTER 1 BIOMEDICAL ENGINEERING
594
CHAPTER 1 BIOMEDICAL ENGINEERING
595
CHAPTER 1 BIOMEDICAL ENGINEERING
596
CHAPTER 1 BIOMEDICAL ENGINEERING
597
CHAPTER 1 BIOMEDICAL ENGINEERING
lumen surface for both the main vessel and the side branches in the
vicinity of bifurcations.”
The news reporters obtained a quote from the research from the City
University of London, “To address this, we propose the estimation of the
centerline and the reference surface through the registration of an ellip-
tical cross-sectional tube to the desired constituent vessel in each major
bifurcation of the arterial tree. The proposed method works directly on
the mesh domain, thus alleviating the need for image upsampling, usu-
ally required in conventional volume domain approaches. We demon-
strate the efficiency and accuracy of the method on both synthetic im-
ages and coronary CT angiograms. Experimental results show that the
new method is capable of estimating vessel centerlines and reference
surfaces with a high degree of agreement to those obtained through
manual delineation.”
According to the news reporters, the researchers concluded: “The
centerline errors are reduced by an average of 62.3% in the regions of
the bifurcations, when compared to the results of the initial solution
obtained through the use of mesh contraction method.”
For more information on this research see: 3-D Quantitative Vascu-
lar Shape Analysis for Arterial Bifurcations via Dynamic Tube Fitting.
IEEE Transactions on Biomedical Engineering, 2012;59(7):1850-1860.
IEEE Transactions on Biomedical Engineering can be contacted at:
Ieee-Inst Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscat-
away, NJ 08855-4141, USA. (Institute of Electrical and Electronics En-
gineers - http://www.ieee.org/; IEEE Transactions on Biomedical
Engineering - http://ieeexplore.ieee.org/xpl/RecentIssue.
jsp?punumber=10)
Our news correspondents report that additional information may be
obtained by contacting Y. Wang, City University of London, Informat
Engn & Med Imaging Grp, London EC1V 0HB, United Kingdom. (2012
Aug 01)
598
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from ESPCI,
“To do so, a dedicated ultrasound array intended to both detect photoa-
coustic waves and emit HIFU with the same elements was used. Such a
dual-mode array provides automatically coregistered reference frames
for photoacoustic detection and HIFU emission, a highly desired fea-
ture for methods involving guidance or monitoring of HIFU by use of
photoacoustics. The prototype is first characterized in terms of both
photoacoustic and HIFU performances.”
According to the news reporters, the researchers concluded: “The
probe is then used to perform an idealized scenario of photoacoustic-
guided therapy, where photoacoustic signals generated by an absorbing
thread embedded in a piece of chicken breast are used to automatically
refocus a HIFU beam with a time-reversal mirror and necrose the tissue
at the location of the absorber.”
For more information on this research see: Photoacoustic-guided
ultrasound therapy with a dual-mode ultrasound array. Journal of
Biomedical Optics, 2012;17(6):119-124. Journal of Biomedical Optics
can be contacted at: Spie-Soc Photo-Optical Instrumentation Engi-
neers, 1000 20TH St, PO Box 10, Bellingham, WA 98225, USA.
Our news correspondents report that additional information may
be obtained by contacting A. Prost, ESPCI ParisTech, Inst Langevin,
CNRS UMR 7587, INSERM ERL U979, F-75231 Paris 05, France.
(2012 Aug 01)
599
CHAPTER 1 BIOMEDICAL ENGINEERING
600
CHAPTER 1 BIOMEDICAL ENGINEERING
601
CHAPTER 1 BIOMEDICAL ENGINEERING
602
CHAPTER 1 BIOMEDICAL ENGINEERING
603
CHAPTER 1 BIOMEDICAL ENGINEERING
604
CHAPTER 1 BIOMEDICAL ENGINEERING
605
CHAPTER 1 BIOMEDICAL ENGINEERING
606
CHAPTER 1 BIOMEDICAL ENGINEERING
(EVestG) for extracting field potentials (FPs) from artefact rich and
noisy ear canal recordings is presented. Averaged FP waveforms can
be used to aid detection of acoustic and or vestibular pathologies.”
Our news editors obtained a quote from the research from Monash
University, “FPs were recorded in the external ear canal proximal to
the ear drum. These FPs were extracted using an algorithm called
NEER. NEER utilises a modified complex Morlet wavelet analysis of
phase change across multiple scales and a template matching (matched
filter) methodology to detect FPs buried in noise and biological and en-
vironmental artefacts. Initial simulation with simulated FPs shows
NEER detects FPs down to -30 dB SNR (power) but only 13-23% of
those at SNR’s <-6 dB. This was deemed applicable to longer dura-
tion recordings wherein averaging could be applied as many FPs are
present. NEER was applied to detect both spontaneous and whole body
tilt evoked FPs. By subtracting the averaged tilt FP response from the
averaged spontaneous FP response it is believed this difference is more
representative of the vestibular response. Significant difference (p <
0.05) between up and down whole body (supine and sitting) movements
was achieved.”
According to the news editors, the researchers concluded: “Patho-
logic and physiologic evidence in support of a vestibular and acoustic
origin is also presented.”
For more information on this research see: A Methodology for De-
tecting Field Potentials from the External Ear Canal: NEER and
EVestG. Annals of Biomedical Engineering, 2012;40(8):1835-1850. An-
nals of Biomedical Engineering can be contacted at: Springer, 233
Spring St, New York, NY 10013, USA. (Springer - www.springer.com;
Annals of Biomedical Engineering - http://www.springerlink.
com/content/0090-6964/)
The news editors report that additional information may be obtained
by contacting B. Lithgow, Monash University, Diagnost & Neurosignal
Proc Res Lab, Clayton, Vic, Australia. (2012 Aug 01)
607
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research from the
National Research Council of Canada, “Here we report the use of a re-
mote optical method, derived from industrial laser-ultrasonics, to detect
ultrasound in tissues. This approach enables non-contact PAT (NCPAT)
without exceeding laser exposure safety limits. The sensitivity of the
method is based on the use of suitably shaped detection laser pulses and
a confocal Fabry-Perot interferometer in differential configuration. Re-
liable image reconstruction is obtained by measuring remotely the sur-
face profile of the tissue with an optical coherence tomography system.
The proposed method also allows non-contact ultrasound imaging (US)
by applying a second reconstruction algorithm to the data acquired for
NCPAT. Endogenous and exogenous inclusions exhibiting optical and
acoustic contrasts were detected ex vivo in chicken breast and calf brain
specimens. Inclusions down to 0.3 mm in size were detected at depths
exceeding 1 cm.”
According to the news editors, the researchers concluded: “The
method could expand the scope of photoacoustic and US to in-vivo
biomedical applications where contact is impractical.”
For more information on this research see: Non-contact biomedical
photoacoustic and ultrasound imaging. Journal of Biomedical Optics,
2012;17(6):228-234. Journal of Biomedical Optics can be contacted at:
Spie-Soc Photo-Optical Instrumentation Engineers, 1000 20TH St, PO
Box 10, Bellingham, WA 98225, USA.
Our news journalists report that additional information may be ob-
tained by contacting G. Rousseau, Natl Res Council Canada, Inst Ind
Mat, Boucherville, PQ J4B 6Y4, Canada. (2012 Aug 01)
608
CHAPTER 1 BIOMEDICAL ENGINEERING
609
CHAPTER 1 BIOMEDICAL ENGINEERING
show the control effectiveness of the MFN to the endoscopic capsule. Fi-
nally, several prototype endoscopic capsules and a prototype MFN are
fabricated, and their actual capabilities are experimentally assessed via
in vitro and ex vivo tests using a stomach model and a resected porcine
stomach, respectively.”
According to the news reporters, the researchers concluded: “Both
in vitro and ex vivo test results demonstrate great potential and practi-
cability of achieving high-precision rotation and controllable movement
of the capsule using the developed MFN.”
For more information on this research see: Magnetic Control System
Targeted for Capsule Endoscopic Operations in the Stomach-Design,
Fabrication, and in vitro and ex vivo Evaluations. IEEE Transactions
on Biomedical Engineering, 2012;59(7):2068-2079. IEEE Transactions
on Biomedical Engineering can be contacted at: Ieee-Inst Electrical
Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ 08855-4141,
USA. (Institute of Electrical and Electronics Engineers - http://www.
ieee.org/; IEEE Transactions on Biomedical Engineering - http:
//ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=10)
Our news correspondents report that additional information may be
obtained by contacting G.S. Lien, National Taiwan University, Dept. of
Elect Engn, Taipei 10617, Taiwan. (2012 Aug 01)
610
CHAPTER 1 BIOMEDICAL ENGINEERING
literature. The gain of the FRFs varied with frequency and no modula-
tion was observed across the stimulus amplitudes, indicating a linear
system response for the stimulations considered. Compared to single
sine stimulation, equivalent FRFs were observed during unpredictable
multisine stimulation, suggesting the responses during both stimuli to
be of a reflexive nature.”
According to the news editors, the researchers concluded: “These
results demonstrate the potential of GVS to investigate the vestibular
contribution to head-neck stabilization.”
For more information on this research see: Galvanic Vestibular
Stimulation Elicits Consistent Head-Neck Motion in Seated Subjects.
IEEE Transactions on Biomedical Engineering, 2012;59(7):1978-1984.
IEEE Transactions on Biomedical Engineering can be contacted at:
Ieee-Inst Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscat-
away, NJ 08855-4141, USA. (Institute of Electrical and Electronics En-
gineers - http://www.ieee.org/; IEEE Transactions on Biomedical
Engineering - http://ieeexplore.ieee.org/xpl/RecentIssue.
jsp?punumber=10)
The news editors report that additional information may be ob-
tained by contacting F. Ehtemam, Northwestern University, Chicago,
IL 60611, United States. (2012 Aug 01)
611
CHAPTER 1 BIOMEDICAL ENGINEERING
612
CHAPTER 1 BIOMEDICAL ENGINEERING
613
CHAPTER 1 BIOMEDICAL ENGINEERING
614
CHAPTER 1 BIOMEDICAL ENGINEERING
615
CHAPTER 1 BIOMEDICAL ENGINEERING
616
CHAPTER 1 BIOMEDICAL ENGINEERING
617
CHAPTER 1 BIOMEDICAL ENGINEERING
618
CHAPTER 1 BIOMEDICAL ENGINEERING
619
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research from the Uni-
versity of Connecticut, “These pulses can damage fibers if the damage
threshold is exceeded. While keeping the total energy under the Food
and Drug Administration limit for avoiding tissue damage, it is nec-
essary to reduce the peak intensity and increase the pulse duration
for minimizing fiber damage and delivering sufficient light for imag-
ing. We use laser-pulse-stretching to address this problem. An initial
17-ns pulse was stretched to 27 and 37 ns by a ring-cavity laser-pulse-
stretching system. The peak power of the 37-ns stretched pulse reduced
to 42% of the original, while the fiber damage threshold was increased
by 1.5-fold. Three ultrasound transducers centered at 1.3-, 3.5-, and
6-MHz frequencies were simulated, and the results showed that the
photoacoustic signal of a 0.5-mm-diameter target obtained with 37-ns
pulse was about 98, 91, and 80%, respectively, using the same energy
as the 17-ns pulse. Simulations were validated using a broadband hy-
drophone.”
According to the news editors, the researchers concluded: “Quanti-
tative comparisons of photoacoustic images obtained with three corre-
sponding transducers showed that the image quality was not affected
by stretching the pulse.”
For more information on this research see: Application of laser pulse
stretching scheme for efficiently delivering laser energy in photoacous-
tic imaging. Journal of Biomedical Optics, 2012;17(6):236-243. Journal
of Biomedical Optics can be contacted at: Spie-Soc Photo-Optical In-
strumentation Engineers, 1000 20TH St, PO Box 10, Bellingham, WA
98225, USA.
The news editors report that additional information may be obtained
by contacting T.H. Wang, University of Connecticut, Dept. of Elect &
Comp Engn, Storrs, CT 06269, United States. (2012 Aug 01)
620
CHAPTER 1 BIOMEDICAL ENGINEERING
621
CHAPTER 1 BIOMEDICAL ENGINEERING
622
CHAPTER 1 BIOMEDICAL ENGINEERING
were 0.85 +/- 0.056 and 0.88 +/- 0.05 without and with post processing,
respectively.”
According to the news editors, the researchers concluded: “The re-
sults showed that force can be estimated in 2 DoFs with high accu-
racy and that the degree of performance depended on the force function
(task) to be estimated.”
For more information on this research see: Simultaneous and Pro-
portional Force Estimation in Multiple Degrees of Freedom From In-
tramuscular EMG. IEEE Transactions on Biomedical Engineering,
2012;59(7):1804-1807. IEEE Transactions on Biomedical Engineering
can be contacted at: Ieee-Inst Electrical Electronics Engineers Inc, 445
Hoes Lane, Piscataway, NJ 08855-4141, USA. (Institute of Electrical
and Electronics Engineers - http://www.ieee.org/; IEEE Transac-
tions on Biomedical Engineering - http://ieeexplore.ieee.org/
xpl/RecentIssue.jsp?punumber=10)
The news correspondents report that additional information may be
obtained from E.N. Kamavuako, University of Gottingen, Dept. of Neu-
rorehabil Engn, Bernstein Center Computat Neurosci, Univ Med Cen-
ter Gottingen, D-37073 Gottingen, Germany. (2012 Aug 01)
623
CHAPTER 1 BIOMEDICAL ENGINEERING
624
CHAPTER 1 BIOMEDICAL ENGINEERING
625
CHAPTER 1 BIOMEDICAL ENGINEERING
average peak ACL internal force, from 1056.1 +/- A 71.4 to 1165.4 +/- A
123.8 N for the right side with comparable increases in the left.”
According to the news editors, the researchers concluded: “In effect
this study demonstrates a technique for estimating dynamic changes to
knee and ACL variables by conducting musculoskeletal simulation on
motion analysis data, collected from actual stop-jump tasks performed
by young recreational women athletes.”
For more information on this research see: A Numerical Simula-
tion Approach to Studying Anterior Cruciate Ligament Strains and
Internal Forces Among Young Recreational Women Performing Val-
gus Inducing Stop-Jump Activities. Annals of Biomedical Engineer-
ing, 2012;40(8):1679-1691. Annals of Biomedical Engineering can be
contacted at: Springer, 233 Spring St, New York, NY 10013, USA.
(Springer - www.springer.com; Annals of Biomedical Engineering -
http://www.springerlink.com/content/0090-6964/)
The news correspondents report that additional information may be
obtained from J. Kar, University of Louisville, Speed Sch Engn, Dept.
of Mech Engn, Louisville, KY 40292, United States. (2012 Aug 01)
626
CHAPTER 1 BIOMEDICAL ENGINEERING
627
CHAPTER 1 BIOMEDICAL ENGINEERING
628
CHAPTER 1 BIOMEDICAL ENGINEERING
629
CHAPTER 1 BIOMEDICAL ENGINEERING
630
CHAPTER 1 BIOMEDICAL ENGINEERING
631
CHAPTER 1 BIOMEDICAL ENGINEERING
632
CHAPTER 1 BIOMEDICAL ENGINEERING
633
CHAPTER 1 BIOMEDICAL ENGINEERING
634
CHAPTER 1 BIOMEDICAL ENGINEERING
635
CHAPTER 1 BIOMEDICAL ENGINEERING
636
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from Wuhan
University, “The hemocompatibility of ChS-n and HChS-n membranes
were comparatively evaluated by measuring surface heparin density,
blood platelet adhesion, plasma recalcification time (PRT), thrombus
formation and hemolysis assay. The surface heparin density analysis
showed that heparinized chitosan/SPI soy protein isolate membranes
have been successfully prepared by blending. The density of heparin on
the surface of HChS-n membranes was in the range of 0.67-1.29 g/cm2.
The results of platelet adhesion measurement showed that the platelet
adhesion numbers of HChS-n membranes were lower than those of the
corresponding ChS-n membranes. The PRT of the HChS-0, HChS-10
and HChS-30 membranes were around 292, 306 and 295 s, respectively,
which were longer than the corresponding ChS-0 (152 s), ChS-10 (204
s) and ChS-30 (273 s) membranes. The hemolysis rate of HChS-n mem-
branes was lower than 1%. The hemocompatibility of ChS membranes
could be improved by blending with heparin. Compared with ChS mem-
branes, HChS membranes showed lower platelet adhesion, longer PRT,
higher BCI, significant thromboresistivity and a lower hemolysis rate
due to the heparinization.”
According to the news reporters, the researchers concluded: “This
widens the application of chitosan and soy protein-based biomaterials
that may come in contact with blood.”
For more information on this research see: Improvement in hemo-
compatibility of chitosan/soy protein composite membranes by hep-
arinization. Bio-medical Materials and Engineering, 2012;22(1):143-
50.
Our news correspondents report that additional information may
be obtained by contacting X. Wang, Dept. of Biomedical Engineering,
School of Basic Medical Science, Wuhan University, Wuhan, China Re-
search Center for Medicine, Wuhan University, Wuhan, People’s Tai-
wan. (2012 Aug 01)
637
CHAPTER 1 BIOMEDICAL ENGINEERING
- Gln - Val - Leu - Ile - Gln - Val - Ile - Gly - Val). These peptides display
homology with fragments of albumin from Trimeresurus flavoviridis.”
According to the news editors, the researchers concluded: “Bolus
intra-arterial injection of the purified or the synthetic peptide produced
a strong and sustained vasopressor response in the anaesthetized snake
(CDT) and rats (Wistar); this hypotensive effect was also potentiated by
captopril-an angiotensin-converting (0.1 mg/kg) enzyme inhibitor.”
For more information on this research see: Characterization of two
vasoactive peptides isolated from the plasma of the snake Crotalus
durissus terrificus. Biomedicine & Pharmacotherapy, 2012;66(4):256-
265. Biomedicine & Pharmacotherapy can be contacted at: Elsevier
France-Editions Scientifiques Medicales Elsevier, 23 Rue Linois, 75724
Paris, France. (Elsevier - www.elsevier.com; Biomedicine & Pharma-
cotherapy - http://www.elsevier.com/wps/product/cws_home/
505810)
The news correspondents report that additional information may
be obtained from S.A. Barreto, Butantan Inst, Pharmacol Lab, BR-
05503900 Sao Paulo, Brazil. (2012 Jul 31)
638
CHAPTER 1 BIOMEDICAL ENGINEERING
assay found that those cells infected by CHIKV E1-H230A mutant bac-
ulovirus showed little fusion activity, and those bearing CHIKV E1-
G91D mutant completely lost the ability to induce cell-cell fusion. Cells
infected by recombinant baculoviruses of CHIKV E1-A226V and E1-
V178A mutants exhibited the same membrane fusion capability as wild
type. Although the E1 expression level of cells bearing monomeric-E1-
based constructs (expressing E1 only) was greater than that of cells
bearing 26S-based constructs (expressing all structural proteins), the
sizes of syncytial cells induced by infection of baculoviruses contain-
ing 26S-based constructs were larger than those from infections having
monomeric-E1 constructs, suggesting that other viral structure pro-
teins participate or regulate E1 fusion activity. Furthermore, mem-
brane fusion in cells infected by baculovirus bearing the A226V muta-
tion constructs exhibited increased cholesterol-dependences and lower
pH thresholds. Cells bearing the V178A mutation exhibited a slight
decrease in cholesterol-dependence and a higher-pH threshold for fu-
sion. Cells expressing amino acid substitutions of conserved protein E1
residues of E1-G91 and E1-H230 lost most of the CHIKV E1-mediated
membrane fusion activity.”
According to the news reporters, the researchers concluded: “Cells
expressing mutations of less-conserved amino acids, E1-V178A and E1-
A226V, retained membrane fusion activity to levels similar to those ex-
pressing wild type E1, but their fusion properties of pH threshold and
cholesterol dependence were slightly altered.”
For more information on this research see: Cell-based analy-
sis of Chikungunya virus E1 protein in membrane fusion. Jour-
nal of Biomedical Science, 2012;19():1-12. Journal of Biomedical
Science can be contacted at: Biomed Central Ltd, 236 Grays Inn
Rd, Floor 6, London WC1X 8HL, England. (BioMed Central -
http://www.biomedcentral.com/; Journal of Biomedical Science -
www.jbiomedsci.com)
Our news correspondents report that additional information may be
obtained by contacting S.C. Kuo, Chung Yuan Christian Univ, Dept. of
Biosci Technol, Chungli, Taiwan. (2012 Jul 31)
639
CHAPTER 1 BIOMEDICAL ENGINEERING
640
CHAPTER 1 BIOMEDICAL ENGINEERING
641
CHAPTER 1 BIOMEDICAL ENGINEERING
642
CHAPTER 1 BIOMEDICAL ENGINEERING
643
CHAPTER 1 BIOMEDICAL ENGINEERING
644
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from Oregon
Health and Science University, “Absorption contrast is achieved by al-
ternating the excitation wavelength: 488 nm (AO fluorescence) and 532
nm (Eo fluorescence). Superposition and false-coloring of these modes
mimics H&E, enabling detection of cutaneous squamous cell carcino-
mas (SCC). The sum of mosaic Eo + R is false-colored pink to mimic
the appearance of eosin, while the AO mosaic is false-colored purple to
mimic the appearance of hematoxylin in H&E. In this study, mosaics of
10 Mohs surgical excisions containing invasive SCC, and five containing
only normal tissue were subdivided for digital presentation equivalent
to 4x histology. Of the total 50 SCC and 25 normal sub-mosaics pre-
sented, two reviewers made two and three type-2 errors (false positives),
respectively. Limitations to precisely mimic H&E included occasional
elastin staining by AO.”
According to the news reporters, the researchers concluded: “These
results suggest that confocal mosaics may effectively guide staged SCC
excisions in skin and other tissues.”
For more information on this research see: Tri-modal confocal mo-
saics detect residual invasive squamous cell carcinoma in Mohs surgical
excisions. Journal of Biomedical Optics, 2012;17(6):460-464. Journal
of Biomedical Optics can be contacted at: Spie-Soc Photo-Optical In-
strumentation Engineers, 1000 20TH St, PO Box 10, Bellingham, WA
98225, USA.
Our news correspondents report that additional information may be
obtained by contacting D. Gareau, Oregon Health Sciences University,
Dept. of Biomed Engn, Portland, OR 97239, United States. (2012 Jul
31)
645
CHAPTER 1 BIOMEDICAL ENGINEERING
646
CHAPTER 1 BIOMEDICAL ENGINEERING
647
CHAPTER 1 BIOMEDICAL ENGINEERING
648
CHAPTER 1 BIOMEDICAL ENGINEERING
649
CHAPTER 1 BIOMEDICAL ENGINEERING
650
CHAPTER 1 BIOMEDICAL ENGINEERING
651
CHAPTER 1 BIOMEDICAL ENGINEERING
652
CHAPTER 1 BIOMEDICAL ENGINEERING
653
CHAPTER 1 BIOMEDICAL ENGINEERING
654
CHAPTER 1 BIOMEDICAL ENGINEERING
655
CHAPTER 1 BIOMEDICAL ENGINEERING
656
CHAPTER 1 BIOMEDICAL ENGINEERING
657
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research from the Uni-
versity of Melbourne, “However, under normal or pathological condi-
tions, valves can exhibit complex motions that are mainly determined by
the instantaneous difference between upstream and downstream pres-
sures.”
According to the news reporters, the researchers concluded: “We
present a simple valve model that predicts valve motion on the basis of
this pressure difference, and can be used to investigate not only valve
pathology, but a wide range of cardiac and vascular factors that are
likely to influence valve motion.”
For more information on this research see: A simple, versa-
tile valve model for use in lumped parameter and one-dimensional
cardiovascular models. International Journal for Numerical Meth-
ods in Biomedical Engineering, 2012;28(6-7):626-641. International
Journal for Numerical Methods in Biomedical Engineering can be
contacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774,
NJ, USA. (Wiley-Blackwell - http://www.wiley.com/; Interna-
tional Journal for Numerical Methods in Biomedical Engineering
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
2040-7947)
Our news correspondents report that additional information may be
obtained by contacting J.P. Mynard, University of Melbourne, Dept. of
Chem & Biomol Engn, Parkville, Vic 3052, Australia. (2012 Jul 30)
658
CHAPTER 1 BIOMEDICAL ENGINEERING
659
CHAPTER 1 BIOMEDICAL ENGINEERING
660
CHAPTER 1 BIOMEDICAL ENGINEERING
661
CHAPTER 1 BIOMEDICAL ENGINEERING
662
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news editors obtained a quote from the research by the authors
from University Hospital, “The inner ear was drained of fluid. Suc-
cessively, one of three different stapes prostheses was inserted. Af-
ter such preparation, the prosthesis piston movement compared to the
incus movement is measured with laser vibrometry. The magnitude
transfer function considered is defined as the amplitude of the prosthe-
sis piston movement compared to the amplitude of the incus movement.
Measurements were made in a frequency range from 500 Hz to 4 kHz.
The measured amplitudes roughly ranged between 10 nm and 100 nm.
A great advantage of the presented method is the fact that only a small
portion of the ossicular chain influences the measurement, mainly the
joint between the prosthesis and the incus. Furthermore, the usage of
cadaver temporal bones allows for an automated measurement setup,
long term experiments and the access of measurement positions inap-
proachable during in vivo measurements.”
According to the news editors, the researchers concluded: “With this
method, the different kinds of prostheses could be evaluated on incuses
of different diameters.”
For more information on this research see: A method for character-
izing stapes prostheses by their mechanical transfer function. Medi-
cal Engineering & Physics, 2012;34(5):659-663. Medical Engineering &
Physics can be contacted at: Elsevier Sci Ltd, The Boulevard, Lang-
ford Lane, Kidlington, Oxford OX5 1GB, Oxon, England. (Elsevier
- www.elsevier.com; Medical Engineering & Physics - http://www.
elsevier.com/wps/product/cws_home/30456)
The news editors report that additional information may be obtained
by contacting A. Sutor, University Hospital Erlangen, Sch Med, Dept.
of Phoniatr & Pediat Audiol, Erlangen, Germany. (2012 Jul 27)
663
CHAPTER 1 BIOMEDICAL ENGINEERING
664
CHAPTER 1 BIOMEDICAL ENGINEERING
665
CHAPTER 1 BIOMEDICAL ENGINEERING
666
CHAPTER 1 BIOMEDICAL ENGINEERING
667
CHAPTER 1 BIOMEDICAL ENGINEERING
668
CHAPTER 1 BIOMEDICAL ENGINEERING
669
CHAPTER 1 BIOMEDICAL ENGINEERING
670
CHAPTER 1 BIOMEDICAL ENGINEERING
671
CHAPTER 1 BIOMEDICAL ENGINEERING
672
CHAPTER 1 BIOMEDICAL ENGINEERING
673
CHAPTER 1 BIOMEDICAL ENGINEERING
674
CHAPTER 1 BIOMEDICAL ENGINEERING
675
CHAPTER 1 BIOMEDICAL ENGINEERING
676
CHAPTER 1 BIOMEDICAL ENGINEERING
677
CHAPTER 1 BIOMEDICAL ENGINEERING
678
CHAPTER 1 BIOMEDICAL ENGINEERING
679
CHAPTER 1 BIOMEDICAL ENGINEERING
680
CHAPTER 1 BIOMEDICAL ENGINEERING
681
CHAPTER 1 BIOMEDICAL ENGINEERING
682
CHAPTER 1 BIOMEDICAL ENGINEERING
683
CHAPTER 1 BIOMEDICAL ENGINEERING
translocation occurs in the depth direction where two probed FISH sig-
nals are overlapped in the projected image plane. Thus, the transloca-
tion cannot be identified. However, when imaging the whole specimen
with a confocal microscope at 27 focal planes with 0.5-mu m step inter-
val, the translocation can be clearly identified due to the free rotation
capability by the three-dimensional (3-D) visualization. Such a translo-
cation detection error of using 2-D images might be critical in detecting
and diagnosing early or subtle disease cases where detecting a small
number of abnormal cells can make diagnostic difference. Hence, the
underlying implication of this report suggests that utilizing 3-D visu-
alization may improve the overall accuracy of FISH analysis for some
clinical cases.”
According to the news editors, the researchers concluded: “However,
the clinical efficiency and cost of using 3-D versus 2-D imaging methods
are also to be assessed carefully.”
For more information on this research see: Potential clinical impact
of three-dimensional visualization for fluorescent in situ hybridization
image analysis. Journal of Biomedical Optics, 2012;17(5):29-31. Jour-
nal of Biomedical Optics can be contacted at: Spie-Soc Photo-Optical
Instrumentation Engineers, 1000 20TH St, PO Box 10, Bellingham, WA
98225, USA.
Our news journalists report that additional information may be ob-
tained by contacting Z. Li, Univ Cent Oklahoma, Edmond, OK 73034,
United States. (2012 Jul 24)
684
CHAPTER 1 BIOMEDICAL ENGINEERING
685
CHAPTER 1 BIOMEDICAL ENGINEERING
686
CHAPTER 1 BIOMEDICAL ENGINEERING
687
CHAPTER 1 BIOMEDICAL ENGINEERING
688
CHAPTER 1 BIOMEDICAL ENGINEERING
689
CHAPTER 1 BIOMEDICAL ENGINEERING
690
CHAPTER 1 BIOMEDICAL ENGINEERING
691
CHAPTER 1 BIOMEDICAL ENGINEERING
692
CHAPTER 1 BIOMEDICAL ENGINEERING
693
CHAPTER 1 BIOMEDICAL ENGINEERING
694
CHAPTER 1 BIOMEDICAL ENGINEERING
695
CHAPTER 1 BIOMEDICAL ENGINEERING
696
CHAPTER 1 BIOMEDICAL ENGINEERING
observed VP, using high resolution micro-CT which captured the mi-
crocalcifications embedded in the fibrous cap. Fluid-structure interac-
tion (FSI) simulations were conducted in the reconstructed model to
examine the combined effects of micro-Ca, flow phase lag and plaque
material properties on plaque burden and vulnerability. This dynamic
fibrous cap stress mapping elucidates the contribution of micro-Ca and
flow phase lag VP vulnerability independently. Micro-Ca embedded in
the fibrous cap produced increased stresses predicted by previously pub-
lished analytical model, and corroborated our previous studies.”
According to the news editors, the researchers concluded: “The
‘micro-CT to FSI’ methodology may offer better diagnostic tools for clin-
icians, while reducing morbidity and mortality rates for patients with
vulnerable plaques and ameliorating the ensuing healthcare costs.”
For more information on this research see: Microcalcifications In-
crease Coronary Vulnerable Plaque Rupture Potential: A Patient-
Based Micro-CT Fluid-Structure Interaction Study. Annals of Biomed-
ical Engineering, 2012;40(7):1443-54. (Springer - www.springer.com;
Annals of Biomedical Engineering - http://www.springerlink.
com/content/0090-6964/)
The news correspondents report that additional information may be
obtained from S.H. Rambhia, Dept. of Biomedical Engineering, Stony
Brook University, Stony Brook, NY, United States. (2012 Jul 18)
697
CHAPTER 1 BIOMEDICAL ENGINEERING
698
CHAPTER 1 BIOMEDICAL ENGINEERING
these changes became significant (10 and 13% for E and G (8), respec-
tively). Generally, in freezer storage, E increased and G (8) showed no
significant change.”
According to the news editors, the researchers concluded: “In pro-
longed preservation (>1 week), the results of -20 °C showed
significant increase in E (20% after 3 weeks) while this increase for -80
°C was not significant, making it a better choice for tissue cold
storage applications.”
For more information on this research see: Characterization
of Changes to the Mechanical Properties of Arteries due to Cold
Storage Using Nanoindentation Tests. Annals of Biomedical En-
gineering, 2012;40(7):1434-42. (Springer - www.springer.com; An-
nals of Biomedical Engineering - http://www.springerlink.com/
content/0090-6964/)
Our news journalists report that additional information may be ob-
tained by contacting A. Hemmasizadeh, Dept. of Mechanical Engineer-
ing, College of Engineering, Temple University, 1947 N 12th Street,
Philadelphia, PA, 19122, United States. (2012 Jul 18)
699
CHAPTER 1 BIOMEDICAL ENGINEERING
700
CHAPTER 1 BIOMEDICAL ENGINEERING
701
CHAPTER 1 BIOMEDICAL ENGINEERING
702
CHAPTER 1 BIOMEDICAL ENGINEERING
703
CHAPTER 1 BIOMEDICAL ENGINEERING
704
CHAPTER 1 BIOMEDICAL ENGINEERING
705
CHAPTER 1 BIOMEDICAL ENGINEERING
706
CHAPTER 1 BIOMEDICAL ENGINEERING
707
CHAPTER 1 BIOMEDICAL ENGINEERING
708
CHAPTER 1 BIOMEDICAL ENGINEERING
709
CHAPTER 1 BIOMEDICAL ENGINEERING
710
CHAPTER 1 BIOMEDICAL ENGINEERING
711
CHAPTER 1 BIOMEDICAL ENGINEERING
712
CHAPTER 1 BIOMEDICAL ENGINEERING
713
CHAPTER 1 BIOMEDICAL ENGINEERING
714
CHAPTER 1 BIOMEDICAL ENGINEERING
715
CHAPTER 1 BIOMEDICAL ENGINEERING
716
CHAPTER 1 BIOMEDICAL ENGINEERING
717
CHAPTER 1 BIOMEDICAL ENGINEERING
718
CHAPTER 1 BIOMEDICAL ENGINEERING
719
CHAPTER 1 BIOMEDICAL ENGINEERING
720
CHAPTER 1 BIOMEDICAL ENGINEERING
721
CHAPTER 1 BIOMEDICAL ENGINEERING
722
CHAPTER 1 BIOMEDICAL ENGINEERING
723
CHAPTER 1 BIOMEDICAL ENGINEERING
724
CHAPTER 1 BIOMEDICAL ENGINEERING
725
CHAPTER 1 BIOMEDICAL ENGINEERING
726
CHAPTER 1 BIOMEDICAL ENGINEERING
727
CHAPTER 1 BIOMEDICAL ENGINEERING
728
CHAPTER 1 BIOMEDICAL ENGINEERING
729
CHAPTER 1 BIOMEDICAL ENGINEERING
730
CHAPTER 1 BIOMEDICAL ENGINEERING
731
CHAPTER 1 BIOMEDICAL ENGINEERING
732
CHAPTER 1 BIOMEDICAL ENGINEERING
733
CHAPTER 1 BIOMEDICAL ENGINEERING
734
CHAPTER 1 BIOMEDICAL ENGINEERING
735
CHAPTER 1 BIOMEDICAL ENGINEERING
736
CHAPTER 1 BIOMEDICAL ENGINEERING
737
CHAPTER 1 BIOMEDICAL ENGINEERING
738
CHAPTER 1 BIOMEDICAL ENGINEERING
739
CHAPTER 1 BIOMEDICAL ENGINEERING
740
CHAPTER 1 BIOMEDICAL ENGINEERING
741
CHAPTER 1 BIOMEDICAL ENGINEERING
742
CHAPTER 1 BIOMEDICAL ENGINEERING
743
CHAPTER 1 BIOMEDICAL ENGINEERING
744
CHAPTER 1 BIOMEDICAL ENGINEERING
745
CHAPTER 1 BIOMEDICAL ENGINEERING
746
CHAPTER 1 BIOMEDICAL ENGINEERING
747
CHAPTER 1 BIOMEDICAL ENGINEERING
748
CHAPTER 1 BIOMEDICAL ENGINEERING
749
CHAPTER 1 BIOMEDICAL ENGINEERING
750
CHAPTER 1 BIOMEDICAL ENGINEERING
751
CHAPTER 1 BIOMEDICAL ENGINEERING
752
CHAPTER 1 BIOMEDICAL ENGINEERING
753
CHAPTER 1 BIOMEDICAL ENGINEERING
754
CHAPTER 1 BIOMEDICAL ENGINEERING
755
CHAPTER 1 BIOMEDICAL ENGINEERING
756
CHAPTER 1 BIOMEDICAL ENGINEERING
757
CHAPTER 1 BIOMEDICAL ENGINEERING
758
CHAPTER 1 BIOMEDICAL ENGINEERING
759
CHAPTER 1 BIOMEDICAL ENGINEERING
760
CHAPTER 1 BIOMEDICAL ENGINEERING
761
CHAPTER 1 BIOMEDICAL ENGINEERING
762
CHAPTER 1 BIOMEDICAL ENGINEERING
763
CHAPTER 1 BIOMEDICAL ENGINEERING
764
CHAPTER 1 BIOMEDICAL ENGINEERING
765
CHAPTER 1 BIOMEDICAL ENGINEERING
Engineering - http://ieeexplore.ieee.org/xpl/RecentIssue.
jsp?punumber=10)
The news editors report that additional information may be obtained
by contacting J.J. Shen, McGill University, Dept. of Mech Engn, Mon-
treal, PQ H3A 0G4, Canada. (2012 Jun 27)
766
CHAPTER 1 BIOMEDICAL ENGINEERING
767
CHAPTER 1 BIOMEDICAL ENGINEERING
768
CHAPTER 1 BIOMEDICAL ENGINEERING
769
CHAPTER 1 BIOMEDICAL ENGINEERING
770
CHAPTER 1 BIOMEDICAL ENGINEERING
771
CHAPTER 1 BIOMEDICAL ENGINEERING
772
CHAPTER 1 BIOMEDICAL ENGINEERING
773
CHAPTER 1 BIOMEDICAL ENGINEERING
774
CHAPTER 1 BIOMEDICAL ENGINEERING
775
CHAPTER 1 BIOMEDICAL ENGINEERING
776
CHAPTER 1 BIOMEDICAL ENGINEERING
777
CHAPTER 1 BIOMEDICAL ENGINEERING
778
CHAPTER 1 BIOMEDICAL ENGINEERING
779
CHAPTER 1 BIOMEDICAL ENGINEERING
780
CHAPTER 1 BIOMEDICAL ENGINEERING
781
CHAPTER 1 BIOMEDICAL ENGINEERING
782
CHAPTER 1 BIOMEDICAL ENGINEERING
783
CHAPTER 1 BIOMEDICAL ENGINEERING
784
CHAPTER 1 BIOMEDICAL ENGINEERING
785
CHAPTER 1 BIOMEDICAL ENGINEERING
786
CHAPTER 1 BIOMEDICAL ENGINEERING
787
CHAPTER 1 BIOMEDICAL ENGINEERING
788
CHAPTER 1 BIOMEDICAL ENGINEERING
789
CHAPTER 1 BIOMEDICAL ENGINEERING
790
CHAPTER 1 BIOMEDICAL ENGINEERING
791
CHAPTER 1 BIOMEDICAL ENGINEERING
792
CHAPTER 1 BIOMEDICAL ENGINEERING
793
CHAPTER 1 BIOMEDICAL ENGINEERING
794
CHAPTER 1 BIOMEDICAL ENGINEERING
795
CHAPTER 1 BIOMEDICAL ENGINEERING
of the OA amplitude with blood SO(2) were also observed for each re-
ceiver at those laser sources.”
According to the news reporters, the researchers concluded: “The
good agreement between simulated and published experimental results
validates the model qualitatively.”
For more information on this research see: Validity of a theoretical
model to examine blood oxygenation dependent optoacoustics. Journal
of Biomedical Optics, 2012;17(5):055002.
Our news journalists report that additional information may be ob-
tained by contacting R.K. Saha, Saha Institute of Nuclear Physics, Ap-
plied Material Science Division, 1, AF Bidhannagar, Kolkata 700 064,
India. (2012 Jun 19)
796
CHAPTER 1 BIOMEDICAL ENGINEERING
797
CHAPTER 1 BIOMEDICAL ENGINEERING
798
CHAPTER 1 BIOMEDICAL ENGINEERING
799
CHAPTER 1 BIOMEDICAL ENGINEERING
800
CHAPTER 1 BIOMEDICAL ENGINEERING
801
CHAPTER 1 BIOMEDICAL ENGINEERING
802
CHAPTER 1 BIOMEDICAL ENGINEERING
803
CHAPTER 1 BIOMEDICAL ENGINEERING
804
CHAPTER 1 BIOMEDICAL ENGINEERING
805
CHAPTER 1 BIOMEDICAL ENGINEERING
study was to compare fentanyl and tramadol with IV PCA after spinal
anesthesia (SA) and general anesthesia (GA) following cesarean section
(C/S).”
The news correspondents obtained a quote from the research by
the authors from the Marmara University School of Medicine, “Ninety
women were randomly assigned to three groups (n=30). Group 1 was
treated with IV fentanyl PCA after SA. Groups 2 and 3 were treated
with IV fentanyl PCA and IV tramadol PCA after GA. Outcome mea-
sures were recorded for the first 24 h post-anesthesia. PCA use was
significantly lower after SA (p <0.05). Eighteen patients in the SA
Group and 27 patients and 24 patients from the GA groups required
additional opioid. Opioid consumption and patient satisfaction were
similar for groups after GA (p >0.05). 638.4 ± 179.1 g fentanyl
was consumed by patients of Group 2, 356.3 ± 87.0 g fentanyl and
559.5 ± 207.0 mg tramadol was consumed by Group 1 and Group 3
respectively. There was no significant difference in the overall severity
and incidence of nausea, drowsiness or pruritus.”
According to the news reporters, the researchers concluded: “Our
study shows that analgesic consumption and post-operative pain scores
after SA in C/S decreased, without increase in adverse reactions.”
For more information on this research see: Comparative study of
intravenous opioid consumption in the postoperative period. Biomed-
ical Papers of the Medical Faculty of the University Palacky, Olomouc,
Czechosl, 2012;156(1):48-51.
Our news journalists report that additional information may be ob-
tained by contacting K.T. Saracoglu, Dept. of Anesthesiology and Re-
animation, Marmara University School of Medicine, Istanbul, Turkey.
(2012 Jun 13)
806
CHAPTER 1 BIOMEDICAL ENGINEERING
values, which will yield a more accurate estimation because of the new
color information that has been incorporated. This method was tested
on in vivo color measurements from 200 skin sites in 10 volunteers. The
results show that the proposed method is able to improve the estimation
accuracy significantly compared with the traditional Wiener estimation
method.”
According to the news editors, the researchers concluded: “The fast
speed of this method may enable the estimation of diffuse reflectance
spectra at multiple tissue locations from color images in real time,
which provides a cost-effective alternative to spectral imaging with the
additional advantage of high spectral resolution.”
For more information on this research see: Modified Wiener esti-
mation of diffuse reflectance spectra from RGB values by the synthesis
of new colors for tissue measurements. Journal of Biomedical Optics,
2012;17(3):4-6. Journal of Biomedical Optics can be contacted at: Spie-
Soc Photo-Optical Instrumentation Engineers, 1000 20TH St, PO Box
10, Bellingham, WA 98225, USA.
The news correspondents report that additional information may be
obtained from S. Chen, Nanyang Technological University, Sch Chem &
Biomed Engn, Div Bioengn, Singapore 637457, Singapore. (2012 Jun
13)
807
CHAPTER 1 BIOMEDICAL ENGINEERING
808
CHAPTER 1 BIOMEDICAL ENGINEERING
809
CHAPTER 1 BIOMEDICAL ENGINEERING
810
CHAPTER 1 BIOMEDICAL ENGINEERING
and comfort were recorded over 7 days. Ejected blood flow volumes and
peak velocities in the popliteal vein during NMES were sustained over a
30-min stimulation session and increased by approximately 100% over
the course of seven days. Mean stimulation intensities increased pro-
gressively throughout the week, while perceived pain during NMES de-
creased significantly. Mean compliance to the 7-day protocol was 100%.
User habituation to a combined NMES and compression protocol re-
sulted in significant increases in ejected venous volume and peak ve-
locity over the course of 7 days. This resulted in the highest ejected
venous volume reported from a single NMES induced contraction of the
calf muscles to date which was twice the magnitude of values previously
reported in the literature.”
According to the news editors, the researchers concluded: “These
findings suggest that NMES based protocols applied over an extended
period of days, weeks or months may provide greater hemodynamic ef-
fect for the prevention of venous stasis than previously observed during
NMES sessions lasting less than a few hours.”
For more information on this research see: Hemodynamic effects of
habituation to a week-long program of neuromuscular electrical stim-
ulation. Medical Engineering & Physics, 2012;34(4):459-465. Medi-
cal Engineering & Physics can be contacted at: Elsevier Sci Ltd, The
Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, Oxon, Eng-
land. (Elsevier - www.elsevier.com; Medical Engineering & Physics -
http://www.elsevier.com/wps/product/cws_home/30456)
Our news journalists report that additional information may be ob-
tained by contacting G.J. Corley, Midwestern Reg Hosp Limerick, Dept.
of Vasc Surg, Limerick, Ireland. (2012 Jun 13)
811
CHAPTER 1 BIOMEDICAL ENGINEERING
and by a factor of fifteen the amount that can be released. The films do
not affect cell viability and exhibit poor cell adhesion.”
According to the news editors, the researchers concluded: “The
straightforward synthesis and predictability of porosity enables the
tuning of the amount of drug that can be loaded.”
For more information on this research see: Porous polysul-
fone coatings for enhanced drug delivery. Biomedical Microdevices,
2012;14(3):603-612. Biomedical Microdevices can be contacted at:
Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands.
(Springer - www.springer.com; Biomedical Microdevices - http://
www.springerlink.com/content/1387-2176/)
The news editors report that additional information may be obtained
by contacting K.M. Sivaraman, ETH, Dept. of Mat Cell & BioMat, CH-
8093 Zurich, Switzerland. (2012 Jun 13)
812
CHAPTER 1 BIOMEDICAL ENGINEERING
813
CHAPTER 1 BIOMEDICAL ENGINEERING
814
CHAPTER 1 BIOMEDICAL ENGINEERING
815
CHAPTER 1 BIOMEDICAL ENGINEERING
816
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research by the au-
thors from Wellman Center for Photomedicine, “We describe a new tech-
nological approach to this problem using detection of diffuse fluorescent
light from relatively large blood vessels in vivo. The diffuse fluorescence
flow cytometer (DFFC) uses a laser to illuminate a mouse limb and an
array of optical fibers coupled to a high-sensitivity photomultiplier tube
array operating in photon counting mode to detect weak fluorescence
signals from cells. We first demonstrate that the DFFC instrument is
capable of detecting fluorescent microspheres and Vybrant-DiD-labeled
cells in a custom-made optical flow phantom with similar size, optical
properties, linear flow rates, and autofluorescence as a mouse limb. We
also present preliminary data demonstrating that the DFFC is capable
of detecting circulating cells in nude mice in vivo.”
According to the news editors, the researchers concluded: “In prin-
ciple, this device would allow interrogation of the whole blood volume
of a mouse in minutes, with sensitivity improvement by several orders
of magnitude compared to current approaches.”
For more information on this research see: Instrument for fluores-
cence sensing of circulating cells with diffuse light in mice in vivo. Jour-
nal of Biomedical Optics, 2012;17(3):150-157. Journal of Biomedical
Optics can be contacted at: Spie-Soc Photo-Optical Instrumentation En-
gineers, 1000 20TH St, PO Box 10, Bellingham, WA 98225, USA.
The news correspondents report that additional information may be
obtained from E. Zettergren, Wellman Center Photomed, Boston, MA
02114, United States. (2012 Jun 13)
817
CHAPTER 1 BIOMEDICAL ENGINEERING
818
CHAPTER 1 BIOMEDICAL ENGINEERING
819
CHAPTER 1 BIOMEDICAL ENGINEERING
820
CHAPTER 1 BIOMEDICAL ENGINEERING
821
CHAPTER 1 BIOMEDICAL ENGINEERING
822
CHAPTER 1 BIOMEDICAL ENGINEERING
823
CHAPTER 1 BIOMEDICAL ENGINEERING
824
CHAPTER 1 BIOMEDICAL ENGINEERING
825
CHAPTER 1 BIOMEDICAL ENGINEERING
826
CHAPTER 1 BIOMEDICAL ENGINEERING
827
CHAPTER 1 BIOMEDICAL ENGINEERING
urine and feces was investigated after intravenous (i.v.) and intragas-
tric (i.g.) administration to rats. DDIE and its metabolites (M-1 and M-
2) were measured using HPLC. The amount of DDIE and its metabolites
excreted was higher in feces than in urine, suggesting that DDIE and
its metabolites are eliminated primarily in the feces. Significant dif-
ferences in the excretion levels of DDIE and its metabolites were seen
between i.v. and i.g. administration. Greater amounts of DDIE and its
metabolites were excreted following i.v. administration, suggesting that
DDIE can exert a longer period of anti-inflammatory activity following
i.g. administration. The accuracy, precision, recovery and stability of
the analytical method in this study were satisfactory for the measure-
ment of DDIE and its metabolites in rat urine and feces.”
According to the news editors, the researchers concluded: “Observa-
tions made in this study will contribute to understanding of the absorp-
tion, distribution, metabolism and excretion pathway of DDIE and will
aid decision-making regarding the best mode of DDIE administration
during treatment to maximize its anti-inflammatory effects.”
For more information on this research see: Analysis of anti-
inflammatory dehydrodiisoeugenol and metabolites excreted in
rat feces and urine using HPLC-UV. Biomedical Chromatography,
2012;26(6):703-707. Biomedical Chromatography can be contacted
at: Wiley-Blackwell, Commerce Place, 350 Main St, Malden 02148,
MA, USA. (Wiley-Blackwell - http://www.wiley.com/; Biomedical
Chromatography - http://onlinelibrary.wiley.com/journal/
10.1002/(ISSN)1099-0801)
Our news journalists report that additional information may be ob-
tained by contacting F. Li, Peking University, Sch Pharmaceut Sci,
Dept. of Nat Med, Beijing 100191, People’s Republic of China. (2012
Jun 06)
828
CHAPTER 1 BIOMEDICAL ENGINEERING
829
CHAPTER 1 BIOMEDICAL ENGINEERING
The news reporters obtained a quote from the research by the au-
thors from the University of Bordeaux, “Temperature images were post-
processed to remove residual motion-related artifacts. Using an MR-
compatible steerable catheter and electromagnetic noise filter, RF ab-
lation was performed in the ventricles of two sheep in vivo. The stan-
dard deviation of the temperature evolution in time (TSD) was com-
puted. Temperature mapping of the left ventricle was achieved at an
update rate of approximately 1 Hz with a mean TSD of 3.6 ± 0.9
°C. TSD measurements at the septum showed a higher precision
(2.8 ± 0.9 °C) than at the myocardial regions at the heart-
lung and heart-liver interfaces (4.1 ± 0.9 °C). Temperature
rose maximally by 9 °C and 16 °C during 5 W and 10 W
RF applications, respectively, for 60 s each. Tissue temperature can be
monitored at an update rate of approximately 1 Hz in five slices.”
According to the news reporters, the researchers concluded: “Typ-
ical temperature changes observed during clinical RF application can
be monitored with an acceptable level of precision.”
For more information on this research see: Feasibility of fast
MR-thermometry during cardiac radiofrequency ablation. Nmr
In Biomedicine, 2012;25(4):556-62. (Wiley-Blackwell - http://
www.wiley.com/; Nmr In Biomedicine - http://onlinelibrary.
wiley.com/journal/10.1002/(ISSN)1099-1492)
Our news correspondents report that additional information may
be obtained by contacting B.D. de Senneville, Laboratory for Molecu-
lar and Functional Imaging: From Physiology to Therapy, FRE 3313
CNRS, Universite Bordeaux 2, Bordeaux, France. (2012 Jun 06)
830
CHAPTER 1 BIOMEDICAL ENGINEERING
831
CHAPTER 1 BIOMEDICAL ENGINEERING
832
CHAPTER 1 BIOMEDICAL ENGINEERING
Our news journalists obtained a quote from the research by the au-
thors from the University of Sydney, “Shear storage modulus (G’) and
loss modulus (G”) measurements were made in eight healthy subjects
for both muscles in vivo before, one hour after, 48 hours after and
1?week after eccentric exercise. The results show a 21% increase in me-
dial gastrocnemius storage modulus following eccentric exercise with a
peak occurring similar to 48 hours after exercise (before exercise 1.15
+/- 0.23?kPa, 48 hours after 1.38 +/- 0.27?kPa). No significant changes
in soleus muscle storage modulus were measured for the exercise proto-
col used in this study, and no significant changes in loss modulus were
observed.”
According to the news editors, the researchers concluded: “This
study provides the first direct measurements in skeletal muscle before
and after eccentric exercise damage and suggests that MRE can be used
to detect the time course of changes to muscle properties.”
For more information on this research see: Measuring changes in
muscle stiffness after eccentric exercise using elastography. NMR in
Biomedicine, 2012;25(6):852-858. NMR in Biomedicine can be con-
tacted at: Wiley-Blackwell, Commerce Place, 350 Main St, Malden
02148, MA, USA. (Wiley-Blackwell - http://www.wiley.com/; NMR
in Biomedicine - http://onlinelibrary.wiley.com/journal/
10.1002/(ISSN)1099-1492)
The news correspondents report that additional information may be
obtained from M.A. Green, University of Sydney, George Inst Global
Hlth, Sydney, NSW 2006, Australia. (2012 Jun 06)
833
CHAPTER 1 BIOMEDICAL ENGINEERING
834
CHAPTER 1 BIOMEDICAL ENGINEERING
835
CHAPTER 1 BIOMEDICAL ENGINEERING
texture features Entropy and Difference Variance, and all three pre-
selected geometric parameters differed significantly between normal
and bulging, normal and herniated, and bulging and herniated discs
(p? <?0.05).”
According to the news reporters, the researchers concluded: “These
findings suggest that T(2) texture features and geometric parameters
are sensitive to the presence of abnormalities at the posterior aspect
of lumbar intervertebral discs, and may thus be useful as quantitative
biomarkers that predict disease.”
For more information on this research see: Quantitative anal-
ysis of lumbar intervertebral disc abnormalities at 3.0 Tesla:
value of T(2) texture features and geometric parameters. Nmr
In Biomedicine, 2012;25(6):866-72. (Wiley-Blackwell - http://
www.wiley.com/; Nmr In Biomedicine - http://onlinelibrary.
wiley.com/journal/10.1002/(ISSN)1099-1492)
Our news journalists report that additional information may be ob-
tained by contacting M.E. Mayerhoefer, Dept. of Radiology, Medical
University of Vienna, Lazarettgasse 14, 1090, Vienna, Austria. (2012
Jun 05)
836
CHAPTER 1 BIOMEDICAL ENGINEERING
837
CHAPTER 1 BIOMEDICAL ENGINEERING
838
CHAPTER 1 BIOMEDICAL ENGINEERING
839
CHAPTER 1 BIOMEDICAL ENGINEERING
840
CHAPTER 1 BIOMEDICAL ENGINEERING
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-1492)
Our news correspondents report that additional information may be
obtained by contacting S. Walker-Samuel, UCL, Inst Neurol, London
WC1E 6DD, United Kingdom. (2012 Jun 04)
841
CHAPTER 1 BIOMEDICAL ENGINEERING
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1099-1492)
The news correspondents report that additional information may
be obtained from A. Vellido, Departamento de Llenguatges i Sistemes
Informatics, Universitat Politecnica de Catalunya, Barcelona, Spain.
(2012 Jun 04)
842
CHAPTER 1 BIOMEDICAL ENGINEERING
843
CHAPTER 1 BIOMEDICAL ENGINEERING
844
Chapter 2
Biomedical Informatics
845
CHAPTER 2 BIOMEDICAL INFORMATICS
According to the news editors, the research concluded: “We find that
over 85% of such extracted phrase candidates are humanly judged to be
of high quality.”
For more information on this research see: Identifying well-formed
biomedical phrases in MEDLINE® text. Journal of Biomedical
Informatics, 2012;45(6):1035-41. (Elsevier - www.elsevier.com; Jour-
nal of Biomedical Informatics - http://www.elsevier.com/wps/
product/cws_home/622857)
Our news journalists report that additional information may be ob-
tained by contacting W. Kim, National Library of Medicine, National
Institutes of Health, Bethesda, MD 20894, United States. (2013 Jan
30)
846
CHAPTER 2 BIOMEDICAL INFORMATICS
847
CHAPTER 2 BIOMEDICAL INFORMATICS
848
CHAPTER 2 BIOMEDICAL INFORMATICS
849
CHAPTER 2 BIOMEDICAL INFORMATICS
850
CHAPTER 2 BIOMEDICAL INFORMATICS
851
CHAPTER 2 BIOMEDICAL INFORMATICS
852
CHAPTER 2 BIOMEDICAL INFORMATICS
853
CHAPTER 2 BIOMEDICAL INFORMATICS
854
CHAPTER 2 BIOMEDICAL INFORMATICS
855
CHAPTER 2 BIOMEDICAL INFORMATICS
856
CHAPTER 2 BIOMEDICAL INFORMATICS
857
CHAPTER 2 BIOMEDICAL INFORMATICS
858
CHAPTER 2 BIOMEDICAL INFORMATICS
859
CHAPTER 2 BIOMEDICAL INFORMATICS
860
CHAPTER 2 BIOMEDICAL INFORMATICS
scenario, the corpus was employed to train and validate models for the
classification of informative against the non-informative sentences.”
According to the news reporters, the research concluded: “A Maxi-
mum Entropy classifier trained with simple features and evaluated by
10-fold cross-validation resulted in the F-1 score of 0.70 indicating a
potential useful application of the corpus.”
For more information on this research see: Development of a bench-
mark corpus to support the automatic extraction of drug-related ad-
verse effects from medical case reports. Journal of Biomedical Infor-
matics, 2012;45(5):885-892. Journal of Biomedical Informatics can be
contacted at: Academic Press Inc Elsevier Science, 525 B St, Ste 1900,
San Diego, CA 92101-4495, USA. (Elsevier - www.elsevier.com; Jour-
nal of Biomedical Informatics - http://www.elsevier.com/wps/
product/cws_home/622857)
Our news journalists report that additional information may be ob-
tained by contacting H. Gurulingappa, University of Sheffield, Dept. of
Comp Sci, Sheffield S1 4DP, S Yorkshire, United Kingdom. (2012 Nov
07)
861
CHAPTER 2 BIOMEDICAL INFORMATICS
862
CHAPTER 2 BIOMEDICAL INFORMATICS
863
CHAPTER 2 BIOMEDICAL INFORMATICS
For more information on this research see: Design for risk con-
trol: the role of usability engineering in the management of use-related
risks. Journal of Biomedical Informatics, 2012;45(4):795-812. (Else-
vier - www.elsevier.com; Journal of Biomedical Informatics - http:
//www.elsevier.com/wps/product/cws_home/622857)
Our news journalists report that additional information may be ob-
tained by contacting J. van der Peijl, Drager Medical GmbH, Moislinger
Allee 53-55, 23558 Lubeck, Germany. (2012 Oct 31)
864
CHAPTER 2 BIOMEDICAL INFORMATICS
865
CHAPTER 2 BIOMEDICAL INFORMATICS
866
CHAPTER 2 BIOMEDICAL INFORMATICS
867
CHAPTER 2 BIOMEDICAL INFORMATICS
868
CHAPTER 2 BIOMEDICAL INFORMATICS
869
CHAPTER 2 BIOMEDICAL INFORMATICS
870
CHAPTER 2 BIOMEDICAL INFORMATICS
871
CHAPTER 2 BIOMEDICAL INFORMATICS
failure (CHF) using an approach that makes use of rough sets (RSs) and
decision trees.”
The news correspondents obtained a quote from the research from
Keimyung University, “Among 72 laboratory findings, it was deter-
mined that two subsets (RBC, EOS, Protein, O2SAT, Pro BNP) in an
RS-based model, and one subset (Gender, MCHC, Direct bilirubin, and
Pro BNP) in a logistic regression (LR)-based model were indispensable
factors for differentiating CHF patients from those with dyspnea, and
the risk factor Pro BNP was particularly so. To demonstrate the use-
fulness of the proposed model, we compared the discriminatory power
of decision-making models that utilize RS-and LR-based decision mod-
els by conducting 10-fold cross-validation. The experimental results
showed that the RS-based decision-making model (accuracy: 97.5%,
sensitivity: 97.2%, specificity: 97.7%, positive predictive value: 97.2%,
negative predictive value: 97.7%, and area under ROC curve: 97.5%)
consistently outperformed the LR-based decision-making model (accu-
racy: 88.7%, sensitivity: 90.1%, specificity: 87.5%, positive predictive
value: 85.3%, negative predictive value: 91.7%, and area under ROC
curve: 88.8%).”
According to the news reporters, the researchers concluded: “In ad-
dition, a pairwise comparison of the ROC curves of the two models
showed a statistically significant difference (p <0.01; 95% CI: 2.”
For more information on this research see: Decision-making
model for early diagnosis of congestive heart failure using rough set
and decision tree approaches. Journal of Biomedical Informatics,
2012;45(5):999-1008. (Elsevier - www.elsevier.com; Journal of Biomed-
ical Informatics - http://www.elsevier.com/wps/product/cws_
home/622857)
Our news journalists report that additional information may be ob-
tained by contacting C.S. Son, Dept. of Medical Informatics, School of
Medicine, Keimyung University, Daegu, South Korea. (2012 Sep 26)
872
CHAPTER 2 BIOMEDICAL INFORMATICS
Our news journalists obtained a quote from the research from Rut-
gers University, “Based on these data, we discuss strategies for placing
RFID tags on medical tools and for placing antennas in the environ-
ment for optimal tracking and activity recognition. Results from our
preliminary RFID deployment in the trauma bay show the feasibility of
our approach for tracking tools and for recognizing trauma team activ-
ities.”
According to the news editors, the researchers concluded: “We con-
clude by discussing implications for and challenges to introducing RFID
technology in other similar settings characterized by dynamic and col-
located collaboration.”
For more information on this research see: Introducing RFID tech-
nology in dynamic and time-critical medical settings: Requirements
and challenges. Journal of Biomedical Informatics, 2012;45(5):958-
74. (Elsevier - www.elsevier.com; Journal of Biomedical Informatics
- http://www.elsevier.com/wps/product/cws_home/622857)
Our news journalists report that additional information may be ob-
tained by contacting S. Parlak, Electrical and Computer Engineering
Department, Rutgers University, 94 Brett Road, Piscataway, NJ 08854,
United States. (2012 Sep 26)
873
CHAPTER 2 BIOMEDICAL INFORMATICS
874
CHAPTER 2 BIOMEDICAL INFORMATICS
875
CHAPTER 2 BIOMEDICAL INFORMATICS
876
CHAPTER 2 BIOMEDICAL INFORMATICS
877
CHAPTER 2 BIOMEDICAL INFORMATICS
878
CHAPTER 2 BIOMEDICAL INFORMATICS
879
CHAPTER 2 BIOMEDICAL INFORMATICS
880
CHAPTER 2 BIOMEDICAL INFORMATICS
881
CHAPTER 2 BIOMEDICAL INFORMATICS
882
CHAPTER 2 BIOMEDICAL INFORMATICS
Our news journalists obtained a quote from the research from the
University of Texas, “This paper demonstrates the complexity and chal-
lenges of mapping across terminological systems in the context of med-
ication information. It provides a review of medication terminological
systems and their linkages, then describes a case study in which we
mapped proprietary medication codes from an electronic health record
to SNOMED CT and the UMLS Metathesaurus. The goal was to cre-
ate a polyhierarchical classification system for querying an i2b2 clinical
data warehouse. We found that three methods were required to accu-
rately map the majority of actively prescribed medications. Only 62.5%
of source medication codes could be mapped automatically. The remain-
ing codes were mapped using a combination of semi-automated string
comparison with expert selection, and a completely manual approach.
Compound drugs were especially difficult to map: only 7.5% could be
mapped using the automatic method.”
According to the news editors, the researchers concluded: “General
challenges to mapping across terminological systems include (1) the
availability of up-to-date information to assess the suitability of a given
terminological system for a particular use case, and to assess the qual-
ity and completeness of cross-terminology links; (2) the difficulty of cor-
rectly using complex, rapidly evolving, modern terminologies; (3) the
time and effort required to complete and evaluate the mapping; (4) the
need to address differences in granularity between the source and tar-
get terminologies; and (5) the need to continuously update the mapping
as terminological systems evolve.”
For more information on this research see: Cross-terminology map-
ping challenges: A demonstration using medication terminological sys-
tems. Journal of Biomedical Informatics, 2012;45(4):613-25. (Else-
vier - www.elsevier.com; Journal of Biomedical Informatics - http:
//www.elsevier.com/wps/product/cws_home/622857)
The news correspondents report that additional information may be
obtained from H. Saitwal, The University of Texas School of Biomedical
Informatics at Houston, 7000 Fannin Suite 600, Houston, TX 77030,
United States. (2012 Sep 04)
883
CHAPTER 2 BIOMEDICAL INFORMATICS
Affairs (VA) has a long history of developing and adopting various types
of health care data standards.”
Our news journalists obtained a quote from the research from Veter-
ans Affairs Medical Center, “The authors present in detail their experi-
ence in this domain. A formal organization within VA is responsible for
helping to develop and implement standards. This group has produced
a Standards Life Cycle (SLC) process endorsed by VA key business and
information technology (IT) stakeholders. It coordinates the identifi-
cation, description, and implementation of standards aligned with VA
business requirements. In this paper, we review the adoption of four
standards in the categories of security and privacy, terminology, health
information exchange, and modeling tools; emphasizing the implemen-
tation approach used in each. In our experience, adoption is facilitated
by internal staff with expertise in standards development and adop-
tion. Use of processes such as an SLC and tools such as an enterprise
requirement repository help formally track and ensure that IT devel-
opment and acquisition incorporate these standards. An organization
should adopt standards that are aligned with its business priorities and
favor those that are more readily implementable.”
According to the news editors, the researchers concluded: “To assist
with this final point, we offer a standard ‘Likelihood of Adoption Scale,’
which changes as standards specifications evolve from PDF documents
only, to PDF documents with construction and testing tools, to fully
functional reference implementations.”
For more information on this research see: Translating standards
into practice: Experience and lessons learned at the Department of
Veterans Affairs. Journal of Biomedical Informatics, 2012;45(4):813-
23. (Elsevier - www.elsevier.com; Journal of Biomedical Informatics -
http://www.elsevier.com/wps/product/cws_home/622857)
Our news journalists report that additional information may be ob-
tained by contacting O. Bouhaddou, US Dept. of Veterans Affairs,
Washington, DC, United States. (2012 Sep 04)
884
CHAPTER 2 BIOMEDICAL INFORMATICS
885
CHAPTER 2 BIOMEDICAL INFORMATICS
886
CHAPTER 2 BIOMEDICAL INFORMATICS
887
CHAPTER 2 BIOMEDICAL INFORMATICS
that contain archetype terms, finding the top two category levels of the
mapped concepts in the SNOMED-CT hierarchy, and calculating the
coverage of each category. A quantitative study of the results com-
pares the coverage of different categories to identify relatively under-
covered as well as well-covered areas. The results show that the cov-
erage of the well-known National Health Service (NHS) Connecting for
Health (CfH) archetype repository on all categories of SNOMED-CT is
not equally balanced.”
According to the news editors, the researchers concluded: “Cate-
gories worth investigating emerged at different points on the coverage
spectrum, including well-covered categories such as Attributes, Quali-
fier value, under-covered categories such as Microorganism, Kingdom
animalia, and categories that are not covered at all such as Cardiovas-
cular drug (product).”
For more information on this research see: Clinical coverage of
an archetype repository over SNOMED-CT. Journal of Biomedical
Informatics, 2012;45(3):408-18. (Elsevier - www.elsevier.com; Jour-
nal of Biomedical Informatics - http://www.elsevier.com/wps/
product/cws_home/622857)
Our news journalists report that additional information may be ob-
tained by contacting S. Yu, Dublin Institute of Technology, School Elect
Eng Systems, Dublin, Ireland. (2012 Jul 11)
888
CHAPTER 2 BIOMEDICAL INFORMATICS
81.2%, precision 83.3%) on the test set, a score that ranks third among
22 participants in the i2b2/VA concept annotation task. The ensemble
system had better precision and recall than any of the individual sys-
tems, yielding an F-score that is 4.6% point higher than the best single
system. Changing the voting threshold offered a simple way to obtain a
system with high precision (and moderate recall) or one with high recall
(and moderate precision). The ensemble-based approach is straightfor-
ward and allows the balancing of precision versus recall of the combined
system.”
According to the news editors, the researchers concluded: “The en-
semble system is freely available and can easily be extended, integrated
in other systems, and retrained.”
For more information on this research see: Using an ensem-
ble system to improve concept extraction from clinical records.
Journal of Biomedical Informatics, 2012;45(3):423-8. (Elsevier -
www.elsevier.com; Journal of Biomedical Informatics - http://www.
elsevier.com/wps/product/cws_home/622857)
The news editors report that additional information may be obtained
by contacting N. Kang, Dept. of Medical Informatics, Erasmus Univer-
sity Medical Center, Rotterdam, Netherlands. (2012 Jul 11)
889
CHAPTER 2 BIOMEDICAL INFORMATICS
890
CHAPTER 2 BIOMEDICAL INFORMATICS
891
CHAPTER 2 BIOMEDICAL INFORMATICS
892
CHAPTER 2 BIOMEDICAL INFORMATICS
893
CHAPTER 2 BIOMEDICAL INFORMATICS
894
Chapter 3
Biomedicine
895
CHAPTER 3 BIOMEDICINE
896
CHAPTER 3 BIOMEDICINE
897
CHAPTER 3 BIOMEDICINE
898
CHAPTER 3 BIOMEDICINE
899
CHAPTER 3 BIOMEDICINE
900
CHAPTER 3 BIOMEDICINE
901
CHAPTER 3 BIOMEDICINE
902
CHAPTER 3 BIOMEDICINE
903
CHAPTER 3 BIOMEDICINE
904
CHAPTER 3 BIOMEDICINE
905
CHAPTER 3 BIOMEDICINE
906
CHAPTER 3 BIOMEDICINE
907
CHAPTER 3 BIOMEDICINE
908
CHAPTER 3 BIOMEDICINE
909
CHAPTER 3 BIOMEDICINE
910
CHAPTER 3 BIOMEDICINE
911
CHAPTER 3 BIOMEDICINE
912
CHAPTER 3 BIOMEDICINE
and Figure of Merit (FoM). FOAM showed the best performance, with
an IMT bias equal to 0.025 +/- 0.225 mm, and a FoM equal to 96.6%.
Among the four automated methods, CARES showed the best results
with a bias of 0.032 +/- 0.279 mm, and a FoM to 95.6%, which was sta-
tistically comparable to that of FOAM performance in terms of accuracy
and reproducibility.”
According to the news reporters, the research concluded: “This is
the first time that completely automated and user-driven techniques
have been compared on a multi-ethnic dataset, acquired using multiple
original equipment manufacturer (OEM) machines with different gain
settings, representing normal and pathologic cases.”
For more information on this research see: Ultrasound IMT mea-
surement on a multi-ethnic and multi-institutional database: Our
review and experience using four fully automated and one semi-
automated methods. Computer Methods and Programs in Biomedicine,
2012;108(3):946-960. Computer Methods and Programs in Biomedicine
can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale
Plaza, East Park Shannon, Co, Clare, 00000, Ireland. (Elsevier -
www.elsevier.com; Computer Methods and Programs in Biomedicine -
http://www.elsevier.com/wps/product/cws_home/505960)
Our news journalists report that additional information may be ob-
tained by contacting F. Molinari, Idaho State University, Dept. of
Biomed Engn, Pocatello, ID 83209, United States. (2013 Jan 24)
913
CHAPTER 3 BIOMEDICINE
outperform the other methods only when all are calibrated on a ran-
domly sampled training set; in all other cases, it performs worse. The
results of bumping do not differ significantly from the overall best per-
forming method bagging. We cautiously conclude that tree-based record
linkage methods are likely to produce similar results because of the low-
dimensionality (p « n) and straightforwardness of the underlying prob-
lem.”
According to the news editors, the research concluded: “Multiview
is possibly rather suitable for problems that are more sophisticated.”
For more information on this research see: Bagging, bumping,
multiview, and active learning for record linkage with empirical re-
sults on patient identity data. Computer Methods and Programs in
Biomedicine, 2012;108(3):1160-1169. Computer Methods and Programs
in Biomedicine can be contacted at: Elsevier Ireland Ltd, Elsevier
House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ire-
land. (Elsevier - www.elsevier.com; Computer Methods and Programs
in Biomedicine - http://www.elsevier.com/wps/product/cws_
home/505960)
Our news journalists report that additional information may be ob-
tained by contacting M. Sariyar, Johannes Gutenberg Univ Mainz, Inst
Med Biostat Epidemiol & Informat, University Medical Center, Mainz,
Germany. (2013 Jan 24)
914
CHAPTER 3 BIOMEDICINE
915
CHAPTER 3 BIOMEDICINE
916
CHAPTER 3 BIOMEDICINE
917
CHAPTER 3 BIOMEDICINE
918
CHAPTER 3 BIOMEDICINE
919
CHAPTER 3 BIOMEDICINE
920
CHAPTER 3 BIOMEDICINE
921
CHAPTER 3 BIOMEDICINE
922
CHAPTER 3 BIOMEDICINE
PPG signals from the finger were also obtained for comparison pur-
poses. Analysis of the amplitudes of all acquired PPG signals indicated
much larger amplitudes for those signals obtained from splanchnic or-
gans than those obtained from the finger. Estimated SpO(2) values for
splanchnic organs showed good agreement with those obtained from the
finger fibre optic probe and those obtained from a commercial device.”
According to the news reporters, the research concluded: “These
preliminary results suggest that a miniaturized ‘indwelling’ fibre optic
sensor may be a suitable method for pre-operative and post-operative
evaluation of splanchnic organ SpO(2) and their health.”
For more information on this research see: A new fibre optic pulse
oximeter probe for monitoring splanchnic organ arterial blood oxy-
gen saturation. Computer Methods and Programs In Biomedicine,
2012;108(3):883-8. (Elsevier - www.elsevier.com; Computer Methods
and Programs In Biomedicine - http://www.elsevier.com/wps/
product/cws_home/505960)
Our news correspondents report that additional information may be
obtained by contacting M. Hickey, School of Engineering and Mathe-
matical Sciences, City University London, London, UK. (2013 Jan 22)
923
CHAPTER 3 BIOMEDICINE
924
CHAPTER 3 BIOMEDICINE
925
CHAPTER 3 BIOMEDICINE
926
CHAPTER 3 BIOMEDICINE
927
CHAPTER 3 BIOMEDICINE
928
CHAPTER 3 BIOMEDICINE
direction for individual bone models were generated, whose scalar dis-
tribution pattern tends to conform very well to the object shape. The
scalar iso-contours were extracted and sampled adaptively to construct
volumetric meshes of high quality. Following, the surface harmonic
fields were expanded over the whole volumetric domain to create longi-
tudinal and radial volumetric harmonic fields, from which the gradient
vector fields were calculated and employed as the orthotropic principal
axes vector fields.”
According to the news reporters, the research concluded: “Con-
trastive finite element analyses demonstrated that elastic orthotropy
has significant effect on simulating stresses and strains, including the
value as well as distribution pattern, which underlines the relevance of
our orthotropic modeling scheme.”
For more information on this research see: Physical modeling with
orthotropic material based on harmonic fields. Computer Methods and
Programs in Biomedicine, 2012;108(2):536-547. Computer Methods and
Programs in Biomedicine can be contacted at: Elsevier Ireland Ltd, El-
sevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000,
Ireland. (Elsevier - www.elsevier.com; Computer Methods and Pro-
grams in Biomedicine - http://www.elsevier.com/wps/product/
cws_home/505960)
Our news correspondents report that additional information may be
obtained by contacting S.H. Liao, Wenzhou Med College, Affiliated Hosp
1, Wenzhou, People’s Republic of China. (2012 Dec 21)
929
CHAPTER 3 BIOMEDICINE
query and management of ECGs are impeded by the diversity and het-
erogeneity of bio-signal storage data formats. In this scope, the pro-
posed work introduces a new methodology for the unified access to bio-
signal databases and the accompanying metadata. It allows decoupling
information retrieval from actual underlying datasource structures and
enables transparent content and context based searching from multiple
data resources. Our approach is based on the definition of an interac-
tive global ontology which manipulates the similarities and the differ-
ences of the underlying sources to either establish similarity mappings
or enrich its terminological structure.”
According to the news editors, the research concluded: “We also in-
troduce ROISES (Research Oriented Integration System for ECG Sig-
nals), for the definition of complex content based queries against the
diverse bio-signal data sources.”
For more information on this research see: Searching biosignal
databases by content and context: Research Oriented Integration Sys-
tem for ECG Signals (ROISES). Computer Methods and Programs in
Biomedicine, 2012;108(2):453-466. Computer Methods and Programs
in Biomedicine can be contacted at: Elsevier Ireland Ltd, Elsevier
House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ire-
land. (Elsevier - www.elsevier.com; Computer Methods and Programs
in Biomedicine - http://www.elsevier.com/wps/product/cws_
home/505960)
Our news journalists report that additional information may be ob-
tained by contacting A. Kokkinaki, Aristotle University, Lab Med In-
format, Fac Med, Thessaloniki 54124, Greece. (2012 Dec 20)
930
CHAPTER 3 BIOMEDICINE
931
CHAPTER 3 BIOMEDICINE
932
CHAPTER 3 BIOMEDICINE
933
CHAPTER 3 BIOMEDICINE
934
CHAPTER 3 BIOMEDICINE
935
CHAPTER 3 BIOMEDICINE
936
CHAPTER 3 BIOMEDICINE
937
CHAPTER 3 BIOMEDICINE
938
CHAPTER 3 BIOMEDICINE
939
CHAPTER 3 BIOMEDICINE
940
CHAPTER 3 BIOMEDICINE
941
CHAPTER 3 BIOMEDICINE
942
CHAPTER 3 BIOMEDICINE
943
CHAPTER 3 BIOMEDICINE
944
CHAPTER 3 BIOMEDICINE
945
CHAPTER 3 BIOMEDICINE
946
CHAPTER 3 BIOMEDICINE
947
CHAPTER 3 BIOMEDICINE
948
CHAPTER 3 BIOMEDICINE
949
CHAPTER 3 BIOMEDICINE
950
CHAPTER 3 BIOMEDICINE
951
CHAPTER 3 BIOMEDICINE
952
CHAPTER 3 BIOMEDICINE
953
CHAPTER 3 BIOMEDICINE
954
CHAPTER 3 BIOMEDICINE
955
CHAPTER 3 BIOMEDICINE
956
CHAPTER 3 BIOMEDICINE
method consists of four steps. First, we obtain the vascular tree struc-
ture using a segmentation algorithm. Then, we extract the profiles. Af-
ter that, we select the best feature vectors to distinguish between veins
and arteries. Finally, we use a clustering algorithm to classify each de-
tected vessel as an artery or a vein. Our results show that compared
with an observer-based method, our method achieves high sensitivity
and specificity in the automated detection of retinal arteries and veins.
In addition the system is robust enough independently of the radii fi-
nally chosen, which makes it more trustworthy in its clinical applica-
tion.”
According to the news reporters, the research concluded: “We con-
clude that the system represents an automatic method of detecting ar-
teries and veins to measure the calibre of retinal microcirculation across
digital pictures of the eye fundus.”
For more information on this research see: Development of an
automated system to classify retinal vessels into arteries and veins.
Computer Methods and Programs in Biomedicine, 2012;108(1):367-376.
Computer Methods and Programs in Biomedicine can be contacted at:
Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shan-
non, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Computer
Methods and Programs in Biomedicine - http://www.elsevier.
com/wps/product/cws_home/505960)
Our news correspondents report that additional information may
be obtained by contacting M. Saez, Hlth Care Inst, Res Unit, Girona,
Spain. (2012 Nov 27)
957
CHAPTER 3 BIOMEDICINE
958
CHAPTER 3 BIOMEDICINE
959
CHAPTER 3 BIOMEDICINE
960
CHAPTER 3 BIOMEDICINE
961
CHAPTER 3 BIOMEDICINE
962
CHAPTER 3 BIOMEDICINE
963
CHAPTER 3 BIOMEDICINE
964
CHAPTER 3 BIOMEDICINE
965
CHAPTER 3 BIOMEDICINE
966
CHAPTER 3 BIOMEDICINE
967
CHAPTER 3 BIOMEDICINE
968
CHAPTER 3 BIOMEDICINE
969
CHAPTER 3 BIOMEDICINE
970
CHAPTER 3 BIOMEDICINE
971
CHAPTER 3 BIOMEDICINE
Our news journalists obtained a quote from the research from the
University of Modena and Reggio Emilia, “In fact, the same amount
of venom affects children more severely than adults because of the re-
duced total dilution volume in children. The only specific and con-
flicting therapy for venomous snakebite is to administer the appropri-
ate anti-venom; the remaining therapy is symptomatic and supportive.
We describe the case of a 22-month-old child who, despite appropriate
symptomatic treatment, developed severe signs and an acute compart-
ment syndrome of the right upper limb, a rare complication of venom
snakebite. Administration of antivenom and fasciotomy were needed to
resolve the acute episode permitting a positive outcome.”
According to the news editors, the researchers concluded: “On the
basis of literature review and our experience we hypothesize an algo-
rithm for the treatment of these patients.”
For more information on this research see: Compartment syndrome
after viper-bite in toddler: case report and review of literature. Acta
Bio-medica De L’ateneo Parmense, 2012;83(1):44-50.
The news correspondents report that additional information may be
obtained from Z. Pietrangiolillo, Dept. of Pediatrics, University of Mod-
ena & Reggio Emilia, Modena, Italy. (2012 Oct 03)
972
CHAPTER 3 BIOMEDICINE
tended to increase, whereas that of glucose did not. Adrenaline and no-
radrenaline levels increased, indicating sympathetic nerve (SN) domi-
nance with increase in granulocytes. WBC number and ratio were di-
vided into two groups according to granulocyte ratio (=or <60%) be-
fore SRDT: a normal group and a SN group. Only in the SN group did
the granulocyte ratio decrease and the lymphocyte ratio and number
increase after SRDT.”
According to the news editors, the researchers concluded: “It is sug-
gested that SRDT is a mild aerobic, systemic exercise that might affect
the immune system via the autonomic nervous system.”
For more information on this research see: Skin rubdown with a
dry towel, ‘kanpu-masatsu’ is an aerobic exercise affecting body tem-
perature, energy production, and the immune and autonomic nervous
systems. Biomedical Research, 2012;33(4):243-8.
The news editors report that additional information may be obtained
by contacting M. Watanabe, Dept. of Immunology, Niigata University
School of Medicine, Niigata, Japan. (2012 Oct 02)
973
CHAPTER 3 BIOMEDICINE
974
CHAPTER 3 BIOMEDICINE
975
CHAPTER 3 BIOMEDICINE
976
CHAPTER 3 BIOMEDICINE
977
CHAPTER 3 BIOMEDICINE
978
CHAPTER 3 BIOMEDICINE
research has been technically oriented, and very few services have been
implemented to support healthcare systems using the technology. It is
thus unclear about the potential that DTN may have for supporting MIS
systems in low resource settings. The goals of the paper are twofold,
first, to gain an initial estimate of interest in different services that can
be supported by DTN. Second, to find out the necessary frequency as-
sociated with each service for supporting health work in low resource
settings. Fifty questionnaires were distributed to attendants at the In-
ternational Conference on Global Health that had acknowledged having
health work experience in a poor connectivity context. The respondents
were using a 5-point Likert scale regarding if 9 different potential DTN
services ‘would be useful’. They also were asked how often data delivery
would be necessary for these services to be useful. The Chi square was
calculated to measure acceptance. 37 responses were received, aggre-
gating the response rate of 74%. The respondents represented having
work experience from 8 months to 15 years from 35 resource poor coun-
tries. The Chi square test showed very high statistical significance for
‘strongly agree and agree’ for the potential usefulness of the proposed
DTN services, with a p-value less than 0.001. The frequency of data
delivery that would be necessary for services to be useful varied con-
siderably. This study provides evidence of potential for DTN to support
useful services that support health work in low resource settings, and
that services like access to email, notification of lab results, backup of
EHR and teleconsultation are seem to be most important services that
can be supported by DTN. The necessary frequency of data delivery for
each service, will be highly dependent on context. In a low resource
setting with limited mobility, the physical transport of digital data at a
frequency of less than once per week should still be sufficient for useful
services like notification of lab results and ordering of medical supplies.
Research comparing different methods for delivery of DTN data should
thus be useful. Further research and collaboration between MIS and
Computer Science research communities is recommended in order to
help develop DTN services that can be evaluated.”
According to the news reporters, the researchers concluded: “Efforts
to enhance awareness among stakeholders about how DTN can be used
to support health services should be worthwhile.”
For more information on this research see: Study on the potential
for delay tolerant networks by health workers in low resource settings.
Computer Methods and Programs in Biomedicine, 2012;107(3):557-564.
Computer Methods and Programs in Biomedicine can be contacted at:
Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shan-
non, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Computer
Methods and Programs in Biomedicine - http://www.elsevier.
com/wps/product/cws_home/505960)
979
CHAPTER 3 BIOMEDICINE
980
CHAPTER 3 BIOMEDICINE
981
CHAPTER 3 BIOMEDICINE
in two sites and were treated for the reduction of facial wrinkles and
rhytides and followed for 3 months after the last treatment. The safety
of using the TriPollar system was established by the physicians’ as-
sessments and observations of adverse events after each treatment. To
evaluate treatment efficacy, pre- and post-treatment photos were as-
sessed using a blinded evaluation by two uninvolved physicians. No
unexpected adverse side effects were detected or reported. All sub-
jects participating in the study reported no pain or mild pain during
the treatments. The photographic analysis of pre- and post-treatment
by the two blinded physicians revealed improvement (downgrade of at
least 1 score according to the Fitzpatrick scale) in 94% (according to first
reviewer) and 97% (according to second reviewer) of study subjects. All
patients (100%) were satisfied from treatment results to a different ex-
tent.”
According to the news editors, the researchers concluded: “The re-
sults of this study clearly indicate that the TriPollar system offers a
non-invasive, effective, safe and virtually painless wrinkle and rhytides
reduction treatment. Lasers Surg. Med. 44:453458, 2012.”
For more information on this research see: Evaluation of safety and
efficacy of the TriPollar technology for treatment of wrinkles. Lasers
in Surgery and Medicine, 2012;44(6):453-458. Lasers in Surgery and
Medicine can be contacted at: Wiley-Blackwell, 111 River St, Hoboken
07030-5774, NJ, USA. (Wiley-Blackwell - http://www.wiley.com/;
Lasers in Surgery and Medicine - http://onlinelibrary.wiley.
com/journal/10.1002/(ISSN)1096-9101)
Our news journalists report that additional information may be ob-
tained by contacting S.D. Shapiro, Kaplan Hosp, Dept. of Plast Surg,
IL-76100 Rehovot, Israel. (2012 Aug 26)
982
CHAPTER 3 BIOMEDICINE
procedures offer the benefit of improved cure rates and maximal tissue
conservation. However, dealing with such tissue successfully presents
the laboratory with a host of technical problems. This report advocates
a set protocol to follow for slow Mohs, based on the experience acquired
from dealing with 37 cases of DFSP over a 12-year period.”
According to the news editors, the researchers concluded: “The re-
port establishes the benefits of slow Mohs paraffin wax-embedded tissue
over frozen sections in terms of improved morphology, tissue preserva-
tion and immunocytochemical labelling with anti-CD34.”
For more information on this research see: Dermatofibrosarcoma
protuberans: dealing with slow Mohs procedures employing formalin-
fixed, paraffin wax-embedded tissue in a busy diagnostic laboratory.
British Journal of Biomedical Science, 2012;69(2):56-61. British Jour-
nal of Biomedical Science can be contacted at: Step Publishing Ltd,
Subscription Dept, North Farm Rd, Tunbridge Wells TN2 3DR, Kent,
England.
Our news journalists report that additional information may be ob-
tained by contacting G.E. Orchard, St. Thomas Hospital, St Johns Inst
Dermatol, Dept. of Dermatopathol, London SE1 7EH, United Kingdom.
(2012 Aug 24)
983
CHAPTER 3 BIOMEDICINE
984
CHAPTER 3 BIOMEDICINE
985
CHAPTER 3 BIOMEDICINE
986
CHAPTER 3 BIOMEDICINE
Center, Sch Biomed Sci, Nottingham NG7 2UH, United Kingdom. (2012
Aug 16)
987
CHAPTER 3 BIOMEDICINE
988
CHAPTER 3 BIOMEDICINE
989
CHAPTER 3 BIOMEDICINE
990
CHAPTER 3 BIOMEDICINE
991
CHAPTER 3 BIOMEDICINE
992
CHAPTER 3 BIOMEDICINE
993
CHAPTER 3 BIOMEDICINE
994
CHAPTER 3 BIOMEDICINE
995
CHAPTER 3 BIOMEDICINE
996
CHAPTER 3 BIOMEDICINE
Our news journalists obtained a quote from the research from Amity
University, “Cinnamon oil produced maximum inhibition zone of diam-
eter (IZD) of 24.0 mm against Streptococcus mutans (major causative
bacteria of dental plaque) as compared to clove oil (IZD=13.0mm). This
is contrary to the popular belief that clove oil is effective in tooth decay
and dental plaque.”
According to the news editors, the researchers concluded: “This
study shows the potential of cinnamon oil over clove oil in the treatment
of dental caries.”
For more information on this research see: Comparative study of
cinnamon oil and clove oil on some oral microbiota. Acta Bio-medica De
L’ateneo Parmense, 2011;82(3):197-9.
The news correspondents report that additional information may be
obtained from C. Gupta, Amity Institute for Herbal Research and Stud-
ies, Amity University, Noida, India. (2012 Aug 07)
997
CHAPTER 3 BIOMEDICINE
998
CHAPTER 3 BIOMEDICINE
999
CHAPTER 3 BIOMEDICINE
1000
CHAPTER 3 BIOMEDICINE
1001
CHAPTER 3 BIOMEDICINE
1002
CHAPTER 3 BIOMEDICINE
1003
CHAPTER 3 BIOMEDICINE
1004
CHAPTER 3 BIOMEDICINE
1005
CHAPTER 3 BIOMEDICINE
1006
CHAPTER 3 BIOMEDICINE
1007
CHAPTER 3 BIOMEDICINE
1008
CHAPTER 3 BIOMEDICINE
1009
CHAPTER 3 BIOMEDICINE
1010
CHAPTER 3 BIOMEDICINE
1011
CHAPTER 3 BIOMEDICINE
1012
CHAPTER 3 BIOMEDICINE
Informat Technol & Engn, Canberra, ACT 2600, Australia. (2012 Jun
26)
1013
CHAPTER 3 BIOMEDICINE
gained recently an increased interest. This interest arises from the pos-
sibility of using changes in these nerves as the basis of a simple and non-
invasive method for early detection and follow-up of peripheral diabetic
neuropathy, a major cause of chronic disability in diabetic patients.”
The news correspondents obtained a quote from the research by the
authors from the Institute of Biomedical Research, “Here, we propose
one method for automatic segmentation and analysis of corneal nerves
from images obtained in vivo through corneal confocal microscopy. The
method is capable of segmenting corneal nerves, with sensitivity near
90% and a percentage of false recognitions with an average of 5.3%.”
According to the news reporters, the researchers concluded: “The
nerves tortuosity was calculated and shows statistically significant dif-
ferences between healthy controls and diabetic individuals, in accor-
dance to what is reported in the literature.”
For more information on this research see: A method for corneal
nerves automatic segmentation and morphometric analysis. Computer
Methods and Programs In Biomedicine, 2012;107(1):53-60. (Elsevier -
www.elsevier.com; Computer Methods and Programs In Biomedicine -
http://www.elsevier.com/wps/product/cws_home/505960)
Our news journalists report that additional information may be ob-
tained by contacting A. Ferreira, IBILI - Institute of Biomedical Re-
search in Light and Image, Azinhaga de Santa Comba, Celas, 3000-548
Coimbra, Portugal. (2012 Jun 21)
1014
CHAPTER 3 BIOMEDICINE
1015
CHAPTER 3 BIOMEDICINE
1016
CHAPTER 3 BIOMEDICINE
1017
CHAPTER 3 BIOMEDICINE
1018
CHAPTER 3 BIOMEDICINE
1019
CHAPTER 3 BIOMEDICINE
1020
Chapter 4
Cellular Reprogramming
1021
CHAPTER 4 CELLULAR REPROGRAMMING
1022
CHAPTER 4 CELLULAR REPROGRAMMING
1023
CHAPTER 4 CELLULAR REPROGRAMMING
(SAT), visceral adipose tissue (VAT), and neck SAT in cloned pigs com-
pared to normal outbred pigs. The variation in gene expression was
found to be similar for the two groups, and the expression of a small
number of genes was significantly affected by cloning. In the VAT and
abdominal SAT, six out of seven significantly differentially expressed
genes were downregulated in the clones. In contrast, most differently
expressed genes in both liver and neck SAT were upregulated (seven
out of eight). Remarkably, acute phase proteins (APPs) dominated the
upregulated genes in the liver, whereas APP expression was either un-
changed or downregulated in abdominal SAT and VAT. The general con-
clusion from this work is that cloning leads to subtle changes in specific
subsets of innate immune genes.”
According to the news reporters, the research concluded: “Such
changes, even if minor, may have phenotypic effects over time, e.g., in
models of long-term inflammation related to obesity.”
For more information on this research see: Expression of in-
nate immune response genes in liver and three types of adipose
tissue in cloned pigs. Cellular Reprogramming, 2012;14(5):407-
17. (Mary Ann Liebert, Inc. - www.liebertpub.com; Cellular
Reprogramming - http://www.liebertpub.com/overview/
cellular-reprogramming-formerly-cloning-and-stem-cells/
9/)
Our news journalists report that additional information may be ob-
tained by contacting T. Rodgaard, Innate Immunology Group, National
Veterinary Institute, Technical University of Denmark, Frederiksberg
C, Denmark. (2012 Dec 26)
1024
CHAPTER 4 CELLULAR REPROGRAMMING
1025
CHAPTER 4 CELLULAR REPROGRAMMING
9?h after activation of SCNT embryos increased both in vitro and in vivo
developmental competence. Treatment of SCNT embryos with 1?M ox-
amflatin significantly increased blastocyst rate and total cell number in
blastocysts (33.3±6.0 and 73.1±1.6, respectively) than that
of controls (10.3±3.7 and 54.1±3.5, respectively) or scriptaid
(16.4±4.6 and 64.4±2.1, respectively). Moreover, oxamflatin
showed significant higher overall cloning efficiency from 0.9% to 3.2%,
whereas scriptaid demonstrated 0% to 1.8%.”
According to the news reporters, the researchers concluded: “These
results indicate that oxamflatin treatment improves the developmental
competence of porcine SCNT embryos.”
For more information on this research see: Oxamflatin im-
proves developmental competence of porcine somatic cell nuclear
transfer embryos. Cellular Reprogramming, 2012;14(5):398-
406. (Mary Ann Liebert, Inc. - www.liebertpub.com; Cellular
Reprogramming - http://www.liebertpub.com/overview/
cellular-reprogramming-formerly-cloning-and-stem-cells/
9/)
Our news journalists report that additional information may be ob-
tained by contacting S.J. Park, 1 Dept. of Theriogenology and Biotech-
nology, College of Veterinary Medicine, Seoul National University ,
Seoul 151-742, South Korea. (2012 Oct 17)
1026
CHAPTER 4 CELLULAR REPROGRAMMING
1027
CHAPTER 4 CELLULAR REPROGRAMMING
to select donor clones capable of converting n-6 into n-3 fatty acids.
Blastocysts derived from the clones that lowered the n-6/n-3 ratio to
approximately 1:1 were transferred surgically into the uteri of recipi-
ents for transgenic piglets. By HMC, 37% (n=558) of reconstructed em-
bryos developed to the blastocyst stage after 7 days of culture in vitro,
with an average cell number of 81±36 (n=14). Three recipients
became pregnant after 408 day-6 blastocysts were transferred into four
naturally cycling females, and a total of 14 live offspring were produced.
The nematode mfat-1 effectively lowered the n-6/n-3 ratio in muscle and
major organs of the transgenic pig.”
According to the news editors, the researchers concluded: “Our re-
sults will help to establish a reliable procedure and an efficient option
in the production of transgenic animals.”
For more information on this research see: Handmade
cloned transgenic piglets expressing the nematode fat-1
gene. Cellular Reprogramming, 2012;14(3):258-66. (Mary
Ann Liebert, Inc. - www.liebertpub.com; Cellular Repro-
gramming - http://www.liebertpub.com/overview/
cellular-reprogramming-formerly-cloning-and-stem-cells/
9/)
Our news journalists report that additional information may be ob-
tained by contacting P. Zhang, State Key Laboratory of Molecular and
Developmental Biology, Institute of Genetics and Developmental Bi-
ology, Chinese Academy of Sciences, Beijing 100101, People’s Taiwan.
(2012 Aug 28)
1028
CHAPTER 4 CELLULAR REPROGRAMMING
0.48% vs. 5.67 ± 0.40%, p<0.05) in blastocysts was greatly re-
duced after VPA treatment. Valproic acid treatment also increased the
immunofluorescent signal for H3K9ac in SCNT embryos in a pattern
similar to that of in vitro fertilized (IVF) embryos.”
According to the news reporters, the researchers concluded: “We
demonstrated that VPA can significantly improve the in vitro develop-
mental competence and enhance the nuclear reprogramming of bovine
SCNT embryos.”
For more information on this research see: Valproic acid im-
proves the in vitro development competence of bovine somatic cell
nuclear transfer embryos. Cellular Reprogramming, 2012;14(2):138-
45. (Mary Ann Liebert, Inc. - www.liebertpub.com; Cellular
Reprogramming - http://www.liebertpub.com/overview/
cellular-reprogramming-formerly-cloning-and-stem-cells/
9/)
Our news correspondents report that additional information may be
obtained by contacting W. Xu, College of Veterinary Medicine, North-
west A&F University, Key Laboratory of Animal Reproductive Physiol-
ogy & Embryo Technology, Ministry of Agriculture, Yangling, Shaanxi,
People’s Taiwan. (2012 Aug 01)
1029
CHAPTER 4 CELLULAR REPROGRAMMING
growth studies did not reveal any significant variations. Despite some
differences observed, the present study revealed that ntESC lines had
similar differentiation competences compared to other ESCs.”
According to the news reporters, the researchers concluded: “The re-
sults indicate that the observed differences may be related to the geno-
type rather than to the nuclear transfer technology.”
For more information on this research see: Comparative anal-
ysis of nuclear transfer embryo-derived mouse embryonic stem
cells. Part I: cellular characterization. Cellular Reprogramming,
2012;14(1):56-67. (Mary Ann Liebert, Inc. - www.liebertpub.com; Cel-
lular Reprogramming - http://www.liebertpub.com/overview/
cellular-reprogramming-formerly-cloning-and-stem-cells/
9/)
Our news correspondents report that additional information may
be obtained by contacting J. Kobolak, Genetic Reprogramming Group,
Agricultural Biotechnology Center, Godollo, Hungary. (2012 Jun 27)
1030
CHAPTER 4 CELLULAR REPROGRAMMING
1031
CHAPTER 4 CELLULAR REPROGRAMMING
1032
CHAPTER 4 CELLULAR REPROGRAMMING
1033
CHAPTER 4 CELLULAR REPROGRAMMING
1034
Chapter 5
Molecular Medicine
1035
CHAPTER 5 MOLECULAR MEDICINE
1036
CHAPTER 5 MOLECULAR MEDICINE
1037
CHAPTER 5 MOLECULAR MEDICINE
1038
CHAPTER 5 MOLECULAR MEDICINE
situ, whereas cultured cell from thrombi was desmin positive but pan-
cytokeratin negative. Cells cultured in endothelial cell medium were
von Willebrand factor positive. The content of coronary thrombectomy
specimens is heterogeneous and consists of blood cells but also possibly
cells from the vascular wall and cholesterol crystals.”
According to the news editors, the research concluded: “The cul-
ture of cells contained in the specimens yielded multiplying cells, some
of which demonstrated features of haematopoietic progenitor cells and
which differentiated into various cell-types.”
For more information on this research see: Cellularity and struc-
ture of fresh human coronary thrombectomy specimens; presence
of cells with markers of progenitor cells. Journal of Cellular and
Molecular Medicine, 2012;16(12):3022-3027. Journal of Cellular
and Molecular Medicine can be contacted at: Wiley-Blackwell, 111
River St, Hoboken 07030-5774, NJ, USA. (Wiley-Blackwell - http:
//www.wiley.com/; Journal of Cellular and Molecular Medicine
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)
1582-4934)
The news correspondents report that additional information may be
obtained from I.S. Jovin, Yale University, Center Vasc Biol & Trans-
plantat, New Haven, CT, United States. (2013 Jan 29)
1039
CHAPTER 5 MOLECULAR MEDICINE
1040
CHAPTER 5 MOLECULAR MEDICINE
1041
CHAPTER 5 MOLECULAR MEDICINE
1042
CHAPTER 5 MOLECULAR MEDICINE
1043
CHAPTER 5 MOLECULAR MEDICINE
1044
CHAPTER 5 MOLECULAR MEDICINE
1045
CHAPTER 5 MOLECULAR MEDICINE
1046
CHAPTER 5 MOLECULAR MEDICINE
1047
CHAPTER 5 MOLECULAR MEDICINE
1048
CHAPTER 5 MOLECULAR MEDICINE
1049
CHAPTER 5 MOLECULAR MEDICINE
1050
CHAPTER 5 MOLECULAR MEDICINE
SH3A may hold up caveolae release from the plasma membrane and
formation of free-transport vesicles, by prolonging the lifetime of as-
sembled dyn2.”
According to the news reporters, the research concluded: “Alto-
gether, our results indicate that ITSN-1s, via its SH3A has the unique
ability to regulate dyn2 assembly-disassembly and function during en-
docytosis.”
For more information on this research see: Regulation of dynamin-
2 assembly-disassembly and function through the SH3A domain
of intersectin-1s. Journal of Cellular and Molecular Medicine,
2011;15(11):2364-76. Journal of Cellular and Molecular Medicine can
be contacted at: Blackwell Publishing Inc, 350 Main St, Malden, MA
02148, USA. (Wiley-Blackwell - http://www.wiley.com/; Journal of
Cellular and Molecular Medicine - http://onlinelibrary.wiley.
com/journal/10.1111/(ISSN)1582-4934)
Our news journalists report that additional information may be ob-
tained by contacting I. Knezevic, Dept. of Pharmacology, Rush Uni-
versity Medical Center, Medical College, Vascular Biology Section,
Chicago, IL 60612, United States.
Publisher contact information for the Journal of Cellular and Molec-
ular Medicine is: Blackwell Publishing Inc, 350 Main St, Malden, MA
02148, USA. (2012 Dec 07)
1051
CHAPTER 5 MOLECULAR MEDICINE
1052
CHAPTER 5 MOLECULAR MEDICINE
Our news journalists obtained a quote from the research from Sun
Yat-Sen University, “The emergence of stem cell transplantation ap-
proaches has recently represented promising alternatives to stimulate
myocardial regeneration. Regarding their tissue-specific properties,
cardiac stem cells (CSCs) residing within the heart have advantages
over other stem cell types to be the best cell source for cell transplanta-
tion. However, time-consuming and costly procedures to expanse cells
prior to cell transplantation and the reliability of cell culture and ex-
pansion may both be major obstacles in the clinical application of CSC-
based transplantation therapy after MI. The recognition that the adult
heart possesses endogenous CSCs that can regenerate cardiomyocytes
and vascular cells has raised the unique therapeutic strategy to re-
constitute dead myocardium via activating these cells post-MI. Several
strategies, such as growth factors, mircoRNAs and drugs, may be imple-
mented to potentiate endogenous CSCs to repair infarcted heart with-
out cell transplantation. Most molecular and cellular mechanism in-
volved in the process of CSC-based endogenous regeneration after MI
is far from understanding.”
According to the news editors, the research concluded: “This article
reviews current knowledge opening up the possibilities of cardiac repair
through CSCs activation in situ in the setting of MI.”
For more information on this research see: Local activation of car-
diac stem cells for post-myocardial infarction cardiac repair. Jour-
nal of Cellular and Molecular Medicine, 2012;16(11):2549-63. Jour-
nal of Cellular and Molecular Medicine can be contacted at: Black-
well Publishing Inc, 350 Main St, Malden, MA 02148, USA. (Wiley-
Blackwell - http://www.wiley.com/; Journal of Cellular and Molec-
ular Medicine - http://onlinelibrary.wiley.com/journal/10.
1111/(ISSN)1582-4934)
Our news journalists report that additional information may be ob-
tained by contacting Z. Wen, Sun Yat-sen Memorial Hospital of Sun
Yat-sen University, Guangzhou, People’s Taiwan.
Publisher contact information for the Journal of Cellular and Molec-
ular Medicine is: Blackwell Publishing Inc, 350 Main St, Malden, MA
02148, USA. (2012 Nov 30)
1053
CHAPTER 5 MOLECULAR MEDICINE
1054
CHAPTER 5 MOLECULAR MEDICINE
1055
CHAPTER 5 MOLECULAR MEDICINE
1056
CHAPTER 5 MOLECULAR MEDICINE
1057
CHAPTER 5 MOLECULAR MEDICINE
1058
CHAPTER 5 MOLECULAR MEDICINE
1059
CHAPTER 5 MOLECULAR MEDICINE
1060
CHAPTER 5 MOLECULAR MEDICINE
1061
CHAPTER 5 MOLECULAR MEDICINE
both the initiation of wound healing by activating PSC, and its comple-
tion by killing senescent stellate cells.”
For more information on this research see: Senescence determines
the fate of activated rat pancreatic stellate cells. Journal of Cellu-
lar and Molecular Medicine, 2012;16(11):2620-30. Journal of Cellu-
lar and Molecular Medicine can be contacted at: Blackwell Publishing
Inc, 350 Main St, Malden, MA 02148, USA. (Wiley-Blackwell - http:
//www.wiley.com/; Journal of Cellular and Molecular Medicine
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)
1582-4934)
Our news journalists report that additional information may be ob-
tained by contacting B. Fitzner, Dept. of Medicine II, Division of Gas-
troenterology, University of Rostock, Rostock, Germany.
Publisher contact information for the Journal of Cellular and Molec-
ular Medicine is: Blackwell Publishing Inc, 350 Main St, Malden, MA
02148, USA. (2012 Nov 26)
1062
CHAPTER 5 MOLECULAR MEDICINE
1063
CHAPTER 5 MOLECULAR MEDICINE
1064
CHAPTER 5 MOLECULAR MEDICINE
1065
CHAPTER 5 MOLECULAR MEDICINE
1066
CHAPTER 5 MOLECULAR MEDICINE
1067
CHAPTER 5 MOLECULAR MEDICINE
1068
CHAPTER 5 MOLECULAR MEDICINE
The news reporters obtained a quote from the research from the Uni-
versity of Manitoba, “This study was undertaken to test that SP sup-
presses the development of atherosclerosis due to high cholesterol diet
(HCD) by decreasing blood viscosity and oxidative stress. For this pur-
pose, 29 rabbits were divided into four groups: control group (normal
diet); normal diet group with SP at the dose of 5 mg/kg/day; HCD group
fed 1% cholesterol; and HCD group with SP at the dose of 5 mg/kg/day.
After 90 days of the experiment, blood samples were collected and the
animals were killed; the thoracic aorta was stained by the Oil Red O
staining method. The results indicate that plasma levels of cholesterol,
triglycerides and malondialdehyde were increased in rabbits fed HCD.
Plasma viscosity and whole blood viscosity were also higher in the HCD
group than that in normal diet group. Treatment with SP prevented
these alterations induced by HCD whereas this agent had no signifi-
cant effect in rabbits fed normal diet. Morphological examination of the
aorta revealed that SP treatment prevented the formation of foam cells
and atherosclerotic plaque.”
According to the news reporters, the researchers concluded: “It is
suggested that the beneficial effects of SP in atherosclerosis may be due
to actions on blood viscosity, lipid levels and oxidative stress.”
For more information on this research see: Suppression of high
lipid diet induced by atherosclerosis sarpogrelate. Journal of Cellu-
lar and Molecular Medicine, 2012;16(10):2394-400. Journal of Cellu-
lar and Molecular Medicine can be contacted at: Blackwell Publishing
Inc, 350 Main St, Malden, MA 02148, USA. (Wiley-Blackwell - http:
//www.wiley.com/; Journal of Cellular and Molecular Medicine
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)
1582-4934)
Our news correspondents report that additional information may be
obtained by contacting Y.J. Xu, Institute of Cardiovascular Sciences, St
Boniface Hospital Research, Dept. of Physiology, Faculty of Medicine,
University of Manitoba, Winnipeg, MB, Canada.
The publisher of the Journal of Cellular and Molecular Medicine
can be contacted at: Blackwell Publishing Inc, 350 Main St, Malden,
MA 02148, USA. (2012 Oct 19)
1069
CHAPTER 5 MOLECULAR MEDICINE
1070
CHAPTER 5 MOLECULAR MEDICINE
1071
CHAPTER 5 MOLECULAR MEDICINE
1072
CHAPTER 5 MOLECULAR MEDICINE
1073
CHAPTER 5 MOLECULAR MEDICINE
1074
CHAPTER 5 MOLECULAR MEDICINE
Our news journalists obtained a quote from the research from the
Baylor University College of Medicine, “We identified 12 subpopula-
tions of putative EPCs that were altered >1.75-fold; two subpop-
ulations (CD146+/CD54/CD45 at 6.63-fold, and CD146+/UEA-1/CD45
at 12.21-fold) were dramatically elevated. To investigate the regen-
erative capacity of putative EPCs, we devised a new assay that maxi-
mally resembled their in vivo scenario, we purified CD34+ and CD146+
cells and co-cultured them with basal and mobilized PBMNCs; both cell
types took up Dil-LDL, but purified CD146+ cells exhibited accelerated
differentiation by increasing expression of CD31 and CD144, and by
exhibiting more active cord-like structure formation by comparison to
the CD34+ subpopulation in a co-culture with mobilized PBMNCs. We
demonstrate that ischaemia due to vascular ligation mobilizes multiple
types of cells with distinct roles.”
According to the news editors, the researchers concluded: “Baboon
CD146+ cells exhibit higher reparative capacity than CD34+ cells, and
thus are a potential source for therapeutic application.”
For more information on this research see: Repertoire of endothe-
lial progenitor cells mobilized by femoral artery ligation: a nonhu-
man primate study. Journal of Cellular and Molecular Medicine,
2012;16(9):2060-2073. Journal of Cellular and Molecular Medicine can
be contacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774,
NJ, USA. (Wiley-Blackwell - http://www.wiley.com/; Journal of
Cellular and Molecular Medicine - http://onlinelibrary.wiley.
com/journal/10.1111/(ISSN)1582-4934)
The news correspondents report that additional information may be
obtained from Q. Shi, Baylor College of Medicine, Texas Heart Inst,
Cardiothorac Res Lab, Houston, TX 77030, United States. (2012 Oct
10)
1075
CHAPTER 5 MOLECULAR MEDICINE
identify the combined mucin and O-glycan features, that is, specific gly-
coforms, in an attempt to increase specificity of these cancer biomark-
ers. Using in situ proximity ligation assays (PLA) based on existing
monoclonal antibodies directed to MUC1, MUC2, MUC5AC and MUC6
mucins and to cancer-associated carbohydrate antigens Tn, Sialyl-Tn
(STn), T, Sialyl-Le(a) (SLe(a)) and Sialyl-Le(x) (SLe(x)) we screened a
series of 28 mucinous adenocarcinomas from different locations (stom-
ach, ampulla of Vater, colon, lung, breast and ovary) to detect spe-
cific mucin glycoforms. We detected Tn/STn/SLe(a)/SLe(x)-MUC1 and
STn/SLe(a)/SLe(x)-MUC2 glycoforms in=50% of the cases, with a vari-
able distribution among organs. Some new glycoforms-T/SLe(a)-MUC2,
STn/T/SLe(a) SLe(x)-MUC5AC and STn/T/SLe(a)/SLe(x)-MUC6-were
identified for the first time in the present study in a variable percentage
of cases from different organs.”
According to the news editors, the researchers concluded: “Applica-
tion of the PLA technique allowed sensitive detection of specific aber-
rant mucin glycoforms in cancer, increasing specificity to the use of an-
tibodies either to the mucin protein backbone or to the O-glycan haptens
alone.”
For more information on this research see: Identification of new can-
cer biomarkers based on aberrant mucin glycoforms by in situ proximity
ligation. Journal of Cellular and Molecular Medicine, 2012;16(7):1474-
84. Journal of Cellular and Molecular Medicine can be contacted
at: Blackwell Publishing Inc, 350 Main St, Malden, MA 02148,
USA. (Wiley-Blackwell - http://www.wiley.com/; Journal of Cellu-
lar and Molecular Medicine - http://onlinelibrary.wiley.com/
journal/10.1111/(ISSN)1582-4934)
Our news journalists report that additional information may be ob-
tained by contacting R. Pinto, Institute of Molecular Pathology and Im-
munology of the University of Porto, Porto, Portugal.
Publisher contact information for the Journal of Cellular and Molec-
ular Medicine is: Blackwell Publishing Inc, 350 Main St, Malden, MA
02148, USA. (2012 Sep 18)
1076
CHAPTER 5 MOLECULAR MEDICINE
1077
CHAPTER 5 MOLECULAR MEDICINE
1078
CHAPTER 5 MOLECULAR MEDICINE
1079
CHAPTER 5 MOLECULAR MEDICINE
1080
CHAPTER 5 MOLECULAR MEDICINE
1081
CHAPTER 5 MOLECULAR MEDICINE
1082
CHAPTER 5 MOLECULAR MEDICINE
1083
CHAPTER 5 MOLECULAR MEDICINE
1084
CHAPTER 5 MOLECULAR MEDICINE
1085
CHAPTER 5 MOLECULAR MEDICINE
1086
CHAPTER 5 MOLECULAR MEDICINE
telocytes also stained positive for vimentin and connexin 43. Telopodes
were observed connecting cell colonies and connecting distant cells.”
According to the news reporters, the researchers concluded: “Our
findings suggest that telocytes may have a role in cell-to-cell communi-
cation over short and long distances within the endometrium.”
For more information on this research see: Culture of rat en-
dometrial telocytes. Journal of Cellular and Molecular Medicine,
2012;16(7):1392-1396. Journal of Cellular and Molecular Medicine can
be contacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774,
NJ, USA. (Wiley-Blackwell - http://www.wiley.com/; Journal of
Cellular and Molecular Medicine - http://onlinelibrary.wiley.
com/journal/10.1111/(ISSN)1582-4934)
Our news correspondents report that additional information may be
obtained by contacting K. Hatta, University of Toronto, Inst Med Sci,
Toronto, ON M5S 1A1, Canada. (2012 Jul 31)
1087
CHAPTER 5 MOLECULAR MEDICINE
1088
CHAPTER 5 MOLECULAR MEDICINE
1089
CHAPTER 5 MOLECULAR MEDICINE
1090
CHAPTER 5 MOLECULAR MEDICINE
1091
CHAPTER 5 MOLECULAR MEDICINE
1092
CHAPTER 5 MOLECULAR MEDICINE
1093
CHAPTER 5 MOLECULAR MEDICINE
1094
CHAPTER 5 MOLECULAR MEDICINE
1095
CHAPTER 5 MOLECULAR MEDICINE
1096
CHAPTER 5 MOLECULAR MEDICINE
1097
CHAPTER 5 MOLECULAR MEDICINE
1098
CHAPTER 5 MOLECULAR MEDICINE
1099
Chapter 6
Reproductive
Biomedicine
1100
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1101
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1102
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1103
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
biopsy’, in which 1-3 of the cells destined to become the placenta are re-
moved from the embryo for chromosomal testing. We report our experi-
ence with trophectoderm biopsy of frozen blastocysts in 12 patients who
underwent 13 cycles of PGD. The implantation rate per embryo trans-
ferred was 46% and the ongoing pregnancy rate per embryo transfer
was 63%. The results from this case series demonstrate that trophecto-
derm biopsy on cryopreserved blastocysts to perform PGD is logistically
feasible.”
According to the news reporters, the research concluded: “In addi-
tion, the rate of implantation and ongoing pregnancy were maintained
within a reasonable range to justify the procedure.”
For more information on this research see: Outcomes of trophecto-
derm biopsy on cryopreserved blastocysts: a case series. Reproductive
Biomedicine, 2012;25(5):504-7. (Elsevier - www.elsevier.com; Repro-
ductive Biomedicine - http://www.elsevier.com/wps/product/
cws_home/721149)
Our news journalists report that additional information may be ob-
tained by contacting R.B. Lathi, Stanford Fertility and Reproductive
Medicine Center, 900 Welch Road, Suite 350, Palo Alto, CA 94304,
United States. (2012 Dec 05)
1104
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1105
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1106
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1107
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1108
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1109
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1110
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1111
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1112
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1113
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1114
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
Biomedicine - http://www.elsevier.com/wps/product/cws_
home/721149)
Our news journalists report that additional information may be ob-
tained by contacting C. Egarter, Medical University of Vienna, Dept.
of Gynaecological Endocrinology and Reproduction, Wahringer Gurtel
18-20, 1090 Vienna, Austria. (2012 Jul 19)
1115
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1116
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1117
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1118
CHAPTER 6 REPRODUCTIVE BIOMEDICINE
1119
Index
1120
INDEX
Assisted Reproduction, 1105, 1111 673, 827, 828, 954, 1027, 1028,
Assistive Technology, 573, 767 1040, 1041
Asthma, 205, 427, 735, 948 Belgium, 84, 101, 141, 142, 243,
Athens, 69, 70, 104, 105, 330, 331 244, 387–390, 411, 412, 436,
Atherosclerosis, 188, 192, 230, 437, 576, 596, 597, 640, 641,
258, 339, 727, 921, 1069 648, 649, 934, 1067, 1068
Atlanta, 44, 45, 103, 599, 600, 639, Belmont, 362, 363
640 Bergen, 1009, 1010
Atopic Dermatitis, 642, 643 Berlin, 511, 512, 516, 517, 561,
Atorvastatin, 443 562, 587, 588, 722, 786, 787
ATPase, 1016, 1080 Bern, 57, 90, 91, 254, 255, 273,
Atrial Fibrillation, 39, 40, 361, 362 398, 492, 493, 522, 523
Auckland, 92, 162, 312–314 Bethesda, 19, 20, 49, 142, 143,
Aurora, 109, 110, 700, 701 754, 755, 845, 846, 848, 849,
Austin, 131, 132, 568, 569, 684, 876, 877, 881, 882, 900, 901,
685, 946, 947, 961 994, 995, 997, 998, 1088, 1089
Australia, 28, 29, 118, 149, 442, Biel, 273
461, 462, 504, 505, 518, 547, Bilbao, 1003, 1004
548, 606, 607, 657, 658, 737, Bilirubin, 73, 872
738, 832, 833, 838, 839, 897, Biochemical, 39, 66, 240, 270, 302,
898, 903, 904, 908, 938, 939, 375, 459, 582, 586, 835, 961,
953, 965, 966, 1002, 1003, 1050, 1070, 1098, 1106
1012, 1013 Biochemical Engineering, 72, 73
Austria, 556, 835, 836, 864, 865, Biochemistry, 48, 72, 115, 298,
1096, 1097, 1114, 1115 925, 961, 1119
Autism, 441, 442 Bioengineering, 53, 104, 145, 166,
173, 174, 379, 429, 438, 450,
Bacteria, 115, 116, 183, 436, 437, 452, 487, 674, 690, 705, 801,
553, 683, 963, 997 1083
Bacterial Infections, 543 Biofuel, 179
Badalona, 206, 207 Biomedical Chromatography, 10,
Baltimore, 74, 140, 141, 298, 376, 14, 39, 82, 84, 88–90, 101, 109,
377, 595, 596, 603, 604, 643, 312, 315, 336, 337, 390, 391,
644, 728, 729, 784, 1000 394, 395, 401, 417, 476–478,
Bangalore, 82, 83, 161, 241, 286, 506–509, 529, 536, 560, 561,
287, 574, 575 564, 567, 569, 574, 575, 705,
Barcelona, 144, 145, 489, 841, 842, 708, 709, 714, 828, 835, 839,
959, 960 840
Basel, 57, 309, 310, 339 Biomedical Engineering, 1–3, 5,
Bayesian Analysis, 852 7–40, 43–45, 51–60, 62–68,
Bayesian Networks, 908 72–74, 79–81, 83–86, 90–100,
Bedford, 600, 601 102–115, 121–133, 135–154,
Beijing, 13, 115, 116, 171, 172, 159, 162–164, 166, 167, 169,
204–206, 311, 312, 331, 332, 171–177, 180, 182, 183, 186–
506, 507, 541, 542, 616, 617, 201, 203–207, 209–230, 232–
1121
INDEX
1122
INDEX
1123
INDEX
Broadband, 6, 256, 268, 269, 318, 990, 1068, 1069, 1086, 1087,
620, 808 1105, 1107
Brussels, 141, 142, 387, 388 Canberra, 442, 908, 1012, 1013
Bucharest, 1046, 1047, 1087, Cancer, 1, 33, 70, 71, 138, 139, 142,
1088, 1095, 1096 152, 153, 155, 168, 202, 234,
Buenos Aires, 683 235, 257, 262, 266, 268, 270,
Buffalo, 54, 55, 418, 419, 981, 272, 279, 281, 299, 302, 303,
1022, 1023 325, 376, 385, 386, 418, 432,
Bunkyo ku, 948 440, 441, 454, 455, 457, 486,
Burgdorf, 492, 493 488, 504–506, 531, 540, 549,
Burn Care, 740 583, 612, 619, 643, 644, 649–
Bypass Graft, 557, 558 651, 687, 714, 719, 751, 753–
755, 798, 813, 815, 818, 837,
Cadiz, 572 851, 925, 939, 966, 981, 983,
Calcutta, 15 984, 994, 1000, 1043, 1054,
Calgary, 523, 524, 975, 976 1058, 1070, 1075, 1076, 1078,
California, 24–26, 53, 58–61, 63, 1085, 1095, 1097, 1098, 1109
64, 72, 73, 75, 93, 94, 126, 127, Cancer Detection, 168, 270, 441
134, 163–165, 186, 202, 208– Cancer Diagnostics, 152
210, 234, 255–259, 294, 295, Capacitive Coupling, 221, 628
341, 342, 380, 382–384, 390, Caracas, 372, 373
459, 495, 496, 517, 524, 525, Carbon Tetrachloride, 1049
699, 700, 734, 735, 775, 791, Carcinogenesis, 163, 650, 715,
815, 828, 830, 831, 854, 859, 753, 794, 992, 1049, 1050, 1097
866, 873, 874, 878, 967–969, Carcinoma, 1, 163, 281, 386, 424,
1000, 1001, 1082, 1083, 1103 440, 441, 505, 541, 837, 983,
Cambridge, 18, 36, 201, 328–330, 991, 994, 995
365, 366, 410, 411, 448, 449, Carcinomas, 242, 265, 440, 645,
744, 745, 761, 762, 764, 765, 994
824, 825, 849, 850, 922, 1019, Cardiac Arrhythmias, 436, 829
1084, 1098, 1099 Cardiology, 230, 247, 388, 436,
Campinas, 37, 38 656, 658, 661, 704, 941, 944,
Campylobacter, 579, 1018 1061, 1073, 1085, 1090
Canada, 12, 64, 65, 91, 92, 95, 96, Cardiomyocyte, 184, 1048, 1049,
102, 119, 137, 207, 208, 236, 1065, 1066, 1081, 1090–1092
237, 252, 253, 281, 283, 293, Cardiovascular, 36, 37, 39, 59, 75,
294, 299, 300, 305, 306, 340, 121, 157, 174, 184, 199, 216,
348, 351–354, 431, 473–475, 328, 364, 367, 381, 388, 443,
491, 492, 499, 500, 523, 524, 458, 459, 519, 551, 552, 656–
546, 547, 549, 550, 559, 560, 658, 661, 688, 690, 704, 718,
593, 594, 607, 608, 613, 630, 727, 797, 842, 888, 912, 965,
631, 664, 665, 674, 676, 677, 967, 973, 1035, 1048, 1060,
689, 730, 731, 750, 765, 766, 1065, 1066, 1069, 1071, 1072,
774, 814, 821, 822, 826, 827, 1079, 1081, 1082, 1094
920, 921, 944, 975, 976, 989,
1124
INDEX
1125
INDEX
1126
INDEX
Dentistry, 237, 273, 331, 398, 420, Dresden, 336, 337, 537, 538
426, 589, 702, 791, 905, 962 Drug Delivery Systems, 72, 116,
Denver, 110, 701, 735, 736 254
Depression, 360, 361, 869, 1048 Drugs, 8, 268, 296, 303, 336,
Dermatofibrosarcomas, 982 337, 414, 445, 457, 476, 494,
Dermatology, 284, 517, 982, 1006, 495, 508, 545, 549, 714, 727,
1096 730, 731, 745, 807, 871, 874,
Detroit, 635, 636, 925, 926, 1084, 876, 883, 959, 966, 1041, 1043,
1085 1045, 1053, 1089
Dexamethasone, 61, 528, 995 Drugs and Therapies, 156, 158,
Diabetes, 24, 61, 401, 547, 571, 581, 611, 876, 986, 995, 1084
655, 660, 759, 807, 843, 958, Dublin, 790, 887, 888, 970
962, 1007, 1013, 1072, 1088, Duchenne Muscular Dystrophy,
1118, 1119 1037, 1038
Diabetes Mellitus, 3, 312, 655, Duisburg, 338, 339
777, 1007 Dunedin, 263, 264
Diabetic Retinopathy, 547, 571, Durham, 83, 193, 194, 391, 392,
759, 760, 1007, 1008 408–410, 726
Diagnosis, 7, 11, 17, 35, 39, 41, 73, Dynamic Light Scattering, 304
76, 88, 129, 153, 159, 163, 168, Dynamic Time Warping, 562
183, 198, 225, 233, 256, 262, Dysplasia, 248, 281, 300, 391, 392,
269, 270, 272, 283, 330, 398, 440
406, 413, 422, 432, 439, 479,
630, 643, 647, 648, 667, 683, East Lansing, 579, 580
684, 687, 717, 747, 748, 785, Ecully, 496, 497
794, 813, 871, 872, 882, 897, Edema, 309, 743, 967, 970, 1004
918, 933, 947, 950, 974, 994, Edinburgh, 483, 484, 601, 602,
998, 1005, 1012, 1096, 1103, 918, 919
1110, 1111, 1116, 1117 Edmond, 259, 260, 619, 683, 684
Diagnostics, 67, 118, 195, 280, Edmonton, 91, 92, 293, 294, 491,
289, 398, 531, 628, 692, 736, 492, 549, 550, 674, 676, 677
772, 803, 819, 965, 971, 1019, Egypt, 170, 171
1093 Eindhoven, 2, 157, 158, 1065, 1066
Diet and Nutrition Disorders, 490 Electrochemical, 63, 64, 440, 815
Digestive System Diseases and Electronic Medical Records, 945
Conditions, 925 Electronics, 11–13, 15–23, 25, 26,
Digital Image Processing, 994 28–38, 40, 122–124, 126, 128,
Dijon, 126, 423, 424 130–133, 135, 137–139, 141–
Dimensionality Reduction, 1013 145, 147, 148, 153, 154, 159,
Dimethyl Sulfoxide, 582 162, 166, 189, 192, 193, 197–
Disease Associations, 231 199, 205, 206, 209, 210, 213–
District of Columbia, 740, 883, 215, 219, 221–223, 225–228,
1104 230, 233, 234, 319–322, 324–
DNA Research, 819, 820 327, 329, 333, 340, 345–347,
Dorset, 940, 941 349–351, 355, 356, 361, 362,
1127
INDEX
371, 406, 407, 474, 475, 480– 352, 353, 355, 358–360, 363–
482, 484, 511, 515–517, 520, 373, 377, 380–383, 388–390,
523, 524, 527, 530–532, 540, 394, 399, 402–404, 406–409,
543–546, 548, 549, 551, 552, 412, 416, 419–421, 427, 431,
563, 597, 598, 602, 606, 610, 434, 435, 437, 438, 440, 442,
611, 613, 615, 617, 623–625, 444, 446, 449, 450, 452, 460,
628, 632, 636, 642, 652, 654, 462–474, 483, 500, 507, 509,
659, 721, 729, 730, 732, 735, 512, 518, 522, 525, 545, 550,
736, 738, 752, 754, 755, 757– 554–556, 558–560, 563, 566,
763, 765–778, 994, 1005 568–572, 581, 587, 588, 590–
Embolization, 98, 379, 568 595, 599, 603, 628, 637, 640,
Embryo Transfer, 1030, 1103– 646, 663, 669, 673, 682, 688,
1106, 1108 696, 699, 700, 707, 720, 721,
Embryonic Stem Cells, 452, 1021, 726, 728, 731, 734, 738, 745,
1023, 1029, 1030, 1034, 1094 749–751, 779–781, 783, 788,
Emergency Treatment, 872 789, 792, 799, 802, 804, 808,
Emerging Technologies, 3 811, 814, 815, 820–822, 825,
Endocrinology, 962, 1092, 1109, 826, 832, 844, 863, 864, 873,
1115 886, 889, 901, 923, 943, 961,
Endodontics, 402, 739 974, 978, 995, 998, 1002, 1008,
Endothelial Cells, 59, 305, 404, 1015, 1025, 1085
644, 694, 751, 831, 1047, 1050, Enshi, 482, 483
1057, 1058, 1062, 1070 Enzymes and Coenzymes, 181
Energy, 17, 32, 42, 90, 100, 105, Epalinges, 213, 214
113, 115, 116, 119, 142, 143, Epilepsy, 528, 717, 958
196, 202, 203, 206, 211, 224, Epithelial Cells, 53, 503, 650, 795,
238, 249, 269, 301, 302, 366, 1056
369, 386, 402, 403, 426, 427, Erlangen, 317, 318, 662, 663
441, 465, 466, 469, 470, 474, Essen, 338, 339, 1081, 1082
489, 491, 493, 511, 518, 570, Europe, 573, 699, 790, 832, 930,
591, 614, 615, 619, 620, 634, 931, 1042, 1109
655, 657, 666, 829, 922, 960, Eustachian Tube, 779
973, 990, 1079 Evanston, 479, 753, 808, 809
Engineering, 6, 42, 47, 51, 54– Extracorporeal Membrane Oxy-
56, 58, 62, 64, 65, 68, 69, 72, genation, 618
73, 75, 78, 79, 81, 82, 86–88, Eye Diseases and Conditions,
92, 95–97, 100, 106, 110, 114, 1000
117–119, 121, 136, 145, 150,
158, 166, 173, 177, 178, 180, Farmington, 274, 440, 441
181, 184–188, 196, 200, 201, Femoral Fracture, 472
206, 207, 211, 215, 220, 224, Ferrara, 952
227, 229, 243, 244, 262, 287, Finland, 539, 540, 678, 934, 935,
289, 292, 309, 317, 318, 320, 1076, 1077
323, 328, 331, 332, 334–336, Florence, 211, 608, 609, 690, 691
338, 339, 341, 343, 344, 348, Florianopolis, 324, 325, 493, 494
1128
INDEX
Florida, 182, 263, 345, 346, 525, 914, 933, 992, 993, 1006, 1008,
542, 543, 573, 646, 647, 719, 1009, 1021, 1022, 1037, 1038,
720, 772, 819, 820, 831, 832, 1057–1062, 1064, 1065, 1069,
957, 958 1070, 1081, 1082, 1085, 1086
Fluorescein, 43, 71, 129, 662, 1086 Ghent, 84, 101, 389, 390, 436, 437,
Foggia, 714, 715 640, 641, 934
Fort Worth, 238, 239 Gimhae, 47, 965
Framingham, 931, 932 Girona, 956, 957
France, 39, 40, 77, 78, 81, 82, 126, Glasgow, 470, 471, 553, 647, 648
139, 140, 159, 223, 224, 264, Glaucoma, 294, 762, 773
265, 337, 338, 414, 415, 423, Glioblastoma, 132, 851
424, 437, 438, 444, 445, 454, Glioblastomas, 279, 841
496, 497, 502, 503, 581, 583, Glioma, 74
584, 586, 587, 598, 599, 638, Glomerulosclerosis, 924
643, 655, 658, 659, 710, 715, Glostrup, 805
791, 829, 830, 897, 917–920, Glutamine, 271, 279
958, 959 Godollo, 1029, 1030, 1034
Frederiksberg, 1023, 1024 Goiania, 708
Freiburg, 822, 1006 Gold Nanoparticles, 40, 41, 589,
Fujian, 185, 186, 554, 804 685
Fukuoka, 949 Golden, 67, 68
Fuzzy Logic, 326, 327, 534 Goteborg, 445, 446
Gothenburg, 189, 190
Gainesville, 345, 346, 525, 646, Gottingen, 56, 424, 425, 622, 623
647, 719, 720, 772, 831, 832 Granulocytes, 973
Gangwon Do, 113, 654 Greater Noida, 406, 407
Garching, 842, 843 Greece, 1, 2, 69, 70, 104, 105, 133,
Gastroenterology, 38, 550, 585, 134, 330, 331, 430, 431, 463,
753, 889, 991, 1049, 1061, 1062 464, 510, 720, 721, 796, 797,
Gene Therapy, 1008, 1009 886, 929, 930, 974, 975, 985,
Genetic Programming, 758, 902 986, 999, 1013–1016
Genetics, 192, 231, 1027, 1028 Grenoble, 919, 920
Georgia, 44, 45, 103, 599, 600, 639, Groningen, 469, 470, 593
640 Guaiacol, 714
Germany, 52, 56, 96, 97, 156, Guaifenesin, 714
157, 195, 199, 268, 297, 310, Guangdong, 14, 70, 71, 203, 251,
311, 317, 318, 336–339, 354, 252, 1063, 1064
355, 399, 417, 418, 424, 425, Guangzhou, 14, 203, 252, 1052,
428–430, 480–482, 511, 512, 1053, 1064
516, 517, 529, 530, 537, 538, Guelph, 814, 989, 990
558, 559, 561, 562, 587, 588, Guimaraes, 427
615, 622, 623, 662, 663, 685, Gyeonggi Do, 910, 960, 961
686, 722, 736, 737, 778, 786, Gyeongnam, 964, 965
787, 791, 822, 842, 843, 857, Gynecology, 784, 1108, 1118
858, 863, 864, 902, 903, 913, Gyunggi Do, 36, 37
1129
INDEX
1130
INDEX
Illinois, 26–28, 249, 262, 333, 346, Irvine, 58–60, 126, 127, 134, 164,
392, 471, 472, 479, 610, 753, 165, 208, 209, 256–259, 294,
767, 808, 1050 295, 699, 700
Imaging Technology, 134, 742, 903 Ischemia, 46, 304–306, 746, 926,
Immune System Diseases and 1020
Conditions, 1003 Islamabad, 947, 948
Immunofluorescence, 455, 488, Israel, 5, 285, 286, 304, 305, 381,
1022, 1061, 1074, 1087 382, 642, 643, 718, 719, 794,
Immunology, 101, 510, 973, 981, 968, 981, 982
1001, 1024, 1075, 1076 Istanbul, 229, 451, 570, 805, 806,
India, 15, 82, 83, 89, 90, 161, 188, 915
189, 241, 272, 273, 286, 287, Italy, 33, 41, 42, 121, 147, 211,
403, 404, 406, 407, 455–457, 217–220, 408, 409, 425, 426,
476, 478, 573–575, 773, 795, 511, 548, 549, 552, 553, 608,
796, 834, 835, 996, 997, 1022, 609, 614, 656, 657, 690, 691,
1023, 1110, 1111, 1118, 1119 693, 694, 701, 714, 715, 777,
Indiana, 16, 177, 242, 289, 509, 798–802, 837, 838, 850–852,
762, 763, 865 880, 881, 895, 896, 906, 907,
Indianapolis, 16, 242, 509, 762, 952, 971, 972, 976, 977, 987,
763, 865, 866 1031, 1032, 1053–1055, 1078,
Indocyanine Green, 58, 136, 156, 1080, 1081, 1101, 1103
158, 599, 786, 787 Ithaca, 68, 69, 191, 374, 446, 447,
Inflammation, 61, 170, 171, 267, 665, 666, 724, 743, 744, 758,
281, 466, 516, 581, 925, 966, 759, 818, 819
1023, 1024, 1057, 1061, 1093
Information Technology, 749, 750, Japan, 120, 176, 177, 179, 180,
773, 849, 866, 875, 880, 883, 184, 231, 292, 393, 394, 401,
884, 892, 1003 402, 480, 521, 522, 565, 582,
Innsbruck, 556 583, 585, 586, 655, 680, 783,
Interstitial Cells of Cajal, 1088 784, 789, 790, 911, 948, 949,
Intravascular, 230, 236, 237, 255, 971–973, 991, 992, 996, 1016–
256, 258, 266, 267, 367, 521, 1018, 1030–1032, 1117, 1118
923 Jena, 736, 737
Inverse Kinematics, 624, 625, 775 Jerusalem, 286, 642, 643
Iowa, 212, 213, 526 Jhongli, 513, 514
Iowa City, 212, 213, 526 Jiangsu, 231, 335, 336
Iraklion, 985, 986 Jinan, 232, 369, 564, 565, 1091,
Iran, 7, 326, 327, 421, 500, 501, 1092
569, 592, 714 Joint Diseases and Conditions,
Ireland, 21, 214, 215, 227, 228, 581
790, 810, 811, 887, 888, 897– Jordan, 94, 95
902, 904, 906–921, 928–945, Juelich, 310, 311
950–957, 975–979, 985–987,
989, 990, 999, 1010–1012 Kaifeng, 563, 564
Kansas, 165, 166, 452, 729, 730
1131
INDEX
1132
INDEX
495, 496, 524, 525, 815, 859, 643, 728, 754, 784, 845, 848,
860, 1000, 1001 876, 877, 881, 900, 994, 997,
Louisiana, 71 1000, 1088
Louisville, 625, 626 Massachusetts, 5, 18, 36, 45, 46,
Louvain, 576, 596, 597 103, 104, 196–201, 245, 277,
Lowell, 505, 506 282, 284, 285, 302, 303, 328–
Lubeck, 863, 864 330, 358, 362, 363, 365, 366,
Lund, 174, 175, 361, 362 404, 405, 410, 416, 448, 449,
Lung Cancer, 455, 456, 818, 819 505, 506, 600, 641, 656, 667,
Lung Neoplasms, 819 691, 725, 744, 761, 764, 816,
Luton, 900 824, 825, 849, 855, 856, 875,
Lymph Nodes, 541, 612 931, 961, 966–968, 988, 1056
Lymphocytes, 1004, 1055, 1061, Mathematical Theories, 325
1080, 1110 Mathematics, 54, 639, 640, 645,
Lysine, 1028 903, 941–944, 956, 987, 989,
999
Machine Learning, 153, 494, 548, Medford, 277, 988
570, 717, 718, 845, 852, 854, Medical Devices, 29, 315, 320, 427,
909, 990 801, 863, 905, 946, 960, 968,
Machine Vision, 798, 902 970, 981
Madison, 9, 98, 632, 633, 955 Medical Engineering and Physics,
Madrid, 439 41, 77, 78, 117–119, 185, 365–
Magnetic Resonance, 17, 22, 27, 372, 462–465, 467–470, 472,
58, 65, 98, 115, 120, 137, 140, 473, 555, 556, 558, 559, 571,
148, 174, 188, 277, 283, 293, 587, 588, 590–593, 595, 645,
314, 320, 337, 362, 387, 388, 780–783, 788
429, 444, 458, 464, 519, 522, Melanomas, 649
524, 525, 554, 613, 616, 630, Melbourne, 28, 29, 504, 505, 658,
642, 689, 707, 716, 720, 743, 737, 738, 897, 898, 938, 939,
770, 778, 817, 818, 832, 836, 965, 966
838, 912, 931, 965, 1005, 1090 Membrane Proteins, 744, 1084
Maharashtra, 272, 273 Menlo Park, 202
Mainz, 199, 857, 858, 913, 914 Menopause, 1109, 1110
Malaga, 1043 Mental Health, 35, 546, 547, 869
Malaysia, 467, 468 Mergers and Acquisitions, 661
Malta, 363 Mesotheliomas, 1097
Manchester, 76, 77, 216, 217, 278 Metabolism, 50, 167, 202, 240,
Manhattan, 729, 730 279, 296, 303, 304, 387, 390,
Manitoba, 1069 391, 409, 508, 575, 727, 827,
Mansoura, 170, 171 828, 960, 1002, 1017, 1071,
Marburg, 52 1072, 1074, 1079
Maribor, 347 Methylene Blue, 505, 611, 671
Marseille, 414, 437, 438, 444, 445 Miami, 182, 263, 573, 957, 958
Maryland, 19, 20, 49, 74, 140, 142,
298, 376, 377, 595, 603, 604,
1133
INDEX
Michigan, 146, 239, 240, 275, 383, Munich, 481, 482, 615, 843, 1064,
527, 528, 579, 580, 635, 780, 1065, 1085, 1086
925, 1078, 1083, 1084 Muscle Cells, 404, 519, 1068,
Microcirculation, 72, 235, 236, 1088, 1089
308, 309, 378, 487, 549, 957 Musculoskeletal Diseases and
Middlesbrough, 379, 380 Conditions, 975
Midlothian, 484, 602, 918, 919 Myeloid Cells, 925, 972
Milan, 147, 614, 656, 657, 798– Myocardial Infarction, 337, 367,
800, 837, 838, 852, 880, 881 931, 1052, 1053, 1064, 1086,
Milano, 800, 838, 852, 971 1090, 1094
Milwaukee, 366, 378, 379, 746, Mysore, 1118, 1119
747, 862, 863, 921 Myxoma Virus, 504, 505
Minneapolis, 114, 115, 148, 237,
238, 528, 529, 738, 869, 870 Naive Bayes Classifier, 717, 852
Minnesota, 48, 78, 114, 115, 148, Nakhon Ratchasima, 1026, 1027
237, 238, 528, 529, 605, 738, Nancy, 581, 587, 710
825, 869, 980 Nanjing, 231, 336, 454, 455, 705,
Mississippi, 449 706
Mississippi State, 449, 450 Nanoparticle, 93
Missouri, 66, 73, 156, 168, 169, Nanoparticles, 93, 252, 589, 811
268, 301, 302, 357, 364, 367, Nanorod, 669
432, 444, 484, 485, 501, 502, Nanorods, 70, 71, 261, 267, 669,
581, 582, 612, 626, 627, 633– 685, 686
635, 649–651, 660, 661, 742, Nanoscale, 68, 262, 650, 743, 744
743, 782, 816, 896, 926, 927, Nanotechnology, 69, 457, 650, 698,
970, 1098 801
Mitochondria, 837, 838, 1035, Nantes, 583, 584
1036, 1081 Nantou, 385, 386
Miyagi, 521, 522 Naples, 217, 218
Modena, 971, 972 Nara, 1030, 1031
Molecular Medicine, 1036–1039, Nashville, 167, 226, 227, 300, 301,
1046, 1062–1066, 1074, 1084, 356, 432, 751, 868, 869, 924
1086, 1089, 1098, 1099, 1111 Natural Language Processing,
Montreal, 236, 237, 283, 348, 474, 854, 856, 867, 868, 870
475, 559, 560, 664, 665, 689, Navi Mumbai, 1110, 1111
765, 766, 826, 827, 944, 1105, Nebraska, 62, 63, 100, 110
1107 Neoplasia, 155
Monza, 1101, 1103 Neoplasms, 4, 819
Morgantown, 433, 434, 591 Nephrology, 400, 924
Moscow, 244, 245, 668 Nervous System Diseases and
Mountain Pleasant, 239 Conditions, 498
Movement Disorders, 778 Netherlands, 2, 43, 44, 85, 86, 116,
Msida, 363 117, 155, 157, 158, 293, 373,
Mucins, 1076 386, 462, 463, 469, 470, 520,
521, 576–578, 580, 582, 583,
1134
INDEX
585, 586, 588, 593, 653, 688, 666, 681, 696, 698, 712, 724,
713, 802, 803, 805, 810, 812, 727, 731, 743, 744, 746, 748,
820, 822, 847, 848, 858, 859, 751, 758, 801, 802, 808, 815,
871, 888, 889, 984, 985, 1062, 818, 820, 821, 836, 837, 846,
1063, 1065, 1066, 1090, 1091 847, 853, 884, 885, 892, 981,
Networks, 18, 55, 56, 59, 60, 156, 1084, 1098, 1099
184, 218, 221, 225, 227, 385, New York City, 136, 230, 284, 436,
405, 433, 434, 520, 545, 644, 453, 836, 846, 884, 892
776, 777, 796, 797, 950, 979, New Zealand, 92, 127, 128, 162,
1009, 1093 263, 264, 312–314
Neural Networks, 344, 947 Newark, 187, 188, 359, 360, 545,
Neurodegenerative Diseases, 1096 546, 995
Neuroengineering, 56, 129, 150, Nicosia, 192, 193, 544, 545
383, 448, 573, 700, 756, 784, Niigata, 972, 973
790, 832 Nijmegen, 462, 463, 802, 803
Neurofibromatosis, 1076 Nizhny Novgorod, 280
Neuroimaging, 18, 383, 399, 652 Noida, 996, 997
Neurology, 192, 483, 710, 840, 980 North Carolina, 83, 193, 391, 392,
Neurons, 18, 34, 68, 69, 181, 220, 409, 434, 538, 726, 807, 808
345, 450, 483, 518, 542, 659, North Ryde, 547
745, 751, 797, 925, 926, 1013, Norway, 51, 253, 254, 388, 389,
1016, 1055, 1059, 1060, 1084 551, 941, 1009, 1010
Neuroscience, 56, 202, 307, 310, Nottingham, 986, 987
311, 824, 1096 Novi Sad, 1006, 1007
New Delhi, 476 Novosibirsk, 785, 786
New Hampshire, 138, 334, 707, Numerical Analysis, 325, 467, 625,
1058 966
New Haven, 386, 387, 435, 441, Numerical Modeling, 6, 640, 961
442, 1038, 1039
New Jersey, 359, 360, 395, 450, Obsessive-Compulsive Disorder,
670, 788, 789, 872, 995, 1116 951
New Mexico, 627, 878, 879 Obsessive-Compulsive Disorders,
New Orleans, 71, 72 951
New York, 9, 30, 41, 47, 48, 54, Obstetrics, 784, 1108, 1118
55, 62, 64, 67–69, 72, 75, 76, Ohio, 30, 99, 124, 158, 159, 269,
80, 83, 85, 91, 93, 94, 98, 99, 296, 416, 417, 439, 486, 543,
121, 125, 136, 140, 149, 151, 645, 694, 695, 779, 833, 1049,
152, 173, 176, 177, 179, 180, 1050
183, 184, 190–192, 194, 220, Oklahoma, 218, 219, 259, 260,
230, 231, 236, 265, 284, 316, 619, 683, 684, 886
330, 342, 357, 374, 404, 406, Olomouc, 288, 806, 914, 915
408, 409, 418–420, 423, 434, Omaha, 62, 63, 100, 869
436, 440, 446, 450, 451, 453, Oncology, 74, 132, 455, 687, 719,
454, 461, 568, 569, 578, 601, 927, 1078
607, 611, 626, 633, 659, 664–
1135
INDEX
Ontario, 65, 102, 431, 474, 594, 811, 835, 840, 841, 904, 958,
731, 750, 990 964, 982, 998, 1017
Ophthalmology, 269, 384, 529, Pain Medicine, 949
533, 700 Pakistan, 947, 948
Oporto, 348, 349, 629, 630 Palermo, 1078
Optical Coherence Tomography, Palo Alto, 854, 855, 1103, 1104
45, 46, 60, 61, 155, 165, 236– Pamplona, 514, 515, 768
238, 252, 260, 274, 280, 299, Pancreas, 660, 1061, 1085
520, 521, 537, 538, 542, 544, Papulosquamous Skin Diseases,
545, 589, 608, 627, 665, 680, 642
728, 729, 808, 809 Paraffin, 983
Optical Technology, 650 Paris, 81, 82, 264, 265, 337, 338,
Oral Administration, 89, 315, 477, 445, 454, 502, 503, 598, 599,
478, 564, 705, 708, 709, 1017 638, 643, 655, 658, 659, 715
Oral Cancers, 272 Parkinsonism, 1080
Orange, 268, 275, 644, 968, 969 Parkinson’s Disease, 7, 23, 553,
Oregon, 132, 250, 332, 644, 645, 778, 1059
669, 809, 810 Parkville, 657, 658
Organ Transplants, 959 Parma, 33, 552, 553
Orlando, 542, 543 Particle Swarm Optimization,
Orthopedics, 288, 306 153, 718
Orumiyeh, 714 Pathology, 156, 164, 259, 280, 281,
Osaka, 176, 177, 184, 480, 655 299, 436, 449, 458, 480, 481,
Oslo, 51, 388, 389, 551 531, 547, 552, 647, 658, 796,
Ottawa, 774 812, 825, 904, 905, 950, 1036,
Oxford, 2, 5, 7, 8, 29, 81, 82, 86, 87, 1046, 1059, 1063, 1075–1077,
92, 95–97, 100, 189, 190, 195, 1084
196, 200, 201, 203, 204, 207, Patras, 974, 975, 1015, 1016
211, 215, 218, 220, 221, 224, Pavia, 777, 976
228, 229, 232, 317, 323, 328, Pediatrics, 316, 779, 972, 1000,
331, 341, 344, 348, 353, 355, 1001, 1101
359–361, 489–496, 507, 509, Pennsylvania, 6, 79, 80, 111, 116,
512, 522, 567, 568, 663, 688, 185, 298, 299, 457, 458, 628,
706, 710–713, 716–719, 785, 650, 698, 704, 817, 894, 923,
793, 797, 798, 802, 804, 811, 924, 1020
814, 821, 955, 956 People’s Republic of China, 5, 13,
14, 22, 46, 70, 88, 115, 116, 130,
Padova, 41, 42 131, 135, 153, 154, 171, 178,
Pain, 6, 7, 9, 66, 76, 100, 154, 276– 185, 203–206, 228, 229, 231,
279, 306, 307, 309, 362, 363, 232, 235, 236, 251, 252, 303,
387, 401, 413, 434, 444, 466, 304, 311, 312, 314, 315, 322–
467, 493, 495, 546, 553, 554, 324, 331, 335, 358, 369, 394,
652, 654, 659, 686, 689, 716, 405, 454, 477, 482, 487, 488,
752, 778, 796, 798, 799, 806, 506–508, 513, 515, 516, 533,
534, 536, 540, 541, 554, 563,
1136
INDEX
564, 577, 602, 616, 617, 636, 437, 462–466, 468–472, 474,
671–673, 686, 692, 705, 706, 507, 509, 512, 513, 522, 530,
709, 723, 757, 758, 797, 798, 542, 553, 555, 556, 558–560,
803, 804, 823, 827, 828, 893, 568, 570–572, 577, 587, 588,
899, 916, 928, 929, 932, 933, 590–595, 640, 646, 663, 674,
943, 954, 977, 978, 983, 984, 678, 687, 688, 690, 702, 723,
1024, 1027, 1028, 1035–1037, 759, 779–781, 783, 789, 795,
1040, 1047, 1052, 1060, 1063, 796, 799, 801, 802, 804, 811,
1064, 1066, 1067, 1072, 1079, 814, 821, 822, 975, 1016
1089–1093, 1107 Pisa, 121, 219, 220, 548, 549, 693,
Peptide Proteins, 585 694, 701, 801, 802
Peptides, 93, 453, 466, 504, 637, Piscataway, 11–13, 15–23, 25, 26,
638, 922, 1081 28–38, 40, 122–124, 126, 128,
Peptides and Proteins, 1096 130–133, 135, 137–139, 141–
Perceptron, 56, 841, 936 145, 147, 148, 153, 154, 159,
Perfusion, 156, 157, 247, 276, 339, 162, 166, 189, 193, 197–199,
342, 351, 352, 377, 458, 585, 205, 206, 209, 210, 213–215,
586, 604, 720, 918, 919, 1020, 219, 222, 223, 225–228, 230,
1062 233, 234, 319, 321, 322, 324,
Pericytes, 404, 831 325, 327, 329, 333, 340, 345–
Perugia, 895, 896 347, 349–351, 355, 356, 361,
Pharmaceuticals, 574 362, 450, 451, 474, 475, 480–
Pharmacodynamics, 574 482, 484, 511, 515–517, 520,
Pharmacogenomics, 854, 874, 876, 523, 524, 527, 530–532, 540,
1042 543–545, 548, 549, 551, 552,
Pharmacokinetics, 311, 337, 390, 597, 598, 602, 606, 610, 611,
391, 417, 478, 564, 575, 705, 613, 615, 617, 623–625, 628,
987 632, 636, 642, 652, 654, 659,
Pharmacology, 109, 179, 337, 529, 730, 732, 735, 736, 738, 752,
966, 1042, 1051 754, 755, 757–763, 765–778,
Philadelphia, 6, 457, 458, 628, 788, 789, 872, 873
698, 699, 817, 818, 1020 Pittsburgh, 111, 116, 117, 185,
Phoenix, 325, 326 298, 299, 650, 651, 704, 705,
Phosphoric Diester Hydrolases, 894, 923, 924
1016 Pocatello, 717, 912, 913
Photocoagulation, 895 Poland, 112, 113, 316, 317, 679,
Photodynamic Therapy, 42, 43, 741, 781, 787, 788, 942, 993,
265, 266, 418, 419, 653, 981 994, 1004, 1005
Physics, 42, 78, 79, 81, 82, 86, 87, Polymerase, 466, 747, 963, 983,
92, 95–97, 100, 117–119, 185, 1018, 1019
186, 196, 197, 200, 201, 206, Polynomial, 758, 759, 777
207, 211, 215, 220, 224, 229, Porsgrunn, 253, 254
230, 317, 318, 323, 328, 331, Portland, 132, 250, 332, 644, 645,
341, 344, 348, 352, 353, 355, 669, 670
359, 365–372, 377, 389, 406,
1137
INDEX
1138
INDEX
Rostock, 428, 529, 530, 778, 1061, 839, 847, 849, 850, 852, 854,
1062 856–863, 884, 885, 893, 922–
Rotterdam, 520, 521, 653, 871, 926, 957, 963, 965, 972, 979,
888, 889 980, 983, 984, 988, 996, 997,
Rouen, 159 1004, 1005, 1007, 1008, 1018–
Russia, 244, 245, 280, 668, 785, 1021, 1025, 1027, 1031–1033,
786 1038, 1047, 1049, 1056, 1057,
1059, 1064, 1069, 1085, 1086,
Sacramento, 60, 61 1096, 1098, 1101, 1105, 1110,
Sagamihara, 1018 1118
Saitama, 401, 402 Scoliosis, 679, 927, 928, 975
Salmonella, 579 Seattle, 149, 150, 487, 755, 756,
Salt Lake City, 271, 272, 867, 868 843, 844, 861, 862
Salta, 107, 108 Sendai, 522, 565
San Antonio, 251, 373 Seoul, 17, 66, 67, 84, 85, 123, 145,
San Francisco, 791, 830, 831, 967 195, 196, 475, 710, 711, 727,
San Martin, 8 748, 749, 1011, 1012, 1025,
Santa Cruz, 734, 735, 775 1026
Santiago, 945 Serbia, 927, 928, 1006, 1007
Santo Andre, 240, 241 Seville, 221, 222
Sao Carlos, 702 Shanghai, 178, 179, 203, 204, 314,
Sao Paulo, 350, 351, 402, 403, 420, 315, 515, 516, 536, 899, 1035–
631, 632, 637, 638, 702 1037, 1047, 1048, 1066, 1067,
Sapporo, 991, 992 1072, 1073, 1092, 1093
Saskatchewan, 351, 352 Sheffield, 722, 723, 860, 861
Saskatoon, 351, 352 Shenyang, 88, 89, 394, 797, 798
Saudi Arabia, 270, 271, 718 Sherbrooke, 12, 920, 921
Science, 7, 13, 34, 46, 47, 61, 67, Shiga, 1117, 1118
68, 71–73, 101, 114, 131, 132, Shiraz, 500, 501, 592
135, 143, 153, 154, 169–171, Siena, 977, 1055, 1080, 1081
173, 181–183, 233, 235, 241, Sign Language, 340
250, 262, 271, 273–275, 286, Signal Processing, 1, 2, 5, 7, 8, 61,
302–305, 307, 314, 320, 322, 158, 169, 188–190, 195, 203,
323, 326, 336, 358, 359, 389, 204, 218, 221, 228, 232, 489–
400, 401, 403, 404, 419, 420, 496, 706, 710–713, 716–719,
432, 434, 436–440, 442–444, 785, 793, 797, 798, 964, 999
448, 456, 467, 471, 488, 492, Silicon, 124, 191, 292, 371, 377,
499, 500, 503–505, 514, 519, 385, 386, 423, 483, 647, 648,
535, 537, 539, 541–543, 545, 654, 732
566, 568, 573, 582, 584, 595, Silver Nitrate, 40, 41
603, 637–639, 642, 644–647, Simian Immunodeficiency Virus,
651, 673, 676, 677, 681–687, 1021, 1022
699, 703, 743, 745–748, 757, Singapore, 10, 246, 247, 276, 290,
758, 774, 776, 784, 790, 794– 291, 421, 422, 557, 558, 580,
796, 817, 819, 820, 823, 833–
1139
INDEX
1140
INDEX
1141
INDEX
1142
INDEX
405, 408, 410, 411, 416, 417, Vancouver, 207, 208, 281, 305,
419, 432–436, 440–442, 444, 306, 340, 472
447, 449–454, 458, 459, 472, Vandoeuvre les Nancy, 415, 586
479, 485–487, 490, 496, 502, Vascular Diseases, 129, 1068
506, 509, 518, 520, 525, 526, Veldhoven, 688
528, 529, 539, 543, 544, 546, Vena Cava, 355, 817, 818
550, 566, 569, 573, 579, 580, Venezuela, 372, 373
582, 591, 596, 600, 601, 604, Verona, 987
605, 611, 612, 619–621, 626– Veterinarian, 936
628, 633–636, 640, 642, 644– Veterinary, 509, 794, 935, 945,
647, 650–652, 656, 660, 661, 1024–1026, 1029
666, 667, 670, 671, 681, 684, Victoria, 737, 738, 894, 966
685, 692, 695–697, 699–701, Video Game, 706
705–707, 712, 717, 720, 724– Vienna, 835, 836, 864, 865, 1096,
726, 729, 730, 733–736, 738, 1097, 1114, 1115
740, 742–745, 747, 750, 751, Vimentin, 1037, 1087
753, 755–757, 759, 762, 763, Viral Load, 545
765, 767, 768, 772, 775, 776, Virginia, 150–152, 180, 181, 183,
779, 780, 783, 784, 789, 791, 385, 407, 408, 925
795, 808–810, 813, 815–820, Virology, 545, 1019
825, 826, 829, 831, 832, 834, Virus, 8, 131, 545, 638, 639, 865,
837, 844, 846, 847, 849, 850, 997, 1008, 1009, 1021, 1097
854–857, 860, 862, 863, 866– Volos, 430, 431
870, 873–879, 882–885, 887, Vomiting, 1114
890, 892, 894, 896, 901, 905,
913, 921, 924–927, 932, 947, Warsaw, 113, 679, 741, 787, 788,
955, 958, 962, 967–970, 980, 993, 994
981, 988, 995, 998, 1000, 1001, Warszawa, 112, 113
1020, 1033, 1039, 1050, 1051, Washington, 66, 73, 149, 168, 169,
1056, 1059, 1075, 1083–1085, 269, 301, 302, 357, 364, 365,
1089, 1095, 1098, 1099, 1104, 433, 444, 484, 485, 487, 566,
1105, 1112, 1117 633–635, 651, 652, 660, 661,
University Park, 79, 80 740, 742, 743, 755, 756, 816,
Urbana, 27, 28, 262, 346 843, 861, 862, 883, 884, 927,
Urea, 809, 810 1098, 1099, 1104, 1105
Urease, 1018 Waterford, 227, 228
Urinary Tract, 1036, 1067, 1068 Waterloo, 119, 473, 474
Urticaria, 1003, 1004 Wave Propagation, 95, 110, 260,
Utah, 271, 681, 867, 868 503, 633, 825, 826
Utrecht, 293, 713, 1090, 1091 Wellesley, 875
Uxbridge, 1010, 1011 Wenzhou, 533, 928, 929, 1060,
1061
Valencia, 739, 839, 840, 879, 880, West Lafayette, 177, 178, 289
962, 963, 1073, 1074 West Roxbury, 1056
West Virginia, 433, 434, 591
1143
INDEX
Yamagata, 680
Yangling, 1028, 1029
Yongin, 37, 412
1144
ISBN 978-1-490-10871-1
9 781490 108711